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The current thesis examined cognitive trajectories following stroke, and tested potential 
predictors of cognitive outcome, and trajectories. It used data from two existing 
databases: the Birmingham Cognitive Screen Study (BUCS) collected in the UK, and 
the C-BCoS collected in China, and newly collected data as part of the HiPPS-CI study 
(The role of Hippocampus Pathology in Post-Stroke-Cognitive Impairment). Chapter 
two aimed to answer the question; does the proportional recovery rule exist in 
cognition, as it does with motor recovery? We found that 80% of patients showed 40-
50% proportional recovery of cognition at nine months post-stroke. This was evident 
across and within cognitive domains. Recovery was not limited to the first three months 
following stroke. We further identified two other recovery trajectories, where around 
10% of patients showed an accelerated recovery, while around 10% showed decelerated 
recovery and even decline. We then investigated the predictive value of years of 
education on post-stroke cognitive outcomes, and recovery rate (Chapter three). We 
found that education improved cognitive outcomes following stroke, and accelerated 
recovery in the first year following stroke beyond age. Finally, we explored the 
predictive value of hippocampal pathology, and the impact of hippocampal pathology 
on post-stroke cognition. We found that beyond stroke and age, hippocampal pathology 
predicted cognition within three months post-stroke. This was evident in grey matter 
volume, mean diffusivity, creatine, choline and N-acetylaspartate. Hippocampus 
pathology (specifically grey matter volume) interacted with education, age, vascular 
risk, cortical atrophy and small vessel disease. These factors also predicted cognition. It 
is concluded that post-stroke cognitive outcomes are affected by pre-stroke clinical, and 
socio-demographic factors, where education ameliorates the impact of stroke on 
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cognition potentially by preserving the hippocampus, while neurovascular health 
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1.1.1 Aim of thesis 
The aim of this thesis is to investigate neuropathological, and cognitive predictors of 
post-stroke cognitive trajectory. In this thesis, post-stroke cognition was examined by 
investigating cognitive profiles and trajectories of recovery.  Using profiles of post-
stroke cognition, this thesis first describes cognitive trajectories following stroke, then 
predictors of cognitive outcomes, and trajectories are examined. These predictors 
include social, demographic, stroke profile, vascular health, and neuropathology.  
1.1.2 Background to stroke 
Stroke is ranked the second leading cause of death worldwide (Lopez et al., 2006). In 
total, there are 1.2 million stroke survivors living in the UK, and a further 100,000 
strokes occurring per year, with 950,000 stroke survivors in the UK aged 45 and over 
(ISD Scotland, 2017; Royal College of Physicians, 2016). The World Health 
Organisation term ‘stroke’ as a ‘rapidly developing clinical signs of focal or global 
disturbance of cerebral function, lasting more than 24 hours, or leading to death, with no 
apparent cause other than that of vascular origin’ (Aho et al., 1980). Around 85% of 
strokes are ischemic, which are caused by a blockage/blood clot in an artery leading to 
the brain, or within the vessels deep inside the brain (Intercollegiate Stroke Working 
Party, 2016). This disruption to the blood flow causes changes in blood flow, oedema, 
metabolisms, inflammation and diaschisis (Murphy & Corbett, 2009). Haemorrhagic 
stroke accounts for the remaining 15% of stroke incidence Haemorrhagic stroke is 
caused when a blood vessel bursts which causes bleeding in the brain, often in 
haemorrhagic stroke outcomes are more severe, and the risk of dying within three 
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months of stroke is elevated, when compared with ischemic stroke (Bhalla et al., 2013). 
In some cases, ischemic stroke can lead to haemorrhagic transformation.  
Stroke causes lesions to be formed in the area of the brain that lost blood supply during 
the ischemic event. Lesions can be formed either the left, right hemisphere, or 
bilaterally, depending on the side of the artery that was blocked during the stroke. 
Although it is the second leading cause of death, innovative treatments such as 
thrombolysis and thrombectomy (Macrae & Allan, 2018), are increasing the number of 
people that survive ischemic stroke (Feigin et al., 2014), which is approximately 85% 
(Donkor, 2018). With an increase in survival rates, post-stroke cognitive outcomes, and 
trajectory are an important factor to be investigated in detail.  
1.1.2.1 Socioeconomic impact of stroke 
The impact of stroke on the individual, and subsequent loss of function depends on the 
stroke severity, lesion size and the brain region that was affected. The effects of the 
stroke can include fatigue, emotional changes, physical impairments, communication 
problems and cognitive impairment (Stroke Association, 2018). This can have a 
devastating impact on the individual, those around them and the society as a whole.  
The cost of stroke to the UK society is approximately £25.6 billion per year, and is 
expected to rise to £43 billion by the year 2025 (Stroke Association, 2018).  
There are global differences in the incidence of stroke, with stroke understood to be a 
burden of the developed world (Donkor, 2018), however most western European 
countries witnessed a decline in stroke between 1975 and 2005 (Lopez et al., 2006). 
While in developing world an increase in the rate of stroke, is reported for Eastern 
Europe, North Asia, Central Africa and South Pacific (Lopez et al., 2006).  
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1.1.3 Risk factors of stroke 
Many factors impact the incidence of stroke. The risk factors can be divided into two 
categories; modifiable (risk factors that relate to aspects of an individual’s lifestyle, 
which can be managed and improved) and non-modifiable (risk factors out of the 
individual’s control) (O'Donnell et al., 2016; Stroke Association, 2018). Modifiable risk 
factors relate to life style, and consist of; high blood pressure, high cholesterol, diabetes 
(type 2), obesity, smoking, alcohol consumption, drug use and lack of exercise (Sacco, 
1995; Stroke Association, 2018). Other risk factors (non-modifiable) consist of, age, 
ethnicity, gender, family and individual history of heart disease, PFO (hole in heart), 
diabetes (type 1), atrial fibrillation, and genetic disposition (CADISIL) (Boehme et al., 
2017; Sacco, 1995; Stroke Association, 2018; Tan & Markus, 2016). An international 
study ‘Interstroke’ found that ten modifiable risk factors account for 90% incidence of 
stroke (O'Donnell et al., 2016), which included hypertension (high blood pressure) and 
inactivity. The risk of stroke can be assessed using rating scales, a commonly used scale 
is the Framingham Stroke Profile (Wolf et al., 1991). The risk calculation includes a 
combination of modifiable and non-modifiable risk factors (e.g. age, gender, systolic 
blood pressure, antihypertensive treatment, diabetes, cardiovascular risk, smoking, atrial 
fibrillation) (Parmar et al., 2015). 
1.2 Post-Stroke Cognition 
 
1.2.1 Cognition 
Cognition is defined as “the mental action or process of acquiring knowledge and 
understanding through thought, experience, and the senses” (Oxford Dictionary, 2019). 
Its impact on our daily function spans “information processing, mental operation, or 
intellectual activity such as thinking, reasoning, remembering, imagining, or learning” 
(Wessinger & Clapham, 2009). However, when exploring the definition of cognition, 
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we must understand, it is not a straightforward concept, due to its heterogeneous nature 
(Langhorne et al., 2011). Cognition involves multiple domains, including; attention, 
executive functioning, visuospatial ability, memory and language (Cumming et al., 
2012). Furthermore, it is suggested that these cognitive domains overlap, and are not 
independent of each other (Cumming et al., 2012).  
1.2.2 Cognitive Impairment 
Post-stroke cognitive impairment is a common consequence of stroke, with about 20% 
to 80% of individuals having cognitive impairments following stroke (Sun et al., 2014). 
The prevalence of cognitive impairment following stroke is related to many factors, one 
of which is location of stroke lesion. It has been found that cognitive impairments are 
found in 74% of stroke survivors with cortical stroke lesions, 46% with subcortical 
stroke lesions, and 43% with infratentorial stroke lesions (Nys et al., 2007). 
Additionally lesion size, and artery location (Jaillard et al., 2010) also play a role in 
determining cognitive impairments; these impact the severity of the impairment, and the 
domains that are specifically affected (Ramsey et al., 2017).  
Cognitive impairment in at least one domain is reported in about 83% of stroke patients, 
and impairment in more than three domains in up to 50% of stroke survivors (Jokinen et 
al., 2015). Commonly reported cognitive impairments following stroke include; neglect 
(attention), aphasia (language), and amnesia (memory) (Bickerton et al., 2015; Engelter 
Stefan et al., 2006; Gottesman & Hillis, 2010; Laska et al., 2001; Nys et al., 2005; 
Riddoch et al., 1995; Ringman et al., 2004; Tatemichi et al., 1994; Wade et al., 1988).  
The relationship between cognitive function and / or impairment and the brain are 
typically investigated using function- lesion mapping. Early studies were driven by a 
single patient, or small groups relying on a description of the lesion rather than 
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statistical tests (Humphreys & Price, 2001; Karnath et al., 2018). For example, it has 
been repeatedly demonstrated that language function is supported by the left 
hemisphere. A left middle cerebral artery infarction causing damage within the left 
posterior, superior temporal gyrus and inferior frontal gyrus, can cause problems with 
speech production (Broca’s aphasia) or speech comprehension (Wernicke’s aphasia) 
(Cumming et al., 2012). In the past few decades the advancement of imaging 
acquisition, voxel-based analyses studies have become more popular (Chechlacz et al., 
2018). To date, with the computational revolution, voxel-based multivariate analysis has 
replaced traditional mass univariate voxel-based analysis (e.g. (DeMarco & Turkeltaub, 
2018; Zhang et al., 2014). However, most of these analyses focus on identifying the 
association of the lesion with the cognitive deficits, ignoring other neuroanatomical 
abnormalities often observed in these stroke cohorts.  
1.2.3 Cognitive Impairment and interacting factors 
Demographic profile contributes to the prevalence of post-stroke cognitive impairments. 
Differences in cognitive outcomes have been dictated by non-modifiable factors; such 
as age, with higher rates of cognitive impairment, and worse cognitive outcomes with 
increased age (Ebrahim et al., 1985; Sun et al., 2014; Wolfe et al., 2011). Sex 
differences not only exist in contributing to stroke incidence, with age related stroke 
higher in males, and stroke incidence in general higher in females (Reeves et al., 2008), 
but also in stroke outcomes (Nys et al., 2005; Petrea et al., 2009). Different rates of 
cognitive impairment, are observed across males and females, with worse cognitive 
outcomes observed in the first six months in females (Chen et al., 2016; Petrea et al., 
2009). 
Cognitive impairment causes lower quality of life post-stroke (Cumming et al., 2014), 
and can predict level of functional outcome following stroke. Bickerton and colleagues 
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found that initial severity of cognitive impairments following stroke (at three months), 
predicted functional outcomes at nine months using the Nottingham Extended Activities 
of Daily Living. This was found beyond the impact of anxiety, depression, and apathy 
(Bickerton et al., 2015). This was specifically identified with spatial attention, 
controlled attention and praxis domains (Bickerton et al., 2015).  
Level of mood following stroke interacts with cognitive impairments, often perpetuating 
deficits. The prevalence of depression after stroke is approximately 29%, and it 
correlates with cognitive impairments (Ayerbe et al., 2018).  Though it is important to 
note the interaction between post-stroke depression and cognitive function is complex 
(Lees et al., 2012; Mukherjee et al., 2006; Quinn et al., 2018). Post-stroke depression is 
reported to affect specific cognitive domains, such as non-verbal problem solving. This 
however was found in both stroke, and non-stroke populations (Kauhanen et al., 1999), 
suggesting this type of impairment is the consequence of depression, and not only the 
cause of stroke.  
1.2.4 Methods of cognitive assessment 
To understand cognitive impairments, it is crucial to comprehensively assess individuals 
following stroke. There are two documented approaches to cognitive assessment 
following stroke; 1) assessment of the stroke survivor when there is concern about a 
specific cognitive problem, and 2) screen all stroke survivors regardless of clear 
cognitive impairments (Quinn et al., 2018). Quinn and colleagues further document the 
global differences that exist on whether we should even conduct cognitive assessments 
in stroke (Quinn et al., 2018). UK guidelines suggest ‘routine screening should be 
undertaken using standardised measures’, similarly the American Heart Association 
state ‘screening for cognitive deficits is recommended for all stroke patients before 
discharge’, in contrast, the European stroke organisation comment ‘assessment for 
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cognitive deficits appear desirable’ (Quinn et al., 2018). Given the known impact of 
cognitive impairment on functional ability, and quality of life (Cumming et al., 2014), it 
seems vital to appropriately assess cognitive impairments following stroke to enable 
appropriate rehabilitation and support (Cicerone et al., 2005).  
The UK guidelines state that all stroke patients should be screened for cognitive 
impairment. If deficits are identified, a detailed assessment should be carried out using 
valid and responsive tools before designing a treatment programme (NICE, 2013). 
Assessment, or screening of cognitive impairments can be performed by a variety of 
neuropsychological testing batteries.  In post-stroke cognitive assessments, the 
assessment tool chosen is normally due to the preference of the department or setting 
(Quinn et al., 2018), and as a result there is a lack of consistency across the UK of what 
neuropsychological assessment tool is used, and how the results are implemented. 
Commonly used cognitive assessment tools include; Mini Mental State Examination 
(MMSE) (Folstein et al., 1983) and Montreal Cognitive Assessment (MoCA) 
(Nasreddine et al., 2005), although there are many more. These neuropsychological 
assessments are used in a variety of clinical populations including stroke and dementia, 
although their initial purpose was for dementia diagnosis (Folstein et al., 1983). These 
two assessments cover the main cognitive domains of interest (memory, language, 
attention), and take about 15 minutes to administer. These test batteries are not stroke 
specific, and as a result rely upon specific cognitive faculties, for example language 
ability in order to complete a memory task (Bickerton et al., 2015). Furthermore their 
sensitivity has come into question, with the MMSE unable to detect impairments in 
single cognitive domains (Lees et al., 2014), and the MoCA although found to be 
sensitive, lacked in specificity. It has been suggested that adapting the threshold from 
<26 cut off to <22 in the MoCA would enable more accurate specificity and sensitivity 
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when assessing post-stroke cognitive impairments (Carson et al., 2018; Demeyere et al., 
2016; Lees et al., 2014). 
It is vital to correctly identify those with cognitive impairments, to ensure they get 
adequate rehabilitation and support (Langhorne et al., 2011), however it is as equally 
important that we do not overestimate cognitive impairments. A recent example of the 
overestimation of cognitive impairment was published by Swanson and colleagues, who 
found high rates of cognitive impairment in government officials, suspecting a ‘sonic 
attack’ in Cuba (Swanson et al., 2018). These findings were criticised for demonstrating 
poor neuropsychology conduct, by using high cut off scores for diagnoses of cognitive 
impairment (Cortex Editorial, 2018; Della Sala & Cubelli, 2018), which demonstrates 
the issues surrounding cut off scores. A further issues of neuropsychology assessment 
tools include, not taking into consideration the individuals baseline cognition (e.g. pre 
stroke/ pre cognitive impairment) (Elliott et al.; Elliott et al., 2019). It should be noted 
that the MMSE does not take into account education level, however the MoCA does 
moderate the overall score for those with less than 12 years education (Nasreddine et al., 
2005).   
When administering neuropsychological assessments in the stroke population, careful 
consideration of common stroke deficits should be taken. There are some commonly 
observed cognitive deficits (e.g. neglect and aphasia) that could potentially impede the 
conduct of the assessment, and also restrict assessment of some cognitive domains 
leading to patients not being appropriately assessed (Pendlebury et al., 2015). For 
example, some patients are untestable with MoCA and MMSE, due to dysphasia, 
hemiparesis and acute confusion (Pendlebury et al., 2015).  
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One common cognitive deficit following stroke is aphasia, and it can be a barrier to 
completion of cognitive assessments that involve comprehension or production of 
language (Demeyere et al., 2016). Another is neglect, where an individual has an 
inattention in one side of their visual field, it poses an obvious challenge for the patient 
to be able to complete cognitive assessments (Demeyere et al., 2016). 
Neuropsychological assessments specifically designed for stroke have been developed 
to combat these barriers, these include the Oxford Cognitive Screen and the 
Birmingham Cognitive Screen (Bickerton et al., 2015; Demeyere et al., 2015; 
Humphreys et al., 2012). Both assessments are designed to be neglect and aphasia 
friendly, enabling those with cognitive deficits to be comprehensively assessed across 
five key cognitive domains (language, memory, attention and executive function, 
number and praxis). This is done by presenting items along vertical line rather than 
horizontal line, using large fonts and uncrowded displays, or allowing force choice 
response that is presented orally and in written formats. The oxford cognitive screen 
was found to be more sensitive than the MMSE, finding higher frequency of 
impairments, specifically in those with milder strokes (Mancuso et al., 2018). Pre-
existing cognitive impairments due to neurological deficit such as previous stroke or 
dementia may also impact the rate of post-stroke cognitive impairment, and in turn 
impedes the ability of individuals to be assessed adequately and receive rehabilitation 
(Elliott et al., 2019; Kalaria & Ballard, 2001; Longley et al., 2018).  
1.2.4.1 Birmingham Cognitive Screen 
The Birmingham cognitive screen (BCoS) was validated in 2012 (Humphreys et al., 
2012). As previously mentioned this cognitive screen was specifically designed for 
stroke patients, in an era when cognitive assessments were more often than not based on 
the assessment of cognitive impairment in dementia (Folstein et al., 1983). Due to the 
22 
 
issues with assessing stroke patients documented in (1.2.4), Humphreys and colleagues 
designed a neuropsychological assessment tool, accounting for deficits in aphasia and 
neglect (Bickerton et al., 2015; Humphreys et al., 2012).  
The BCoS takes about 1- 2 hours to administer, depending on severity of impairment. It 
can be divided into two assessment sessions. It includes 23 tasks to assess five key 
cognitive domains: (a) attention and executive function, (b) language, (c) memory, (d) 
number, and (e) praxis (Humphreys et al., 2012). In brief, the attention and executive 
function domain includes five tasks that tap into visuospatial impairment, sustained 
attention and rule finding. The language domain includes six tasks: picture naming, 
sentence production reading and writing. The memory domain consists of four tasks that 
tap into long term memory (orientation), verbal episodic memory (story recall) and non-
verbal episodic memory (task recall). The number domain covers reading, writing of 
numbers and calculation (three tasks). Finally, the praxis domain (five tasks) includes 
three gesture tasks, copying complex figure and interacting with a real object 
(assembling a torch) (Massa et al., 2015). The BCoS has been adapted to other 
languages and cultures including Cantonese and Mandarin (Kong et al., 2017; Pan et al., 
2015).  
The validation of the English version of the BCoS involved a study called The 
Birmingham University Cognitive Screen (BUCS). This study involved recruitment of 
stroke patients between November 2006 and January 2011 from 12 west-midlands 
hospitals. Inclusion criteria consisted (a) medically stable, within 3 months of their 
latest stroke, and able to give informed consent; (b) clinical diagnosis of a stroke. 
Exclusion criteria were (a) insufficient understanding of English; (b) inability to 
concentrate for 35 min per the clinical judgment of the treatment team and the 
researcher; and (c) pre- morbid conditions affecting cognition (e.g., dementia). This 
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information has been taken from Bickerton and colleagues, who fully report the 
recruitment to the BUCS (Bickerton et al., 2015). In total 908 stroke patients were 
assessed within three months of stroke, with 826 stroke patients completing 75% of the 
23 tasks of the BCoS assessment. Common reasons for failure to complete all tasks 
were due to lack of time or fatigue. Neuropsychological assessment and lesion 
information was collected via clinical CT scans, along with basic demographical 
information (age, sex, education), see Bickerton for full consort diagram (Bickerton et 
al., 2015). Further information was collected on their mood, and functional ability using 
the Hospital Anxiety and Depression Scale, and Barthel Index (Mahoney & Barthel, 
1965; Zigmond & Snaith, 1983). The Hospital anxiety and depression scale is a mood 
measure often used in measuring mood levels in clinical populations (Zigmond & 
Snaith, 1983). The hospital anxiety and depression scale is a mood measure of both 
depression and anxiety. This measure takes about five minutes to complete, depression 
and anxiety are calculated separately, and the measure contains seven questions for 
each. The total out of 21 is calculated, with less than seven on each indicating non-
clinically relevant levels, eight- ten represents mild mood levels, 11-14 moderate and 
15-21 severe. The Barthel Index (Mahoney & Barthel, 1965),  was used to measure 
functional abilities. This measure focuses on activities of daily living, and includes 
questions about self-care and mobility. In total 100 points out of 10 questions would 
indicate complete independence, with lower scores indicating dependence in activities 
of daily living. In addition to the stroke patients recruited in the BUCS study, 100 
healthy aged-matched controls based on the 2001 UK population consensus were also 
recruited. They underwent the same assessment protocol, and this provided age specific 
cut-offs at 5th percentile for each test (age 50-64, 65-74 and 75 and above) (Bickerton et 
al., 2015). In addition, a total of 380 stroke patients were followed-up at nine months, 
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reasons for not being followed up included refusal, death, and no response, a full list is 
documented in (Bickerton et al., 2015) (Also See Appendices – 1.2.4.1 for consort 
diagram).  
The utility and predictive value of the BCoS on functional outcomes were assessed by 
Bickerton and colleagues, using a dataset of the two time points of < three months post-
stroke and at nine months post-stroke (n=380) (Bickerton et al., 2015). Bickerton and 
colleagues report that deficits in executive function and attention, and praxis domains 
were predictive of functional outcome at nine months above initial functional ability 
(Bickerton et al., 2015).  
The validation of the Cantonese BCoS was conducted in Guangzhou First People’s 
Hospital in China. As reported above, the English version of the BCoS was translated in 
to Cantonese, and most tasks underwent direct translation. Translation of a handful of 
tasks in the BCoS were computed from the English version to the Chinese BCoS to 
ensure that they were both linguistically, and culturally appropriate (Pan et al., 2015). In 
the picture naming task, some of the pictures used in the English version were changed,  
for example the colander was removed as this is not used in Chinese cooking, and was 
replaced by a spatula. In the sentence, and nonword reading tasks, in these tasks 
appropriate use of words in these sentences, and their orthography, and phonology were 
assessed, and adapted to be linguistically appropriate. In the gesture production and 
recognition tasks, some gestures were adapted to fit the Chinese culture and daily 
habits. For example the gesture of hitchhiking was removed, due to it not being a 
common activity in the Peoples Republic of China, and replaced by a gesture of rubbing 
one’s thumb and forefinger together to indicate money. In the word writing task, 
Chinese character writing is an equivalent task to (real) word writing in the English 
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version of the task. In total 105 stroke patients were recruited (of which 98 stroke 
patients were recruited between July 2013 and March 2014 are reported by (Pan et al., 
2015)), inclusion criteria consisted of (a) age 50 years and above, (b) within two weeks 
of clinical diagnoses of stroke, with no prior stroke, (c) able to concentrate for 45 
minutes, (d) able to consent for participation. Exclusion criteria included (a) past history 
of cognitive impairment, (b) The presence of chronic heart failure, anaemia, or other 
diseases that may lead to cognitive impairment. In addition, 343 healthy controls were 
recruited (of which 133 were reported by (Pan et al., 2015)). Criteria for inclusion 
required them to be aged 50 years or above, without a history of brain lesion and 
memory impairment (Pan et al., 2015). The control group provided 5th percentile cut off 
scores for the patients, for each test (age 50-64, 65-74 and 75 and above). The databases 
discussed here (BUCS, Mandarin and Cantonese BCoS) will be utilised in chapter two 
and three of this thesis.  
1.3 Post-Stroke cognitive recovery 
 
Stroke is characterised by lack of fresh oxygen to the brain due to disruption of blood 
flow, causing acute stress of the neurons, and other brains cells. In response to the 
neuronal stress, cells initiate biological processes aimed to ameliorate the dire 
consequences of stroke, and facilitate recovery (Allen & Bayraktutan, 2009). The 
biological recovery from stroke is hypothesised to be divided into three phases which 
are assumed to overlap to some degree (Cramer, 2008): The first stage consists of the 
initial impact of the stroke which involves changes in blood flow, oedema, metabolisms, 
inflammation and diaschisis. The second stage involves the beginning of repair in the 
first days after stroke which continues for several weeks (Cramer, 2008). Homeostatic 
mechanisms are activated during this early stage of stroke recovery (1-4 weeks), this 
occurs to re-establish the function of the stroke affected areas. These mechanisms 
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operate through the adaptation of structural and functional circuits (Murphy & Corbett, 
2009). The third phase is reported to begin weeks to months following stroke, when 
spontaneous behavioural gains have reached a plateau, this is a stable but modifiable 
chronic phase (Cramer, 2008). In stage three, any recovery is likely to be driven through 
explicit targeted rehabilitation and/or personal motivation. However, it should be noted 
that the above timeline for recovery following stroke (Cramer, 2008; Murphy & 
Corbett, 2009) is based on animal models, and that the translation of these phases and 
timelines to human stroke survivors is primarily theoretical (Ward, 2017). Therefore, it 
is possible that homeostatic repair in humans lasts longer, enabling a longer window for 
plasticity induced rehabilitation intervention. To date, evidence on the impact of the 
initiation time of rehabilitation intervention is unclear (Ward, 2017).  
Cognitive recovery following stroke is complex. There is a growing consensus that 
some of the observed cognitive recovery is due to biological plasticity, which occur in 
the first few weeks and months post-stroke (Ward, 2017). It has been suggested that 
spontaneous recovery occurs within this plasticity period (the first three months) 
(Klnsella & Ford, 1980; Wade et al., 1988). This period of heightened plasticity has 
been the focus of many rehabilitation clinical trials, predominantly in motor recovery 
(Zeiler et al., 2015) (Biernaskie et al., 2004). However, the three-month recovery 
window has been challenged by new findings, with recovery documented beyond one-
year post-stroke (Ballester et al., 2019; Desmond et al., 1996).   
1.3.1 Post-stroke cognitive trajectories 
It is hypothesised that recovery trajectories are not the same for all stroke patients 
(Mijajlović et al., 2017). Firstly, it is important to note that not all stroke patients start at 
the same pre-stroke baseline cognition, this could be due to different levels of education 
(Parisi et al., 2012), or pre stroke cognitive impairments (Kovalenko et al., 2017). There 
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is some evidence suggesting higher rates of pre-stroke cognitive decline in those 
experiencing stroke compared with stroke free individuals (Pendlebury & Rothwell, 
2009; Zheng et al., 2019). It has also been found that global cognition declines faster in 
stroke patients compared to non-stroke over a median period of six years (Levine et al., 
2015). In an examination of self-reported recovery rates, four different rates of recovery 
patterns were noted: meaningful recovery, cycles of recovery and decline, ongoing 
disruption, and gradual ongoing decline (Hawkins et al., 2017). These self-reported 
trajectories seem to follow the suggested model by Mijajlović and colleagues 
(Mijajlović et al., 2017). They challenge the traditional view that individuals start with 
no previous cognitive impairments (or dementia), and following stroke either have 
cognitive impairments which are disabling leading to dementia diagnosis, or have no 
cognitive impairments (Mijajlović et al., 2017). In Figure 1 we see their suggestion of 
post-stroke cognitive trajectory, where individuals have varied pre-stroke cognition, and 
following stroke follow varying cognitive trajectories, with trajectory changes observed 




Figure 1. Mijajlović and colleagues ‘Cognitive Trajectory in stroke’. A) is the 
traditional view of post stroke decline, B) is the real-world depiction of cognitive 
decline (Mijajlović et al., 2017). 
There is a debate whether recovery rates differ across cognitive domains. In a ten year 
cohort study, there were differences in the recovery rate across cognitive domains, 
global cognition improved, while speed of processing decreased between one year and 
ten years post-stroke (Elgh & Hu, 2019).  The potential for different profiles of 
cognitive deficits, and their co-existence, gives rise to the hypothesis that recovery rate 
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is inherently related to the cognitive impairments the stroke patient acquires (Ramsey et 
al., 2017). It has also been found that recovery rates, are similar across cognitive 
domains, and relate specifically to biological mechanisms such as brain networks, 
formation of synapses and genetic activation (Ramsey et al., 2017).  
The timing of cognitive assessments when assessing recovery rates is important. It 
should include at least two time-points to assess change (Hurford et al., 2013). 
Assessments should not only be carried within the first month post-stroke, as the rate of 
cognitive impairments are likely to be higher within this period and would not represent 
the recovery for prolong durations after the stroke (Hurford et al., 2013). The severity of 
the initial deficit following the stroke also impacts cognitive recovery, suggesting that 
recovery is proportional to initial deficits (Lazar et al., 2010; Ramsey et al., 2017; Ward, 
2017).  
The persistence of cognitive impairments has been found to extended beyond the acute 
stage of stroke, with reports of cognitive impairments in up to 50% of patients > 12 
months post-stroke, 22% at five years, and 21% at 14 years post-stroke (Mellon et al., 
2015; Nakling et al., 2017; Nys et al., 2005). Beyond this, not only do some stroke 
patients not recover, and live with persistence cognitive impairments, there is evidence 
that the persistence of cognitive impairments actually develops into cognitive decline 
(Elgh & Hu, 2019; Hénon et al., 2006; Levine et al., 2015; Mijajlović et al., 2017; 
Pendlebury, 2009). We investigate post-stroke cognitive trajectories in chapter two, 
examining whether individuals recover proportionally to their initial post-stroke 
deficits, or whether they follow different cognitive trajectories.  
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1.4 Post-stroke decline 
 
In the past decade large scale epidemiological, retrospective and prospective studies 
have examined the potential mechanisms that link stroke and dementia (Brainin et al., 
2015; Gottesman & Hillis, 2010; Hénon, 2006; Levine et al., 2015; Mijajlović et al., 
2017; Pendlebury & Rothwell, 2009; Sahathevan et al., 2012). It is however still 
debated whether the two are linked causally, or just co-exist due to the similarity of risk 
factors e.g. vascular disease, history of stroke, metabolic abnormalities, diabetes, 
inflammation, genetic (APOE4) (Brainin et al., 2015; Hénon, 2006; Sahathevan et al., 
2012). Due to the common shared risk factors, dementia patients also have higher risk 
of stroke (Hennerici, 2009), as with stroke patients being at a higher risk of developing 
dementia. There is some evidence to suggest that post-stroke dementia (PSD) is more 
common following left hemisphere stroke (Censori et al., 1996). Though this 
observation may be an artefact of the cognitive assessment tools which rely on language 
abilities (Humphreys et al., 2012). Others suggest PSD is more common following 
cerebral arteries stroke (Desmond et al., 2000), with stroke severity associated with 
increased risk for PSD (Censori et al., 1996). General brain health has been repeatedly 
reported to be associated with PSD, such as small vessel disease, leukoarasiosis, and 
focal neuronal pathology (Corriveau et al., 2016; Grau-Olivares & Arboix, 2009; 
Kalaria et al., 2016; Pantoni, 2010; Pantoni et al., 2005). Biomarker predictors of PSD 
have also been noted; such as APOE4 (Mijajlović et al., 2017). However, it has been 
questioned whether the stroke incidence simply aggravates pre-existing pathology, and 
thus causes dementia onset (Hénon et al., 2001; Hénon et al., 1997).  
1.4.1 Diagnosing dementia 
The fourth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 
sets the criteria for diagnoses of dementia and its sub-types. A crucial element of the 
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diagnosis is the loss of functional independence due to cognitive difficulties. The DSM-
IV criteria for Alzheimer’s type dementia involves 1) The development of multiple 
cognitive deficits manifested by both memory impairment and one or more cognitive 
disturbances in (aphasia, apraxia, agnosia, executive functioning); 2) Criteria one and 
two lead to impairment in social of occupational functioning; 3) It is characterized by a 
gradual onset and continued cognitive decline; 4) Cognitive deficits in one are not due 
to central nervous conditions or systemic conditions; 5) Deficits do not occur 
exclusively during delirium and 6) The disturbance is not better accounted for by 
another disorder (American Psychiatric Association, 2000). Similarly, the DSM-IV 
criteria for vascular dementia includes 1) Memory impairment; 2) One or more 
cognitive disturbances in (aphasia, apraxia, agnosia, executive functioning); 3) Criteria 
one and two lead to impairment in social of occupational functioning; 4) Focal 
neurological signs and symptoms and 5) The deficits do not occur exclusively during 
delirium (American Psychiatric Association, 2000). Importantly in the diagnoses of 
vascular dementia using DSM-IV criterion, there is no requirement to measure it as a 
progressive decline or gradual onset, for example assessment of cognition across more 
than one time point. Thus, suggesting that vascular dementia can be a diagnoses of 
stable impairment and not progressive, as a measurement at one time-point is a 
cognitive outcome. 
Importantly, many studies examining post-stroke dementia or decline noted specifically 
within this thesis will have been published in the era of DSM-IV. The DSM-5 was 
published in 2013, and some adaptions to the criteria for vascular dementia were made, 
such as removal of evidence of memory impairment in vascular dementia diagnoses 
(Sachdev et al., 2019).  
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Interestingly, in a study examining the differences between DSM-IV and DSM-5, expert 
clinical diagnosis of dementia using DSM-5 criteria was in line with DSM-IV for 90% 
of cases. However there was a 127% increase of dementia diagnoses using DSM-5 
(Eramudugolla et al., 2017).  
There is heated debate over the comorbidity of the two most common dementias; 
Alzheimer’s disease and vascular dementia, in their similarity and difference (de la 
Torre, 2004). The DSM-5 criterion diagnoses for both overlap heavily. In their purest 
form, they both have different cause’s e.g. Alzheimer’s disease with plaque, and 
vascular dementia with infarctions. But it is suggested that they both sit on a continuum, 
with overlapping features such as cholinergic deficit (Kalaria, 2002). More recently 
Alzheimer’s disease has been argued to be associated with vascular risk factors, and 
vascular brain health (Snyder et al., 2015).  
Due to the complex aetiology of cognition following stroke, involving both non-
vascular neurodegenerative processes, and stroke insult there are a variety of definitions 
and classifications to describe post-stroke cognitive impairment and post-stroke 
cognitive decline (Mijajlović et al., 2017). These not exclusively include; mild cognitive 
impairment (MCI), vascular cognitive impairment (VCI), post-stroke dementia (PSD), 
and delayed post-stroke dementia (DD). There is still lacking a consensus on 
terminology that best describes a cognitive impairment following stroke that 
progressively worsens, and a cognitive impairment that is not progressive. We will 
briefly describe some different classification labels below.  
1.4.1.1 Mild Cognitive Impairment 
Mild cognitive impairment is defined as having abnormal memory for age, but an 
ability to carry out activities of daily living, with no other cognitive domains affected 
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(Petersen et al., 1999). It is identified as presenting differently to healthy ageing, and as 
a pre-cursor of Alzheimer’s disease. In some cases it marks the beginning of progressive 
decline in cognition at a faster rate than healthy ageing controls; while in others mild 
cognitive impairments are reversible or stable (Petersen et al., 1999).   
1.4.1.2 Vascular cognitive impairment 
Vascular cognitive impairment was previously called multi-infarct dementia (Gorelick 
et al., 2011), however this term has been coined to describe the spectrum of cognitive 
disorders that are a result of cerebral vascular brain injury, not stroke in isolation 
(Gorelick et al., 2011). This is said to include impairment across the spectrum of mild 
cognitive impairment through to fully developed dementia (Dichgans & Leys, 2017), 
and often is a label used to identify those who are likely to develop vascular dementia 
(Petersen et al., 1999).   
1.4.1.3 Post-stroke dementia 
Mijajlović and colleagues propose the use of PSD for any dementia that develops 
following a cerebrovascular incident (Mijajlović et al., 2017). Due to the complex 
neuropathological processes that occur, the term PSD does not align itself to one 
vascular process, but instead encompasses all vascular insults and also 
neurodegenerative processes (Biernaskie et al., 2004; Brainin et al., 2015; Mijajlović et 
al., 2017).  
1.4.1.4 Delayed post-stroke dementia 
It is suggested that following stroke, an individual presents with a cognitive impairment 
or dementia which is present immediately following stroke (within three months). 
However delayed dementia, includes cognitive deficits or cognitive decline which was 
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not present immediately following stroke. It is classified as a presentation of cognitive 
decline following stroke beyond three months (Kalaria et al., 2016; Mok et al., 2016).  
1.4.2 How prevalent is post-stroke dementia? 
It is estimated that around one third of stroke survivors develop dementia (Brainin et al., 
2015).  The prevalence of dementia in stroke survivors is almost double than that in 
stroke free individuals (Brainin et al., 2015). Evidence suggests that up to one in three 
stroke survivors are at risk of developing vascular dementia within five years of stroke 
(Leys et al., 2005). Although it has been debated that the prevalence of PSD is 
overestimated, potentially due to the assessment tool used (Rasquin et al., 2005), or the 
diagnosis and/or definition of post-stroke cognitive impairment or post-stroke dementia 
(Petersen, 2004). The diagnoses of vascular dementia which is often applied to those 
experiencing cognitive issues following stroke, would not be an applicable diagnoses 
classification for stroke survivors. It involves having a loss of occupational ability, 
which may be due in fact to physical impairments such as hemiparesis following stroke. 
1.4.3 Diagnoses of post-stroke cognitive decline 
As noted in 1.4.1, most commonly used diagnoses tools are the DSM-IV and DSM-5 for 
dementia subtypes in clinical practice. The terms taken from these tools are often used 
interchangeably across research studies, which often leads to confusion as to what type 
of cognitive impairment, or cognitive decline authors are specifically referring to. Often 
the MoCA is used to demonstrate post-stroke dementia classification < 26 out of 30 
(Mijajlović et al., 2017), however as previously described in 1.2.4, there are many 
issues surrounding the use of this tool and its sensitivity in stroke populations. The 
different tools used to diagnose post-stroke cognitive impairment will in turn provide 
different rates of incidence. It is suggested that using the diagnostic criteria that we use 
for dementia, may not be applicable to stroke patients experiencing cognitive decline 
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(Mijajlović et al., 2017), as some of those experiencing cognitive impairment may not 
experience the limitations of daily activities associated with dementia (Petersen et al., 
1999). On the other hand, the diagnostic criteria commonly used for dementia includes 
loss of occupational function, which is not an appropriate diagnostic criterion for the 
stroke population, where loss of function is common in this group as a result of 
hemiparesis, and other motor deficits (Mijajlović et al., 2017). The VASCOG criteria 
for the diagnoses of vascular cognitive disorders may be more applicable to the stroke 
population, as it requires neuroimaging evidence, although it bears strong similarities to 
the DSM-5 (Sachdev et al., 2014; Sachdev et al., 2019). This VASCOG criteria was 
found to be more sensitive and specific compared with older criteria for vascular 
dementia (Sachdev et al., 2014; Sachdev et al., 2019).   
As mentioned previously, in order to measure trajectories, whether it be in terms of 
recovery or decline –more than one time-point is required. With only one time point 
measurement, it is difficult to differentiate progressive cognitive decline, from stable 
cognitive impairment. The global understanding is that dementia is progressive decline. 
However, the DSM criterion lacks measurement of change (e.g. no criteria requires 
repeat assessment at six months interval), suggesting that evidence of cognitive 
impairment at one time-point is enough to diagnose post-stroke dementia. Mijajlović 
and colleagues suggest a diagnoses of dementia at six months post-stroke (one time 
point), and not before is appropriate (Mijajlović et al., 2017). Thus, it seems that those 
experiencing cognitive impairment at six months would be given a post-stroke dementia 
diagnoses, regardless of the nature, and expected progression. Based on this criteria it 
may not be surprising that over a third of stroke patients develop dementia (Brainin et 
al., 2015), due to the fact that stroke often causes cognitive impairments. Though this 
diagnosis does not suggest that these patients will keep declining in rates faster than 
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expected in normal aging. Furthermore, increased rates of dementia following stoke do 
not take into consideration those already with dementia, estimated to be about 10% 
(Mijajlović et al., 2017).  
DSM philosophy is that diagnoses are based on clinical symptoms. Therefore, DSM 
criteria for dementia diagnoses does not account for the aetiology root cause of the 
issue, or the long-term prognosis, only the current cognitive impairment and 
functionality. Due to this, it does not take into account pre-stroke cognitive condition, 
which is important to understand the condition and future rehabilitation potential of the 
patient.  
How useful is a post-stroke dementia label for prognosis, and planning of future care? It 
does not predict whether the cognitive impairment is persistent or progressive. Since 
providing, and justifying rehabilitation in a time pressured work environment is 
challenging (Longley et al., 2018), a diagnosis label of dementia may exclude 
individuals from rehabilitation programs. A further issue regarding diagnoses, not 
excluding the complex aetiology, is the timing of diagnoses. It is possible that the 
cerebrovascular incident exasperates previous symptoms, or just simply alerts 
healthcare professionals to an issue that preceded the ischemic incident (Hénon et al., 
2001; Hénon et al., 1997).  
In summary, even though many studies have attempted to clarify post-stroke cognition 
in terms of dementia, the range of classification criteria, and tools out in the field make 
it difficult to understand and follow. For researchers examining post-stroke cognition, 
looking at recovery and/ or decline, more consensus on ‘dementia’, and whether it is a 
stable cognitive impairment or progressive would be useful, not only for replication 
across studies, but also clinically for the patients themselves.  
37 
 
For the purpose of this thesis cognitive deficit following stroke will be referred to as 
post-stroke cognitive impairments. When measuring only one time point, the cognitive 
state will be labelled as post-stroke cognitive outcome. When cognition is measured at 
two time points, and the difference between these two time points is assessed, it will be 
described as post-stroke cognitive trajectory. The thesis describes groups of patients that 
may be experiencing progressive cognitive decline. However, it does not attempt to 
classify them as having developed vascular or post-stroke dementia.  




Sociodemographic status typically includes key information about the individuals; such 
as age, sex, ethnicity, socio-economic status, life style and education level. 
Sociodemographic profile is inherently related to stroke incidence due to its interaction 
with our overall health (Kleindorfer, 2009). As a result, it is not surprising that it is has 
also been found to be a predictor of cognition following stroke. Age has been reported 
to be an important determining factor for onset of cognitive decline following stroke 
(Ebrahim et al., 1985; Gorelick et al., 2011; Leys et al., 2005; Sun et al., 2014; Wolfe et 
al., 2011). And as previously reported (1.2.3), differences are observed in cognitive 
recovery for females and males, (Levine et al., 2015; Mahon et al., 2017; Nys et al., 
2005).   
1.5.1.2 Education 
A modifiable predictor of cognitive outcome is education level. Lower education level 
predicts worse outcomes when specifically examining cognitive outcomes (Chaudhari et 
al., 2014; Chen et al., 2016; Elkins et al., 2006; Leys et al., 2005; Parisi et al., 2012). 
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The theoretical underpinnings of why higher education of an individual may protect 
against worse cognitive outcomes, is shrouded in cognitive/ brain reserve (Nunnari et 
al., 2014). Cognitive brain reserve is a concept that accounts for potential ‘resilience’ of 
an individual against cognitive ageing, and ageing related diseases. This concept can be 
broken down into different aspects of potential resilience, one of which is cognitive 
reserve, the other is brain reserve. Cognitive reserve refers to ‘the adaptability of 
cognitive processes that helps to explain differential susceptibility of cognitive abilities, 
or day to day function to brain ageing, pathology, or insult’ (Stern et al., 2018). In the 
current thesis, cognitive reserve would refer to the resilience of the individual brain to 
neurological insult (stroke), and possible decline. For each individual, cognitive reserve 
is determined by cognitive and functional brain processes. Of which are both at the 
influence of individual differences, made up of innate (e.g genetics), and lifetime 
exposures (e.g education). Stern and colleagues describe cognitive reserve to be a 
malleable model, of which cognitive and brain processes can be dynamic, and can cope 
with brain changes or damage (Stern et al., 2018). For example, when examining 
Alzheimer’s disease in post-mortem studies, an observation is made for those with 
preserved functioning in those with higher education level, but with evidence of severe 
Alzheimer’s pathology (Stern et al., 2018). A second aspect to note is brain reserve. 
Brain reserve refers specifically to the pathology of the brain, including number of 
neurons and synapses (Stern et al., 2018). Its individual structural characteristics allow 
some to cope better with insult, and age-related changes. Brain reserve is a fixed 
construct; however life experience can add to brain reserve. Stern refers to cognitive 
reserve as the software, and brain reserve as the hardware (Stern et al., 2018).  
In chapter three we examine cognitive reserve using level of education as a measure of 
cognitive reserve. Education and its influence on ageing and cognitive decline/ dementia 
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has been well documented (Brayne et al., 2010; Brayne et al., 2006; Brayne & Miller, 
2017; Christensen et al., 2007; Farfel et al., 2013; Pinter et al., 2015; Skoog et al., 2017) 
(Zieren et al., 2013). Additionally it has been found to correlate with post-stroke 
cognition (Mirza et al., 2016; Sun et al., 2014; Withall et al., 2009). With level of 
formal education (measured in either level of education, or years), having a positive and 
‘protective’ effect on cognition following stroke, with increased education. Del Ser 
describes education as a marker of higher socioeconomic status, which in turn related to 
a more advantaged and health lifestyle, with also less exposure to environmental toxins 
(Del Ser et al., 1999). This combination may protect individuals at a higher level against 
brain diseases.   
To investigate the effects of cognitive reserve (resilience), on cognitive outcomes 
following stroke, education was deemed an appropriate, and accessible measure. In 
chapter three, the cognitive resilience of an individual following an insult (stroke), and 
the abilities of individuals to overcome this insult was measured by years in formal 
education. To establish the impact of formal education years on cognitive resilience 
across three key groups 1) Ageing, 2) Post-stroke outcome, 3) Post-stroke recovery at 
nine months, and across two countries 1) U.K, 2) China. 
1.5.2 Clinical profile 
The clinical risk factors of stroke (Boehme et al., 2017; Stroke Association, 2018; Tan 
& Markus, 2016), are in turn predictors of post-stroke cognitive outcomes. For example, 
diabetes, hypertension and cholesterol have all been identified as determinants of worse 
cognitive outcomes, and specifically risk factors for a decline cognitive trajectory 
following stroke (Censori et al., 1996; Chaudhari et al., 2014; Leys et al., 2005). 
Additionally, another condition increasing stroke incidence is atrial fibrillation. It has 
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been identified as a predictor of poor cognitive prognosis, and cognitive trajectory 
following stroke (Censori et al., 1996; Leys et al., 2005).  
1.5.3 Stroke profile 
1.5.3.1 Stroke severity 
Individual stroke profiles are a reported predictor of cognitive recovery following 
stroke. Stroke lesion location has been found to be a strong predictor of cognitive 
outcome (Chaudhari et al., 2014; Leys et al., 2005; Munsch et al., 2016; Pendlebury & 
Rothwell, 2009). Initial stroke severity as measured by NIHSS, was also a predictor of 
cognitive outcome (Chaudhari et al., 2014; Leys et al., 2005). And there is evidence that 
history of previous stroke can further impact cognitive outcome following subsequent 
ischemic events (Chaudhari et al., 2014; Chen et al., 2016; Leys et al., 2005). Recurrent 
stroke is also argued to be an important predictor for cognitive recovery trajectories, 
with a third of those with recurrent stroke being identified as having dementia 
(Pendlebury & Rothwell, 2009).  
1.5.3.2 Lesion severity 
Stroke severity is a predictor of outcome and cognitive recovery trajectory, so 
inherently lesion profile contributes. Evidence of strategic single infarcts to the 
thalamus, angular gyrus, caudate, globus pallidus, basal forebrain or hippocampus have 
been found to cause post-stroke dementia, affecting post-stroke cognitive trajectory. 
Furthermore lesions in this region (subcortical circuit) are associated with rapid 
cognitive decline (Moorhouse & Rockwood, 2008). Territorial infarct was also 
identified as an independent predictor of cognitive impairment when measured at one 
month, six and 12 months following stroke (Rasquin et al., 2004).  
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1.5.3.3 Lesion location 
Lesion location as with lesion severity has been dubbed a window of opportunity to 
predict cognitive outcomes and recovery. When determining recovery from aphasia, it 
has been repeatedly reported that lesion location, is as reliable at predicting recovery as 
lesion volume and severity of impairment (Plowman et al., 2012). Furthermore, lesion 
location has been used to map recovery trajectories in aphasia, in collaboration with 
time since stroke and lesion volume (Hope et al., 2013).  
1.5.4 Neuropathological 
1.5.4.1 Brain Health 
Beyond the individual profile of stroke, and its neurological impact on cognitive 
trajectory, additional neuropathological factors impact cognitive trajectories. Small 
vessel disease has been found to be an independent predictor of worse cognitive 
outcomes. In stroke patients with small vessel disease, and lower brain volume, poorer 
executive function was observed compared to controls (Lawrence et al., 2013). 
Evidence of small vessel disease in the post-stroke brain, indicates poor brain health, 
and in turn impacts recovery, putting those with small vessel disease at risk of cognitive 
decline following stroke insult (Mijajlović et al., 2017; Mok et al., 2016). 
Another indicator of poor brain health, or cerebrovascular insult is white matter 
changes; like small vessel disease, those with white matter changes are at increased risk 
for cognitive decline following stroke (Hennerici, 2009; Leys et al., 2005).  
Global grey matter atrophy has been observed in those with post-stroke cognitive 
impairments compared to those without cognitive impairments (Stebbins et al., 2008). 
Specifically, medial temporal lobe atrophy, is a predictor of worse cognitive outcomes 
in the short-term following stroke, and is also associated with cognitive decline 
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(Brodtmann et al., 2012; Casolla et al., 2018; Chen et al., 2016; Leys et al., 2005; 
Mijajlović et al., 2017; Pendlebury & Rothwell, 2009).   
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1.5.4.2 Methods of magnetic resonance imaging  
Magnetic resonance imaging (MRI) is a non-invasive method of measuring a multitude 
of properties within the brain, and can provide detailed information on anatomy, 
neuronal activity, connectivity and pathologies (Jenkinson, 2018). MRI can be used to 
capture a wide variety of information, by adjusting the acquisition parameters.  
The basis of the acquisition is on atomic nuclei, sometimes referred to as spins, that act 
as bar magnets, and interact with magnetic fields which allows us to measure, and 
manipulate the nuclei magnetic state. Specifically in MRI, it is the hydrogen nuclei 
within the water molecules of the tissue, that are targeted and manipulated. In order to 
manipulate these molecules, MRI uses coils which are made of electronically 
conducting wire. When electric currents are passed through a coil, it creates a magnetic 
field. Shifting these magnetic fields within a coil induces electrical currents, both of 
which are important in the function of MRI.  
The M in MRI stands for magnetic. The strength of MRI is defined by the B0 field (the 
filed that is parallel to the tube). The magnetic field (B0 field) is created from a large 
superconducting coil, which is always active, and is continually cooled by liquid 
helium. In MRI there are varying gradients of magnetic strength, which is measured in 
tesla, and can vary for example from 1T to 7T, with 7 being the strongest. The ability to 
affect hydrogen nuclei, depends on a strength of magnetic field, where the bar magnets 
of nuclei will point in the same direction – along the magnetic field. In a none-magnetic 
environment the sum of the hydrogen magnetic field is nearly zero, where each passes 
along different angles.  
It is common that the magnetic field experiences external interferences, which we call 
non-uniformities. To control for these uniformities in the B0 field, we can utilise other 
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coils; called ‘shimming coils’, which can control for imaging artefacts. These shimming 
coils are applied at the start of the scanning, and this is called shimming.  
The R in MRI stands for resonance, which is the B1 field. The bar magnets in the 
hydrogen nuclei when in a strong magnetic field, rotate round the axis of the B0 field. 
The frequency of the rotation is proportional to the strength of the magnetic field. This 
rotation interaction creates oscillating fields- the B1 fields. We have an ability to detect 
and externally manipulate these oscillating fields. We refer to this resonance frequency 
as Lamor frequency.  
The I in MRI stands for imaging. So far, we have the MR signal, which originates from 
contributions from all the nuclei which are identified within the bore of the scanner. To 
determine the where the MR signal is coming from, we can separate out the difference 
signal frequencies in order to determine the location of the frequency. Gradient coils are 
used at this stage to purposefully add extra carefully controlled magnetic fields with 
varying locations. By adding this extra field during acquisition of signal measurements, 
it allows us to measure how strong a signal is and also work out where the signal is 
originating from, and thus enables us to form an image.  
The I in MRI allows us to acquire an image, and if we manipulate the MR then we can 
acquire different types of images. There are characteristics is are similar to the 2D 
version of pixels. The resolution of the image refers to the voxel size. The voxel size, 
and number of voxels multiplied together create the field of view (FOV). 
When we acquire structural images it shows the anatomy of the brain; optimising the 
separation of grey matter, white matter and cerebrospinal fluid. Most commonly these 
are T1-weighted images, in these images the most important principles are proton 
density, and relaxation processes. For example for T1-weighted images, this is T1 
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relaxation constants. These properties are determined by the microscopic environment 
in the water molecules, and are different within the three tissue properties that can be 
identified in structural images. The proton density is simply the concentration of water 
within the molecule. Both the proton density, and relaxation constants allow us to obtain 
information about different structural properties within the brain.  
Reduction in volume of grey matter often correlates with ageing, and cognitive decline 
(Raz & Rodrigue, 2006). Grey matter volume can be measured with MRI from T1-
weighted images (Amiri et al., 2018), as this sequence gives optimal contrast between 
the three tissue types. Computing a regional volume can be done in two ways. The first 
is manually delineating a region (e.g. tracing the hippocampus borders) then counting 
how many voxels are within the traced area. 
A second is to use an automated approach to quantifying grey matter volume. These are 
often combined with standardised atlases to classify tissues types across each brain 
structure (Amiri et al., 2018; Ashburner & Friston, 2005; Ashburner & Ridgway, 2013). 
The unified-segmentation algorithm is a common automated approach to classifying 
tissues within the brain, the approach uses probability maps to determine the probability 
of the tissue type within each voxel (Whitwell, 2009). The toolbox CAT12 is an 
improved version of the above algorithm, where the main aim is to study local grey 
matter volume changes. The output of this procedure is a probability map of grey matter 
in the normalized space. The intensity of each voxel is weighed by the amount of 
transformation a region has undergone to fit it to the normalized space. Such that if the 
hippocampus had to be stretched to better fit the a-priori tissue probability map, then the 
signal in those stretched voxels will be reduced to represent this deformation. These are 
called modulated grey matter images. Following the automated method of tissue type 
quantification, regions of interest (ROI) across all brain regions, can be selected using 
46 
 
automated ROI atlases such as the SPM anatomy toolbox (Eickhoff et al., 2005) defined 
by the Montreal neurological institute (MNI) (Garrison et al., 2015; Mazziotta et al., 
1995).  
Both approaches are commonly used to determine grey matter volume. It is important to 
note that it is yet unclear what the physiological contributors to the grey matter signal 
measured by MRI are, and consequently what the meaning of the signal intensity in the 
tissue probability map is (Eriksson et al., 2009). This is because MRI, measures relative 
level of disturbances to the local magnetic field, and there are many factors that can 
affect this. In contrast, Computerised Tomography (CT) has a very clear physiological 
meaning, as CT measures the density of the tissue, but this is the only property that can 
be measured by CT.  
Diffusion MRI (dMRI) also focuses on the water molecules, and specifically their 
movement (Brownian motion). In dMRI we can measure how much molecules move, 
and also in which direction and over what time period. Typically water molecules 
diffuse along the same direction of the axons, and the direction they are orientated. In 
diffusion imaging there are diffusion-encoding gradients, these gradients change the 
magnetic field strongly enough in one direction in space. The water molecules that do 
not mirror this direction, are unaffected by the gradients. Those that do move in the 
same direction, have their resonant frequency changed, which in turn leads to changes 
in phase, which is important for the diffusion signal. The more the movement 
(diffusion) in the same direction as the gradient, the smaller the signal will be. 
Additionally we can collect information on the timing, and strength of the gradients, 
which together make the b-value.  Diffusion represents displacement of water molecules 
within a single voxel (Le Bihan et al., 2001). Mean diffusivity of a voxel provides 
information about the molecular diffusion rate (e.g. how far on average a molecule 
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travelled in a given time) (Soares et al., 2013). Depending on the tissue type, diffusion 
rates differ. In grey matter tissue diffusivity is less anisotropic compared to white matter 
tissue, and in CSF it is isotropic. Fluctuations in values of  diffusion often indicate 
structural changes within the brain, with higher mean diffusivity values indicating 
damaged or impaired fibres, and loss of directionality in movement of molecules 
(Soares et al., 2013). Due to a low signal to noise ratio in diffusion weighted imaging, it 
is vulnerable to motion artefacts, although software can be used to account for this in 
the data (Andersson & Sotiropoulos, 2016), only in extreme cases would the data need 
to be removed from the analyses. 
MRI can also be used to measured magnetic resonance spectroscopy (1H-MRS). In 
contrast to most methods of MRI acquisition, spectroscopy does not utilise the water 
molecules to form the image, instead it uses other molecules, such as NAA, Choline etc. 
Specifically these molecules have lower concentrations than water (Oz, 2016). This 
acquisition relies upon a function called chemical shift. Where the signal in each type of 
molecule causes a shift in the frequency, allowing us to measure the contribution of 
each molecule and its quantification. The most commonly used approach to this 
method, is single-voxel spectroscopy (Wilson, Andronesi, et al., 2019). The signal to 
noise ratio is lower as a result of this, compared with many other MRI methods (Oz, 
2016). Spectra of metabolites often overlap each other (Oz, 2016), so to obtain more 
reliable absolute measurements of metabolites, metabolite ratios are calculated (Wilson, 
Andronesi, et al., 2019). Different metabolites each provide different information. The 
metabolites have different concentrations in different tissue types, hence it is important 
to account for these differences in the analysis (e.g. weight the signal by the amount of 
grey matter in the voxel). For example, neuronal health can be measured using (N-
acetylaspartate), demyelination/increased membrane turnover using (Choline), and 
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decreased energy metabolism with (N-acetylaspartate and Creatine). This method has 
historically been used for the identification of tumours (Preul et al., 1996) due to the 
indication of metabolic changes in abnormal brain tissue. However, more recently it has 
been used in identification of neurodegeneration (Seo et al., 2012; Tumati et al., 2013), 
and also temporal changes within brain lesions following stroke (Muñoz Maniega et al., 
2008). 
1.5.4.3 Hippocampal pathology 
The hippocampus is situated within the medial-temporal lobe, its robustness and health 
is often linked with neurodegeneration. The hippocampus is one of the first areas of the 
brain to undergo damage with the onset of Alzheimer type dementia. The progression of 
Alzheimer’s, and its subtypes are associated with progressive decrease in hippocampal 
volume (Vijayakumar & Vijayakumar, 2012).  
As documented in section 1.4 we describe the relation between stroke, and onset of 
cognitive decline, or as some describe it; post-stroke dementia. There is sample of 
convincing literature on the link between dementia, specifically Alzheimer’s and the 
hippocampus (Casolla et al., 2018; Chen et al., 2016; Kliper et al., 2013; Leys et al., 
2005; Mijajlović et al., 2017; Pendlebury & Rothwell, 2009; Schaapsmeerders et al., 
2015; Sun et al., 2014). The hippocampus is a known vulnerable structure in the disease 
of dementia and ageing.  
If we want to explore potential drivers of post stroke dementia, then examining the 
pathology of the hippocampus in the post-stroke brain may provide an insight into the 
pathological onset of post-stroke dementia. Some studies have implicated the 
hippocampus as an important structure in post-stroke dementia, with decreased 
hippocampal volume following stroke evident even within the early stages post-stroke 
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(Brodtmann et al., 2012; Werden et al., 2017). These studies are described in more 
detail in Chapter four.  
In the post-stroke brain, there has been reported neuronal loss in the hippocampus, 
causing more severe cognitive outcomes (Kliper et al., 2013; Schaapsmeerders et al., 
2015; Sun et al., 2014). Atrophy in this structure has been associated poor cognitive 
outcomes, and an increased risk of cognitive decline following stroke (Casolla et al., 
2018; Chen et al., 2016; Leys et al., 2005; Mijajlović et al., 2017; Pendlebury & 
Rothwell, 2009). Hippocampal mean diffusivity has been found to predict memory 
abilities following stroke independent of lesion volume (Hosseini et al., 2017; Kliper et 
al., 2013). Kliper and colleagues further suggest that mean diffusivity precedes 
volumetric changes in the hippocampus, making it a potential biomarker for early 
cognitive decline following stroke (Kliper et al., 2016). 
Metabolic changes have been observed in dementia, where N-acetylaspartate (NAA) is 
found to be lower in Alzheimer’s Disease (Kantarci, 2007). Decreased NAA and Cr 
have been found to predict dementia onset (Metastasio et al., 2006). Specifically in the 
hippocampus, and there is evidence of lower NAA in Alzheimer ’s disease, and 
subcortical ischemic vascular dementia (Shiino et al., 2012), with increased Ch in the 
hippocampus in Alzheimer’s disease progression compared to healthy controls. 
Following stroke, Ross and colleagues examined the predictive value of metabolites 
(NAA/Cr) in the frontal white matter, and found that it predicted cognitive decline in 
the first 12 months following stroke (Ross et al., 2006). Focusing on the hippocampus 
of middle cerebral artery stroke patients in the chronic stage, Tang and colleagues show 
that relative to controls (matched on age and education), patients’ hippocampus was 
reduced in volume, and also the ratio between NAA and creatinine (Tang et al., 2012). 
Patients with larger hippocampi volume reduction also showed cognitive deficits (Tang 
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et al., 2012). It is worth noting that the Tang and colleagues did not comment of 
whether they accounted for volume changes in their spectroscopy analyses (Tang et al., 
2012).  
In Chapter four,  DTI,  Spectroscopy, and volumetric measurements were taken using 
MRI. Please see section 1.5.4.2 for methodological description of the MR modalities 
used in Chapter four. We investigated hippocampal pathology using these three 
modalities, allowing us to examine whether hippocampal changes are evident in our 
stroke cohort, as with other stroke cohorts reported in studies examining hippocampal 
pathology within three months of stroke (Brodtmann et al., 2012; Haque et al., 2019; 
Werden et al., 2017). DTI and volumetric measurement of the non- lesioned 
hippocampus in the post stroke brain has been previously examined. Where decreased 
volume, and increased levels of mean diffusivity was identified in the post-stroke 
hippocampus (as discussed above). Additionally, both lowered volume of the 
hippocampus, and increased mean diffusivity of the hippocampus correlated with 
lowered cognition. These studies are described in more detail in Chapter four.  
We utilised a third MR modality – Magnetic Resonance Spectroscopy (MRS), which 
has previously focused on chemical levels (metabolites) within the lesion site following 
stroke. MRS has also been used to examine chemical changes in cognitive decline, with 
metabolite NAA highly implicated in the process of cognitive decline (Kantarci, 2007; 
Liang et al., 2017; Targosz-Gajniak et al., 2013). We will mirror the use of this 
modality as previously done in dementia research, and like the DTI and volumetric 
measurements, explore whether hippocampal pathology is evident in our stroke cohort, 
as it is with others in stroke cohorts and in cognitive decline research. The MR 
modalities are described in more detail in section 1.5.4.2. Using all three modalities 





The literature suggests that not all stroke patients recover in the same way, and that 
some are at risk of cognitive decline. The studies advocating cognitive decline 
following stroke use varied definitions of what constitutes cognitive decline, with a 
large number of definitions, and lack of clarity (Mijajlović et al., 2017). A large 
proportion of studies comment on cognitive decline examining only one cognitive 
domain, and using a brief cognitive screens (Suzuki et al., 2013). When establishing 
potential post-stroke cognitive trajectories there is a necessity to assess two or more 
time-points, in order to establish cognitive change over time. In order to understand the 
potential cognitive trajectories, it is important to consider all these factors; the whole 
profile of cognition using detailed cognitive assessments across multiple domains, and 
measuring change across more than one time point.  
The suggested factors affecting recovery trajectories, and influencing cognitive decline 
following stroke are wide ranging; from socio and clinical demographics, to stroke 
profile and overall brain health. Epidemiological and longitudinal cohort studies have 
attempted to answer the impact of these factors on post-stroke cognitive impairment, 
with only a handful examining their impact on cognitive trajectories using a detailed 
cognitive profiling approach (Ramsey et al., 2017).  
1.7 Outline of thesis 
 
The current thesis aimed to describe cognitive trajectories following stroke, and 
examine potential predictors of cognitive outcome, and trajectories. It used data from 
two existing databases: the Birmingham Cognitive Screen Study (BUCS) collected in 
the UK, and the C-BCoS collected in China. It also reports newly collected data as part 
of the HiPPS-CI study which aimed to examine the role of hippocampal pathology in 
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post-stroke cognitive impairment. Stroke cohorts across all three studies represented 
stroke patients with mild-moderate severity strokes. Recruitment was as inclusive as 
possible with minimal exclusion criteria to provide a representative sample of these 
types of survivors. Across all three chapters (two-four), the BCoS was used to provide a 
detailed cognitive profile of patients within and across cognitive domains.  
1.8 Chapter Outline 
 
Chapter two aimed to answer the question; does the proportional recovery rule 
(recovery of a percentage of deficits proportional to initial post-stroke deficit) exist in 
cognition, as it does with motor recovery? In other words, can short term cognitive 
outcomes following stroke be used to predict long term outcome. In motor recovery it 
has been argued that in the long term, recovery is proportional to initial deficits. We 
also examined whether all stroke patients follow the proportional recovery rule, and if 
they do not, what other trajectories of cognitive recovery exist in post-stroke cognition?. 
In chapter two, Rosanna Laverick (RL) was presented with the BUCS database. The 
database contained both baseline and follow up cognitive data (n=380), which was 
somewhat organised. RL further cleaned and organised the data,  and additionally 
computed more details. RL calculated the number of missing data (number of tasks per 
individual), and consequently extracted only individuals that reached the data inclusion 
threshold. In those with a small number of missing data, a conservative approach was 
taken by inputting the group average. RL then calculated the number of intact tasks, and 
deviation scores for each patient, and deviation scores only for controls. The statistics 
within the chapter (e.g proportional recovery calculations) were also calculated by RL, 
and all figurative presentations were also completed by RL. RL wrote the chapter in 
manuscript format, with draft reviews from supervisors and collaborators. This chapter 
has been submitted for review: Laverick R, A.A Hosseini, W-L Bickerton, N 
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Demeyere, D Sims And P Rotshtein. Recovery trajectories following stroke: the 
proportional recovery rule in cognition. (Submitted). Please note that this chapter has 
been submitted to a journal as a research article, and has been presented at national 
conferences.  
Chapter three investigated the protective factor of education level on cognition across 
and within cognitive domains. The impact of education on cognition was examined in 
relation to other clinical-demographic factors such as age, mood and functional 
independence. The relationship between education and cognition was examined in three 
different contexts. Firstly, we examined whether education predicted level of cognition 
in an ageing population across, and within UK and China cohorts. Secondly, we 
assessed whether years of education can determine cognitive outcomes within three 
months of stroke across, and within UK and China cohorts. And finally, expand our 
understanding of the predictive value of level of education on cognitive outcomes at 
nine months post-stroke, and its impact on recovery rates between three, and nine 
months post-stroke. In chapter three, Rosanna Laverick (RL) utilised the work 
computed in chapter two with the BUCS database, with the addition of >500 additional 
data points of baseline cognition for the UK cohort. As with chapter two, RL calculated 
the same information for these additional data points. In addition to the data from the 
BUCS database, data from the C-BCoS was also included. RL organised and translated 
this database from Cantonese and Mandarin, and organised in accordance with the 
BUCS database format. Following database cohesion, the same calculations as 
mentioned above were also computed across the C-BCoS database, with both patients 
and controls. The statistics within the chapter were also computed by RL, and all 
figurative presentations were completed by RL. RL wrote the chapter in manuscript 
format, with draft reviews from supervisors and collaborators. This chapter has been 
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submitted for review: Rosanna Laverick, Haobo Chen, Johnny King Lau, Wai-Ling 
Bickerton, Akram A. Hosseini, Nele Demeyere, Don Sims, Jin Zhou, Xiaoping Pan, Pia 
Rotshtein. Education improves short and long-term stroke cognitive outcomes in UK 
and China. (Submitted). Please note that this chapter has been submitted to a journal as a 
research article, and has been presented at international and national conferences. 
Chapter four used neuroimaging methods to assess whether stroke causes abnormal 
hippocampal pathology in the first three months following stroke. Secondly, we aimed 
to examine the relationship between abnormal hippocampal pathology, and post-stroke 
cognition. Neuroimaging methods used for these analyses included; mean diffusivity of 
the hippocampus using diffusion tensor imaging, grey matter voxel intensity of the 
hippocampus using T1-weighted images, and metabolite levels using magnetic 
resonance spectroscopy. Chapter four included a newly collected database from the 
HiPPS-CI project. The project (HiPPS-CI) presented in chapter four, was initiated in 
2015 prior to the start of this PhD. At the start of the PhD project, ethical approval was 
obtained, and recruitment of participants and their assessments had begun (n=10) at one 
NHS site. Following the start of the PhD, RL took over responsibility for this project, as 
trial manager. This included ethical amendments, of which focused on increasing 
recruitment size. RL successfully assisted in obtaining clinical research network 
portfolio adoption of the project, and the addition of a second recruiting NHS site. 
Management of the project involved ethical, recruitment, data management, and 
assessments of individuals (Cognitive and MRI). Two undergraduate students, and one 
masters’ student assisted with the data collection at different time points in the duration 
of the project. Data collection, data cleaning, and organisation of data for both cognitive 
and imaging data by RL. Analysis of imaging and cognitive data was completed RL, 
and in the case of the imaging data the pre-processing, modelling and statistics. The 
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writing of this chapter was completed by RL, with reviews by supervisors. Please note 





 Chapter 2: Recovery trajectories following stroke: the 





There is some evidence that post-stroke recovery is proportional to the initial severity of 
the impairment. This has been repeatedly reported in post-stroke motor recovery. 
Though, not all patients with severe motor impairments recover proportionally. 
2.1.2 Aims 
This chapter aimed to examine whether proportional recovery is observed within and 
across cognitive domains following stroke; and whether all patients show similar 
recovery trajectories. 
2.1.3 Method 
The data of 380 stroke patients from the BUCS study were analysed. Cognitive ability 
was assessed using the Birmingham Cognitive Screen (BCoS) at baseline (within three 
months of stroke) and at follow up (nine months post-stroke). The BCoS assessed 
cognition along five domains: language, memory, praxis, attention and executive 
function and number. Proportional recovery from baseline to follow up was computed 
using the number of impaired tasks, as well as domain specific impairments. A formal 
outlier analysis was used to identify patients that did not follow the proportional 
recovery rule. 
2.1.4 Results 
Within the first nine months, 80% of patients recovered 40-50% of their loss of 
cognitive abilities recorded at post-stroke baseline. This is shown within and across 
cognitive domains. The outlier analysis identified two groups that did not follow the 
57 
 
proportional recovery rule. 10% of patients showed an accelerated recovery, while 
around 10% showed a decelerated recovery or decline. In the decline group, 2/3 had 
severe cognitive impairment at post-stroke baseline, while 1/3 had mild impairments. 
2.1.5 Conclusion 
The analysis demonstrated proportional recovery of cognition at nine months following 
stroke, both across and within domains, in 80% of the sample. However, in contrast to 
the literature examining motor recovery, trajectories of cognition were variable, 
showing accelerated recovery in some patients and decline even in patients with mild 
impairments at post-stroke baseline. 
2.2 Introduction 
 
A proportional recovery rule in the first three months post-stroke has been well 
documented in the motor domain (Krakauer, 2006; Krakauer, 2015). The proportional 
recovery rule in motor recovery predicts that, on average, stroke patients will achieve 
about 60% of their potential for recovery (Krakauer, 2006; Krakauer, 2015). Potential 
for recovery is defined as the difference between post-stroke performance, and intact 
motor ability. However, some patients who have severe motor impairments do not 
recover as predicted by the proportional recovery rule (Buch et al., 2016; Shyam et al., 
2007). These patients are described as ‘non-fitters’ (Buch et al., 2016; Shyam et al., 
2007). The proportional recovery rule is less established for cognition than for motor 
recovery, although it has been demonstrated in research in specific cognitive domains, 
such as aphasia (Lazar et al., 2010) and neglect (Marchi et al., 2017). Ramsey and 
colleagues (Ramsey et al., 2017) examined recovery across cognitive domains, and 
found that initial deficit predicted outcome, with most recovery occurring within the 
first three months. In the current chapter, we will re-examine the proportional recovery 
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rule across and within cognitive domains. We will systematically assess whether 
individual patients fit the rule. 
Research suggests that 80% percent of acute stroke patients have cognitive impairments 
in at least one cognitive domain (Demeyere et al., 2015; Sun et al., 2014). Cognitive 
deficits predict patients’ ability to function independently (Bickerton et al., 2015) (see 
1.2.4.1). There is mixed evidence regarding long-term cognitive outcomes following 
stroke. While most stroke patients improve their functional and cognitive abilities 
(Bickerton et al., 2015; Ramsey et al., 2017), one third develop dementia after stroke 
(Pendlebury, 2009). Most studies reporting on prevalence of dementia following stroke 
rely on a single time point measure (Barker-Collo & Feigin, 2006; Hénon, 2006; 
Pendlebury, 2009) (see 1.4.3). Mijajlović and colleagues advocate for a diagnosis of 
post-stroke dementia, based on presence of cognitive impairment at six months post-
stroke (Mijajlović et al., 2017) . The authors acknowledge that their diagnosis cannot 
differentiate between vascular insult and neurodegeneration aetiology. To be able to 
distinguish between different causes it is critical to study cognition as a trajectory of an 
individual’s change between at least two time points (Ramsey et al., 2017; Vigliecca, 
2017), following stroke (Brainin et al., 2015; Lodder, 2007).  
We retrospectively analysed the data obtained from the Birmingham University 
Cognitive Screen (BUCS) study (Humphreys et al., 2012). The BUCS study was 
conducted to validate the Birmingham Cognitive Screen (BCoS) in stroke. The BUCS 
recruited patients up to three months after stroke, for a baseline assessment, and 
followed them up at nine months. Detailed cognitive, functional and mood assessments 







As documented in 1.2.4.1, the BUCS study was designed to validate a cognitive screen. 
The data was collected between 2006 and 2011. On average, the baseline assessments 
were conducted four weeks after the stroke, ranging from one to ninety days. No 
patients were assessed during the hyper-acute stage <12 hours from stroke onset (Table 
1). It is worth noting that in 2008, the UK NICE guidelines introduced thrombolysis as 
an early intervention for hyper-acute stroke. Consequently, it is possible that a small 
portion of the patients in this study will have received thrombolysis.  
The current study only included patients who were followed up at nine months post-
stroke (n=380). The demographics and baseline clinical history of this study population 
is presented in Table 1. 
The recruitment criteria were designed to be as inclusive as possible, with minimal 
exclusion criteria. This was to gain a representative sample of stroke patients who had 
high chance of survival at nine months. Stroke patients were recruited if they were: (a) 
medically stable, (b) within three months of clinical diagnosis of stroke, (c) able to give 
informed consent. They were excluded if they had (a) insufficient understanding of 
English, (b) inability to concentrate for 35 min (c) and if they failed the BCoS force-
choice orientation questions (e.g. what city you are in? what is the year?) suggesting 
lack of comprehension. Patients who were initially too impaired to participate, were 
approached to take part, again at a later point within three months. This means that 
stroke severity negatively correlated with time of testing in the BUCS dataset (Lau et 
al., 2015).  
The original BUCS study included 908 stroke patients, of whom 380 were followed up 
60 
 
at nine months after stroke. Reasons for missing follow up were: (a) incomplete 
baseline data (20%) (b) refusal (11%), (c) death (8%), (d) inability to contact (17%), (e) 
hospitalisation or other serious conditions (4%), (f) other reasons (2%). Informed 
consent was obtained according to the approved ethics protocols by the U.K. National 
Research Ethics Committee. Please see details of the trial CONSORT flow diagram for 
recruitment and attritions in Bickerton and colleagues (Bickerton et al., 2015). In the 
full BUCS dataset, no differences in sex, age and baseline Barthel Index, were reported 
between patients who were followed up or lost to follow up (Bickerton et al., 2015) (See 
Appendix 1.2.4.1).   
We computed required sample size for chapter two using effect sizes documented in 
(Lazar et al., 2010) and G*Power. Effect size used to compute required sample size for 
predicting baseline cognition to follow-up cognition was r=.69 with power at 80% 








Table 1. Clinical and demographic information 
Notes. Std= Standard Deviation, HADs= Hospital Depression and Anxiety scale (higher scores indicate 
higher severity), Barthel Index (higher scores indicate more functional ability).  
 
2.3.2 Measures  
All the data were collected by examiners (psychologists, occupational therapists, or 
stroke researchers), who were trained, tested and supported by the BCoS team. The 
database also includes normative data from 100 healthy age-matched and socio-
economic matched controls (Humphreys et al., 2012).  
The data for each patient included demographic information (Table 1),  level of 
functional independence measured by the Barthel Index (Mahoney & Barthel, 1965), 
and mood status was assessed by the Hospital anxiety and Depression Scale (HADS) 
(Zigmond & Snaith, 1983), (See 1.2.4.1 for description of these measures). Evidence for 
neurological history (previous stroke, TIA, tumour, dementia, epilepsy, other) was 
recorded based on the patient’s hospital records. Neurological incidents between 
 
   Stroke (n=380) 
 
   Mean/Ratio SD 
Age (years) 69.28 12.87 
Sex (Male: Female) 213:167 
 
Neurological History (History: No History) 127:253 
 
Type of Stroke (Ischaemic: Haemorrhagic) 358:22 
 
Stroke incidences from Baseline-Follow Up 19  
Stroke to Baseline Assessment (months) 0.55 1.08 
Baseline to Follow Up Assessment (months) 8.75 1.07 
Years of Education 11.59 3.03 
Baseline Barthel 12.63 5.92 
Baseline HADS anxiety 6.46 4.48 
Baseline HADS depression 6.23 3.92 
Follow up Barthel 17.02 4.02 
Follow up HADS anxiety 5.82 4.33 
Follow up HADS depression 5.87 3.80 
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baseline and follow up were self-reported by the patients (See 2.4.1 for neurological 
history breakdown). All patients had at least 80% of the data completed. For each task, 
less than 5% of the data were missing (incomplete individual tasks, for example due to 
fatigue, aphasia), and in these instances we adopted a conservative approach and 
replaced the missing data by the group mean, to ensure this would not affect the 
regression analyses. 
2.3.3 Cognitive measures 
The BCoS was used to assess cognition (Humphreys et al., 2012), focusing on domain 
specific abilities, across five cognitive domains (a) attention and executive function, (b) 
language, (c) memory, (d) number, and (e) praxis. A full description of the BCoS is 
documented in section 1.2.4.1.  
2.3.4 Dependent measures 
Two measures were computed for each patient per task at baseline and follow up: (a) 
Patients were categorised as ‘impaired’ or ‘not impaired’ on the task. Impairment was 
defined as performance within the 5th percentile of aged matched controls (Humphreys 
et al., 2012). General cognition was computed by counting the number of tasks in which 
a patient was classified as impaired. Due to the uneven number of tasks per domain, this 
measure may be biased toward language abilities, as these were measured using six 
tasks (as opposed to numerical ability, which was assessed with three tasks).  This 
measure was used as it adheres to common approaches in standardised cognitive tests 
(e.g. MoCA (Nasreddine et al., 2005), and OCS (Demeyere et al., 2015)); (b) a 
deviation score from the control data was computed (Z=(meanControl–Patient 
score)/stdevControl) (Sampanis, 2015). Using Z scores enabled a finer measurement of 
cognitive ability, accounting for change in deficit severity. Ability within domain was 
computed by averaging the Z scores of the relevant tasks. General cognitive ability was 
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computed by averaging across the five domains; hence it was not confounded by the 
number of tasks per domain.  
First, step-wise regression was performed to test whether age, education, previous 
neurological history, stroke type, time to baseline assessment, time between baseline 
and follow up assessments, lesion side (left, right or bilateral), and mood measures 
(HADs) were confounding variables to the relationship of baseline and follow up 
cognition. This procedure was applied for each of the dependent measures. The only 
reliable association was found between performance on baseline, education and follow 
up performances, whereas all other associations were unreliable ( -.1 < partial r < .1, P > 
.1). To simplify, the proportional recovery analyses only included the baseline 
performances as a predictor. To ensure the results were not driven by education or age, 
we computed linear regression for each cognitive domain and general cognition where 




Table 2. Cognitive domain correlation with residuals  
after controlling for education 
Cognitive Domains R2(F) B 
   
General  .144 (63.83) .168** 
Memory .097 (40.78) .290** 
Attention and Executive Function .274 (143.01) .429** 
Language .352 (205.25) .442** 
Praxis .117 (49.94) .263** 
Number .326 (182.70) .457** 
** Significant at P<001 level 
   
2.3.5 Analysis 
2.3.5.1 Proportional recovery 
 
To calculate the proportional recovery for general cognition (i.e. number (#) of impaired 
tasks) two regression models were implemented. In both models, the potential for 
recovery at baseline was used as a predictor. The models differed in their dependent 
variables. Regression (1) followed the reported formula by (Krakauer, 2006; Lazar et 
al., 2010). This model was used to predict proportional recovery in the domains of 
motor abilities and aphasia.  
Regression (1): 
ΔD = T1 − 	T0 
ΔD = 	β1 ∗ (23 − T0) + 	β0	; 
01 = 	β1 ∗ 100 
T0 is the number of tasks that were intact at baseline; T1 is the number of tasks that 
were intact at follow up; ΔD is the difference between the two. 23 is the total number of 
tasks that were assessed. In regression (1) the dependent variable was the difference 
between patients’ ability at follow up and their ability at baseline. β1 and β0 are 
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estimated parameters. In this case, β1 reflected the proportion of task that recovered as a 
function of the initial number of impaired tasks. PR is proportional recovery.  This 
model may be confounded by mathematical coupling (Blomqvist, 1977; Hope et al., 
2018; Krakauer, 2015). This confound is inflated if the difference in the variability 
between patients at baseline and follow up is large. We therefore computed proportional 
recovery using a dependent variable that was completely independent from the baseline 
measurement.  
Regression (2): 
231 = 23 − 31 
231 = 	41 ∗ (23 − 30) + 	40 
01 = (1 − 	β1) ∗ 100 
 
Predicted outcomes (performance at follow up) were computed using the betas obtained 
in regression 2.  
2315 = 	41 ∗ (23 − 30) + 	40 
 
The difference between the predicted and observed outcomes represented the deviation 
from the outcome that would have been expected based on the proportional recovery 
rule. 2315  represents the predicted deficit, and ∆ represents the difference between 
predicted and observed. 
 
∆	= 2315 − 	231 
For the number of impaired tasks, negative delta (∆) in the formula represented an 
accelerated recovery (fewer impaired tasks than expected), whereas positive delta 
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represented a decelerated recovery (more impaired tasks than expected). For the 
regressions based on the Z scores, negative delta (∆) represented a decelerated recovery 
rate (poorer performance than expected), while positive delta represented an accelerated 
recovery rate (better performance than expected) in comparison to the predicted 
outcome.  
The baseline scores were used for prediction of the actual follow up scores. This is the 
recommended way to predict recovery, since it reduces the measurement noise 
confounds, and decouples the predictors from the dependent variables (Cronbach, 
1970). In this case, the estimated parameter reflected the proportion of ability that did 
not recover from baseline (measured as number of tasks or Z score), hence to compute 
the proportion of impairment that recovered we present it as the difference from 100%.  
2.3.5.2 Recovery trajectories: Fitters and non-fitters 
 
To identify non-fitters, outlier analyses in SPSS23 were performed for patients whose 
recovery did not follow the proportional rule. This was computed for each domain as 
well as for the measures of general cognition. The SPSS algorithm used the distribution 
of the data (i.e. the delta) to identify outliers (i.e. non-fitters).  Outliers were identified 
as patients’ scores that were outside a conservative range. Specifically, the range was 
determined by 50% of the population ± 1.5 the interquartile range. The interquartile 
range was computed as the difference between the highest and the lowest scores of 50% 
of the sample. Further analyses were done to explore and describe the demographic and 
cognitive characteristics of the non-fitter patients.  
2.3.5.3 Post-stroke recovery time 
  
The extended time window at the baseline assessment (three months) enabled us to test 
whether in this sample, recovery depended on the time window between baseline and 
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follow- up assessments. We analysed each individual’s proportionate change from 
baseline to follow up [(baseline-follow up)/baseline] in each of the seven dependent 
cognitive measures (i.e. number of impaired tasks, Z-scores across and within each of 
the five domains). The study population was divided into 12 groups based on the week 
of baseline assessment (number of weeks since stroke). One-way ANOVA was 
performed to test for reliable differences between the groups. To ensure that the results 
were not driven by a floor effect, we ran additional separate analyses for patients who 
were more severely impaired (more than 1.65 from the control mean) and those who 
were mildly impaired at baseline (>1.65). Linear regression was performed to test for 
reliable differences between the individual as a function of time from stroke to baseline 
assessment. To assess whether the evidence supported the alternative (time of testing 
affected recovery rate) or the null hypothesis (it does not), we computed Bayes factor 
(BF01) (Jaroz, 2014) applying the conventions that BF01 > 3 would support the null 
hypothesis, and BF01 < 1/3 would support the alternative.  
2.4 Results 
 
2.4.1 Demographics and cognitive profile 
Table 1 presents a full description of the 380 stroke patients included in these analyses. 
At baseline, 253 patients had no recorded neurological history; for 99 participants a 
prior history of stroke/TIA was recorded, four had documented head injury, two were 
diagnosed with dementia prior to the stroke, and 21 had a history of other neurological 
conditions (e.g. tumour, epilepsy). Information on one patient was not recorded. At 
follow up, 19 patients’ self-reported recurrent incidence of stroke/TIA, while nine 
reported new epileptic seizures, for five patients this information was not recorded at 
follow up. Of the 19 patients who reported a second stroke at follow up, two had 
decelerated non-fitter pattern, and showed deterioration across all cognitive scores. One 
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patient performed poorly at baseline (showing deficits on more than 65% of the tasks, 
with an average severity score of -7.9), the second patient only had a mild impairment at 
baseline, (showing deficits on ~7% of the tasks, with an average severity of -.92). One 
patient showed substantially declined performance on attention and executive function 
(identified as decelerated non-fitter for this domain), while two others had significant 
improvements in their overall cognitive scores (accelerated non-fitter). Of the nine who 
reported epilepsy, four had decelerated non-fitter data; only one of them showed 
deceleration across domain while the three others showed deceleration only in two of 
the domains. The performance at follow up for the two patients with pre-stroke 
dementia was predicted by their baseline performances, i.e. their recovery fitted the 
proportional rule of the group. 
The cognitive data were not normally distributed and were positively skewed, with 
more patients showing relatively mild cognitive impairment (Table 3). There was a 
medium to high correlation between the baseline and the follow up performances. The 
overall cognition and performances within each domain improved at follow up (Table 3, 
Figure 2).  
Overall functional ability, as measured by the Barthel Index (lower Barthel Index 
demonstrates a lower functional status), improved across all patients from baseline to 
follow up, as did their mood measured by the HADs (lower HADs demonstrates a better 




Table 3. Baseline and Follow Up Cognition 
  
  
Baseline Follow up BL-FU  
Mean (SD) Median Mean (SD) Median T (379)  
Intact cognitive Tasks 
(Max=23)  
15.26 (6.28) 17.00 17.41 (5.26) 19 -9.17**  
Overall severity (Z) -3.01 (3.79) -1.36 -1.97 (2.94) -0.935 -6.55**  
Domain Severity (Z) 
     
 
Language -4.18 (7.22) -1.00 -2.47 (5.53) -0.379 -5.89**  
Attention and 
Executive Function 
-2.41 (3.45) -2.00 -3.53 (4.06) -9.72 -6.07**  
Number -2.59 (3.79) -0.69 -1.68 (3.14) -0.125 -5.68**  
Praxis  -2.02 (2.85) -1.03 -1.32 (2.26) -0.548 -4.75**  
Memory -2.70 (4.19) -0.71 -1.98 (3.95) -0.314 -2.99* 
Notes. **Significant at p < .001 level (2-tailed), *Significant at p < .005 (2-tailed), SD=standard deviation.  
  
Domains= five cognitive domains in BCoS, Max intact score= 23 tasks, Z= 0 is not impaired and negative 
numbers represent the distance from healthy controls 
        
     
2.4.2 Proportional recovery 
Regression model one (a similar procedure to Krakauer and colleagues (Krakauer, 2006; 
Krakauer, 2015) showed that overall, patients recovered 41% of their lost function at 
nine months (Table 4), as judged by the number of impaired tasks. Regression model 
two, which is not confounded by mathematical coupling, showed similar results; 
baseline deficits linearly predicted performances at nine months follow up (Table 4, 








Figure 2. Cognitive recovery is proportional to initial impairment in general cognition 
(Z score). 
Baseline general cognition is represented on the x-axis, and Follow up general cognition 
is represented on the y-axis. Cognition is measured in Z score, with 0 demonstrating no 
impairment, and negative numbers representing impairment, and distance from healthy 






Table 4. Proportional recovery: Linear Regression Models 
       
Formula R2(F) B1 (CI) B0 (CI) 
Proportional 
(%) Outliers Decelerate  
Outliers 
Accelerate 
General cognition:       
#T: FU-BL=B1 (max-BL) +B0 0.32 (179.59) 0.41 (0.35:0.47) -1.05 (-1.65:-1.45) 41% 
  
#T: FU=B1(max-BL) +B0 0.49 (362.80) 0.59 (0.53:0.65) 1.00 (0.44:1.65) 41% n=22 Δ#T ≤ -6.8 n=6 Δ#T ≥ 7.5 
Z: FU=B1(BL)+B0 0.37 (222.56) 0.47 (0.41:0.54) -0.55 (-0.85:0.25) 53% n=31 ΔZ ≤ -2.6 n=18 ΔZ ≥ 3.1 
Cognitive Domains (Z):  
     
Memory 0.12 (50.75) 0.32 (0.23:0.41) -1.10 (-1.56:0.66) 68% n=47 ΔZ ≤ -2.8 n=9 ΔZ ≥ 4.3  
Attention and Executive Function 0.30 (164.94) 0.47 (0.40:0.54) -0.75 (-1.14:0.37) 53% n=34 ΔZ ≤ -3.5 n=10 ΔZ ≥ 4.3  
Language 0.40 (253.32) 0.49 (0.42:0.54) -0.44 (-0.94:0.06) 51% n=37 ΔZ ≤ -2.0 n=34 ΔZ ≥ 2.8  
Praxis 0.15 (66.92) 0.31 (0.23:0.38) -0.70 (-0.95:-0.44) 69% n=27 ΔZ ≤ -2.9 n=3 ΔZ ≥ 4.1  
Number 0.37 (218.63) 0.50 (0.44:0.57) -0.38 (-0.69:-0.07) 50% n=38 ΔZ ≤ -2.8 n=18 ΔZ ≥ 3.5  
Notes. #T= number of tasks; Z,= standardised deviation from healthy controls; FU= follow up; BL= Baseline; B1= the fitted parameters for the baseline data, B0= the fitted 
parameters for the constant; CI= confidence interval for the fitted parameters.; F test with (1,379) degrees of freedom; n=number of patients classed as outliers.  Outliers 
defined from the SPSS outlier software (described  on page 60).  ΔZ represents the outlier direction, with negative delta (∆)representing an accelerated recovery (fewer 
impaired tasks than expected), whereas positive delta represented a decelerated recovery (more impaired tasks than expected).  
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When patients’ deficit severity was analysed as a continuous measure (Z scores), the 
expected proportional recovery was larger. Across the five cognitive domains, patients 
were expected to recover more than 50% of their deficits. The lowest recovery level was 
observed for numerical abilities (50%) and the highest for praxis abilities (69%) (Table 
4).  
2.4.3 Recovery trajectory: time from stroke 
Figure 3 presents the number of impaired tasks based on the week patients had their 
baseline assessments. Patients’ overall cognitive performance improved at follow up 
irrespective of the time of assessment. A formal analysis of recovery based on the time 
of baseline assessment revealed no reliable effects for all the seven dependent measures 
(for all Fs (20,359) < 1.4, p > .118). To ensure that these null results were not driven by 
a floor effect (the mild patients), we recomputed the analysis with linear regression 
using the general cognition separately for patients with mild impairment (n=172, R2 = 
.001), P =1.00, BF01 < .01), and those who were more severely impaired at baseline 
(n=208, R2 = .001, P =1.00, BF01 < .01). The analysis showed that the effects were not 
reliable, in all analyses. Note that the Bayes factor (BF01) in all analyses was smaller 
than 0.3, meaning the data provide sufficient evidence to support the hypothesis that 









Figure 3. Number of Cognitive Deficits by Time of Baseline Assessment. The x-axis 
represents the number of weeks from stroke that baseline assessment was completed. N 
denotes the number of patients assessed at each time point. The y-axis represents the 
average number of deficits (0-23). Blue represents baseline and grey follow up.  
2.4.4 Recovery trajectories: Fitters and non-fitters 
The outlier analyses detected two types of non-fitter data for each measure (Table 4, 
Figure 2). Those with accelerated recovery rates exhibited better than predicted 
performance at follow up. Non-fitter data characterised by decelerated recovery 
revealed poorer than expected performance at nine months. There were more 
decelerated non-fitters than accelerated. When considering the number of impaired 
tasks, all patients who showed a decelerated recovery (below the regression line, fewer 
deficits than expected, Figure 2) performed relatively poorly at baseline. However, 
performances at baseline varied for the decelerated recovery group (above the 
74 
 
regression line, more deficits than expected); some showed severe impairments at 
baseline, while others showed very mild baseline cognitive impairments. See  
Figure 4.  
 
 
Figure 4. Cognitive domain outlier box-plots. Each cognitive domain is represented by 
a box-plot. The Y axis plots the difference between the predicted cognitive deficit (Z) at 
follow-up, as opposed to the observed (Z). 
A detailed examination of the outliers who declined at follow up revealed that 6.84% 
(26/380) of patients showed overall cognitive deceleration (i.e. they were identified as 
decelerated outliers in more than three domains). A total of 18.15% (69/380) of patients 
were identified as non-fitters in only one or two domains. In Table 5, we provide 
descriptive information (demographic, mood, functional and clinical information) for 
two decelerated groups: 1) those who declined only on one/two cognitive domain(s); 2) 

































combined. The clinical and demographic profile did not differ between any of the 
groups (see Table 5).  







 Decelerated  
(non-fitter >2 
domains) 
N 281 69 26 
Age (years) 69.12 69.86 (13.55) 69.64 (18.32) 
Gender (Male: Female) 164:121 34:35 15:11 
Neurological History (yes: No 
History) 98:187 48:21 8:18 
Type of Stroke (Ischaemic: 
Haemorrhagic) 268:13 66:3 24:2 
Stroke recurrence from Baseline-
Follow Up 16 1 2 
Stroke to Baseline Assessment 
(months) .52 (1.18) .62 (.72) .61 (.75) 
Baseline to Follow Up Assessment 
(months)  8.72 (1.08) 8.79 (1.07) 8.92 (.95) 
Years of Education 11.86 (2.96) 11.17 (2.90) 9.78 (3.44) 
Baseline Barthel 13.21 (5.84) 10.92 (5.77) 10.74 (6.22) 
Baseline HADS anxiety 6.11 (4.30) 7.22 (4.84) 7.97 (4.93) 
Baseline HADS depression 5.98 (3.71) 6.64 (4.31) 7.85 (4.69) 
Follow up Barthel 17.65 (3.54) 15.68 (4.57) 13.69 (4.97) 
Follow up HADS anxiety 5.67 (3.60) 6.42 (4.90) 5.83 (4.05) 
Follow up HADS depression 5.50 (3.60) 6.63 (4.23) 7.81 (4.01) 
Notes: Mean is represented in the table, with standard deviation noted alongside the mean, HADs= 
Hospital Depression and Anxiety scale (higher scores indicate higher severity), Barthel Index (higher 






The present study offers evidence for proportional recovery across the cognitive 
spectrum at nine months following stroke.  A proportional recovery rate of 40% was 
observed for the number of impaired cognitive tasks. Higher recovery rates were 
demonstrated when using a continuous measure of severity (50% - 69%), both for 
overall cognitive performance and for specific cognitive domains. Recovery rate at nine 
months was not affected by the time of baseline assessment. In other words, patients 
recovered at similar rates when assessed within one week of the stroke or at three 
months following stroke.  The analysis also identified “non-fitter” patients who did not 
follow the proportional recovery rule. We identified a small group of patients (<10%), 
who showed more improvement in cognitive abilities than expected, displaying 
accelerated recovery. A second group of patients (~10%), presented decelerated 
recovery. The available clinical and demographic information did not clearly 
differentiate between the fitters and the decelerated non-fitters. 
2.5.1 Recovery up to nine months 
This study demonstrated proportional recovery in cognition at nine months following 
stroke. The cognitive recovery rate within and across domain matches previous reports 
(Ramsey et al., 2017).  
Proportional recovery in previous studies focused on recovery at shorter time scales, 
between 72 hours to 90 days (Lazar et al., 2010; Marchi et al., 2017), (though see 
(Ramsey et al., 2017; Winters et al., 2016)). Based on the biological recovery timeline 
(Cramer, 2008; Murphy & Corbett, 2009), the proportional rule measured in those 
studies reflected the restoration of functions based on a mixture of homeostatic 
processes (one to four weeks post-stroke, adapting structural and functional neural 
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circuits, recovery phase, and  2) and rehabilitation (weeks to months, recovery phase 3). 
In contrast, in the current chapter, the time scale was much longer (up to nine months), 
and the observed recovery processes possibly reflected the impact of formal and 
informal rehabilitation. It is likely that some of the patients in the current analysis had 
formal rehabilitation between baseline and follow up assessments, especially those with 
moderate to severe post-stroke deficits. Thus, the observed recovery rates at least partly 
reflect the benefits of the intervention pathways used at that time (2006-2011) in the 
UK. The current study highlights that any new intervention needs to take into account 
the current observed recovery rate for each cognitive domain, and show advantages 
beyond evidence of proportional recovery.   
In the present dataset, the time of baseline assessment and duration between baseline 
and follow up were not predictors of the follow up performance (Table 1,Figure 3), and 
did not affect the recovery rates. It is plausible that time by recovery rate interactions 
were examined as cross-sectional rather than within individuals. Furthermore, the 
sampling of patients in previous studies (Lazar et al., 2010; Murphy & Corbett, 2009; 
Winters et al., 2016) might have been biased towards those who could complete the 
study within days of stroke (Cramer, 2008; Murphy & Corbett, 2009).  
The results of the current study suggests a large recovery potential that continues 
beyond the spontaneous biological repair processes (three months) (Winters et al., 
2016). However, as the timeline for post-stroke recovery (Cramer, 2008; Murphy & 
Corbett, 2009) is based on animal models, the translation of these phases and timelines 
to human is theoretical (Ward, 2017). It is possible that homeostatic repair in human 
occurs over a longer period, enabling a larger window for plasticity induced 
intervention. To date, evidence for the impact of the initiation time of intervention is 
unclear (Ward, 2017).  
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2.5.2 Fitters and Non-fitters 
In contrast to previously reported studies in proportional recovery for motor deficits, 
aphasia and neglect (Krakauer, 2015; Lazar et al., 2010; Marchi et al., 2017; Winters et 
al., 2016), we observed patients who showed accelerated recovery. Baseline cognitive 
impairments for these patients were moderate to severe. The number of patients who 
showed an accelerated recovery varied depending on the domain (Table 4), but was less 
than 10% in each. The relatively small proportion of accelerators may explain why these 
have been missed by previous studies that looked at domain specific recovery (Lazar et 
al., 2010; Marchi et al., 2017; Wilson, Eriksson, et al., 2019; Winters et al., 2016). 
Although regression to the mean (Hope et al., 2018) can partly explain these observed 
results, future research should examine this group in more detail, as they might provide 
useful insights into mechanisms of successful recovery.  
Around 10% of our study population showed decelerated recovery (Table 4, Figure 2). 
These were identified as non-fitters in specific domains or across overall cognition. In 
the literature (Krakauer, 2015; Lazar et al., 2010; Marchi et al., 2017; Winters et al., 
2016), decelerated recovery is typically reported for patients who show severe 
impairments at baseline. In contrast, in the current analysis some of our decelerated 
recovery patients presented only mild impairments at baseline, meaning they actually 
declined following the stroke incident. This pattern of declined abilities of some mild 
patients has not been reported before (Krakauer, 2015; Lazar et al., 2010; Marchi et al., 
2017; Winters et al., 2016). It is possible that the decline pattern only applies to 
cognition but not to motor abilities. The relatively small sample of previous studies may 
have hindered their ability to identify these declined patients. However, in qualitative 
analyses of self-reported recovery trajectories, four recovery trajectories were identified, 
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with stroke patients reporting; (a) meaningful recovery, (b) cycles of recovery and 
decline, (c) ongoing disruption, (d) gradual, ongoing decline (Hawkins et al., 2017).  
A trajectory of post-stroke cognitive decline may be a pre-cursor to developing delayed 
dementia (Snaphaan, 2007; Vigliecca, 2017).  The cognitively decelerated group 
showed slightly lower functioning and mood at baseline and follow up, and fewer years 
in education (Table 4). However, none of these characteristics reliably differentiated 
between those who decelerated and those who recovered. Neurological events, age, or 
type of stroke (ischemic/haemorrhagic) did not distinguish between the decelerated non-
fitters and the rest of the patients. Thus, for the current sample, the factors contributing 
to the deceleration of recovery remains unclear.  
2.5.3 Methodological considerations 
The BCoS was specifically designed for stroke patients (Humphreys et al., 2012). The 
broad approach of the BCoS allowed enabled investigation of proportional recovery 
across and within domains. However, the BCoS requires patients to concentrate for at 
least 35 minutes, and to have sufficient English comprehension; therefore, the BUCS 
database is biased towards patients who are sufficiently unimpaired to meet these 
limiting criteria.  
The inclusion criteria used in the BUCS meant that the study population represents mild 
to moderate stroke patients. Notably, the extended time window from stroke to the 
baseline meant that patients who were initially too severe to be tested within a few days 
after stroke, could be assessed later at the rehabilitation phase.  
The formula used in proportional recovery in other studies, such as motor recovery 
(Krakauer, 2015), is likely to be inflated by mathematical coupling because baseline 
performances form part of the independent and the dependent variables (Blomqvist, 
80 
 
1977; Chiolero et al., 2013; Fisk, 1967; Tu, 2016), as well as ceiling/floor effects of the 
measurements, and change in the distribution of scores from baseline to follow up 
(Hope et al., 2018). In the present study, therefore, we calculated proportional recovery 
using a regression model that does not suffer from the above problems. We 
demonstrated similar cognitive proportional recovery using both formulas. However, 
the data were skewed, suggesting potential floor effects, which might lead to 
overestimation of the recovery rate (Hope et al., 2018). There were a number of patients 
who had recurrent stroke/TIA, which could be considered a limitation. However, even 
after removing these patients there was no change in the outcome of the proportional 
recovery rates.  
2.5.4 Conclusions 
The study demonstrated that 80% of patients showed 40-50% proportional recovery of 
cognition at nine months. This was evident across and within cognitive domains. 
Recovery was not limited to the first three months following stroke. The study also 
identified that less than 10% showed an accelerated recovery, while around 10% 
showed decelerated recovery and even decline. This highlights the importance of 
considering individual cognitive trajectories following stroke exist we should take this 
into account. Firstly, when conducting rehabilitation trials, and secondly in clinical 
practice when planning individual rehabilitation. Currently NICE guidelines advise that 
stroke patients should be followed up in primary care at six months post-stroke, and 
annually thereafter. In the present study we show that cognitive trajectories may 
accelerate or decline within nine months, even in those with mild stroke deficits 
initially. It would be beneficial to have healthcare professional input earlier than six 
months post-stroke, as it may provide opportunity to identify those on the decline 
trajectory at an earlier stage. Furthermore, it would be important that the same 
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healthcare professional carried out the follow up in order to observe potentially subtle 
symptoms of decline, in the U.K it is often be difficult to see the same healthcare 




Chapter 3: Can education protect cognition? A study in UK 




With an increasing ageing population, the risk for cognitive decline and cognitive 
associated diseases (e.g. stroke, dementia) increases. In the present chapter we 
examined the effect of years in education on cognitive abilities in ageing, and stroke 
populations. In study 1, we tested whether education predicts cognitive ageing. Study 2 
tested whether education improves outcomes following stroke, and study 3 tested 
whether education predicts nine months cognitive outcomes, and recovery rates. 
3.1.2 Aims 
To examine the predictive value of cognition in an ageing population, across and within 
UK and China cohorts. To assess whether years of education has an impact on post-
stroke cognition within three months of stroke across and within UK and China cohorts. 
And, to examine the impact of level of education on post-stroke cognitive recovery at 
nine months across and within a UK cohort.  
3.1.3 Methods 
A prospective population-based cohort study in two settings: West-Midlands, UK and 
Guangzhou, China. The analysis included 100 non-stroke and 826 stroke patients from 
the UK, of which 380 were followed up at nine months; 343 non-stroke and 105 stroke 
patients from China. Correlational analyses were used to assess the predictive value of 
years in education on cognitive abilities. Cognitive abilities were measured using the 
English and Chinese versions of the Birmingham Cognitive Screen (BCoS, C-BCoS). It 
includes the following domains: language, memory, attention and executive functions, 
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praxis and number. Analyses were computed within and across cognitive domains for 
non-stroke participants (Study 1), stroke patients (< three months post-stroke) (Study 2), 
and stroke recovery at nine months using longitudinal data (< three months) up to nine 
months post-stroke (Study 3). 
3.1.4 Results 
 
 Beyond age and setting, education was a reliable predictor of general cognitive ability 
in non-stroke cognitive ageing (Study 1: r =.187); education predicted cognitive ability 
in all five domains (r >.134).  Following stroke (Study 2), after age and setting were 
accounted for, education reliably predicted cognitive outcomes (Study 2: r =.090); this 
effect was primarily related to preservation of the language and number domains. 
Finally, when accounting for age and baseline assessment (< 3 months), education 
predicted cognitive recovery at nine months (Study 3: r = .157); as well as recovery rate 
(r=.260). 
3.1.5 Conclusion 
In these cohort analyses education was a protective factor of cognitive ageing. 
Education also improved cognitive outcome following stroke, and accelerated recovery 
in the first year following stroke beyond age. However, important socioeconomic and 






With an increasing ageing population, the risk for cognitive decline and cognitive 
associated diseases (e.g. stroke, dementia) also rises (WHO, 2018). This intensifies 
financial demands on the economy, and has devastating societal impact (WHO, 2017). 
As a consequence, international efforts are directed to diminish the impact of ageing on 
cognition (Brayne & Miller, 2017). In this chapter, we assessed whether increasing the 
number of years spent in education can protect cognition against age related decline, 
and disease. In chapter one section 1.5.1.2, we provide a detailed description of the 
influence of education on cognitive reserve, and the suggested mechanisms behind it. 
The impact of education on cognition is reported in the context of cognitive ageing. For 
example, in both male and female individuals (60-64 years) from Australia, higher years 
in education correlated with an increase in cognitive ability (Christensen et al., 2007). 
This is also demonstrated in a sample from Low-Income and Low-Literacy settings 
(Africa) (Humphreys et al., 2016). A systematic review of six studies reporting data 
from over 2000 people also confirm that education attainment attenuates the impact of 
small vessel disease on cognitive abilities (Pinter et al., 2015).  Furthermore, education 
is reported to ameliorate dementia symptoms, at 85 years old, those with diagnosed 
dementia were less educated than those who did not develop the condition (Skoog et al., 
2017). Similar results were reported in a study population from Brazil (Farfel et al., 
2013). However, not all studies found this association between education and cognitive 
ageing (Ramakrishnan et al., 2017).  
In the context of stroke, analysis of data from the Rotterdam study (Mirza et al., 2016) 
suggests that education can also protect against long-term cognitive outcomes following 
stroke (Mirza et al., 2016; Sun et al., 2014; Withall et al., 2009). A meta-analysis of 
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2064 stroke patients, report that low levels of education doubled the chances of 
cognitive impairments following stroke (Pendlebury & Rothwell, 2009).  
In the current chapter, we present three studies which examine whether education 
protects cognition in ageing and stroke populations, in the UK and China. Study 1 
examined the impact of education on cognitive abilities in ageing controls participants 
(UK and China). Study 2 examined the impact of education on post-stroke cognition 
(UK and China), and Study 3 measured the impact of education on cognitive recovery 
following stroke.   
3.3 Methods 
 
This study is a retrospective analysis of the data obtained by the BUCS study (see 
1.2.4.1) (Birmingham University Cognitive Screen, 2006 – 2011), and the China-
Birmingham Cognitive Screen study (C-BCoS) (2012 – 2017). The BUCS and C-BCoS 
studies validated the utility of a cognitive screen for stroke (Birmingham Cognitive 
Screen (BCoS) (Bickerton et al., 2015; Humphreys et al., 2012), and its Mandarin and 
Cantonese translated versions (Pan et al., 2015). It is worth noting that there are 
multiple dialects spoken by people living in and around Guangzhou city. The official 
language is Mandarin, though as Guangzhou was the capital of Canton, many speak a 
specific local Yue dialect, known as Cantonese. Participant in the current analysis, were 
assessed using the version (Mandarin/Cantonese) they felt most comfortable with; the 
examiners were well versed in both languages.  
The studies recruited stroke patients and also control groups of age and demographic 
matched participants who reported no previous history of neurological or 
cerebrovascular disorders.  
The BUCS was approved by the UK National Research Ethics Committee. The C-BCoS 
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study was approved by the University of Birmingham, and the Guangzhou First 
People’s Hospital research ethical committees. All participants gave written informed 
consent.  
3.3.1 Participants 
3.3.1.1 Study 1: Healthy Ageing 
  
The controls were recruited using an opportunistic sample of individuals of 50 years old 
and above. The demographics for these controls are presented in Table 6. The UK 
control participants (n=100) were recruited from the West Midlands, with the purpose 
that they represent the 2001 UK population census on the distribution of sex and 
education across the three age groups. The two china control groups included Cantonese 
speakers (n=156), and mandarin speakers (n=187). We excluded participants who 
completed less than 75% of cognitive data available. We computed two separate sample 
size calculations for chapter three. For those in Study 1: Healthy ageing with controls, 
we used (Kim & Park, 2016) to obtain a reference effect size in an analysis similar to 
the one presented in chapter three. We used G*Power to calculate required sample size 
with power at 80% alpha considering multiple comparisons p= .050/6: p=.008 = N=358. 
3.3.1.2 Study 2: UK and China Stroke 
  
Recruitment criteria for stroke patients were designed to be as inclusive as possible, 
with minimal exclusion criteria to gain a representative sample of patients with good 
survival chances. Demographics are reported in Table 9. 
For full description of recruitment and BUCS study please see 1.2.4.1. Please see details 
of the trial CONSORT flow diagram for recruitment and attritions in Bickerton and 
colleagues (Bickerton et al., 2015). The initial sample included 908 stroke patients. In 
this study, a total of 826 stroke patients were included in the final analyses, as we 
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excluded those who had less than 75% of cognitive data available.  
China stroke cohorts were recruited from a neurological department in Guangzhou first 
people's Hospital. Due to the hospital structure, the sample represented patients who 
were medically stable with mild to moderate cognitive impairments. See 1.2.4.1 for full 
description of recruitment. Patients completed the C-BCoS (Wong et al., 2009) in the 
language that they felt most comfortable with (Mandarin/Cantonese).  
Across both samples, assessments were carried out on average within the first month of 
stroke; UK (29 days), based on 794 participants information, C-China (9 days), based 
on 91 participants and M-China (5 days), based on 43 participants.  
For those in Study 2 and 3: Stroke, we used (Mirza et al., 2016), to obtain a reference 
effect size in an analysis similar to the one presented in chapter three. Where the authors 
report the incidence of developing dementia following stroke. Using levels of education 
(high, intermediate or low) to compare incidence of dementia following stroke. We 
computed a Chi square based on the data in table 2 of (Mirza et al., 2016). We used 
G*Power to calculate the required sample size, square of 91.88 = r=.70), N=15. 
3.3.1.3 Study 3: UK stroke recovery 
 
The initial sample of stroke patients included 908, of which 380 were followed up at 
nine months’ post- stroke. The assessment at follow up included identical measures as 
were taken at the initial baseline assessment. No differences in sex, age and baseline 
Barthel Index is reported between the followed up and non-followed up patients were 
identified (Bickerton et al., 2015). Please see Bickerton and colleagues for consort 
diagram for information on loss to follow-up (Bickerton et al., 2015). Average time 




All the UK data was collected by examiners (psychologists, occupational therapists, or 
stroke researchers). The China data was collected by medical personnel (e.g. neurologist 
trainee). All attended training and were assessed, and supported by the same University 
of Birmingham team.  
3.3.2.1 Cognitive measures: BCoS and C-BCoS 
 
The BCoS was used to assess cognition (Bickerton et al., 2015; Humphreys et al., 2012; 
Pan et al., 2015), focusing on domain specific abilities, across five cognitive domains 
(a) attention and executive function, (b) language, (c) memory, (d) number, and (e) 
praxis. A full description of the BCoS and C-BCoS is documented in section 1.2.4.1. 
3.3.2.2 Demographic measures  
 
Education was coded as self-reported number of years in formal education. For 
example, eleven years of education in the UK was recorded to be equivalent to 
compulsory years in education (high school, GCSE). Thirteen years of education in the 
UK, and twelve years in China was equivalent to college education (A level or 
diploma), and above thirteen years was equivalent to University level of education.  
For UK stroke patients (study 2) in addition to the cognitive data, further demographic 
information was collected (Table 9), level of functional independence using the Barthel 
Index (Mahoney & Barthel, 1965), and mood status using the Hospital anxiety and 
Depression Scale (Zigmond & Snaith, 1983). Evidence for neurological history 
(previous stroke, TIA, tumour, dementia, epilepsy, other) was recorded based on the 
patient’s hospital records.  
A sub-sample of the china cohort participants were also assessed using the Chinese 





We excluded controls, and patients who had less than 75% of cognitive data available. 
Missing data was replaced by the average of the group. Analysis was computed with 
SPSS24. 
Demographic, and cognitive characteristics are reported in Table 6, Table 9, and Table 
12 . Independent t-tests were used to compare between the three samples. As samples 
differed in their size, statistics reported assume unequal variance for all analyses. These 
were corrected for multiple comparisons; using Bonferroni-Holmes correction. Whether 
significance remained after corrections is noted in each correlation.  
To compute summary statistics, individual scores for each task were normalized. The 
standardised distance from the sample specific control mean was calculated. Thus, for 
the China and UK control cohorts separately were used to compute Z scores for their 
corresponding samples of stroke patients. Cut off scores were based on their own 
cultural and language cut offs. For the control group, we computed Z scores based on 
their group average and standard deviation scores. For each domain the Z scores were 
averaged across tasks and for the general cognition score the Z scores were averaged 
across the five domains (language, attention and executive function, number, praxis and 
memory).  
To assess the relationship between education and cognition (within and across 
domains), we computed partial correlations accounting for age and setting. This was 
computed across the three settings and for each setting separately (Study 1 and 2). For 
study 3, partial correlation also accounted for baseline cognitive abilities. 
To further elucidate the relations between education and cognition while accounting 
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other measures, we used step-wise linear regression including the measures available for 
each group.  For the UK stroke cohort, beyond age it also included the HADs and 
Barthel Index. Note that in study 3, the baseline, and follow up measures of the HADs 
and Barthel Index and baseline cognition were included. 
The relationship between education and cognition was also assessed using the MoCA in 
the sub-sample of the China participants. 
3.4 Results  
 
3.4.1 Study 1: Heathy ageing 
Figure 5 and Table 6, present the demographic data for each cohort. UK cohort median 
age was 70, M-China was 65 and C-China was 64; UK vs. M-China t(100.85)=-4.77, 
p<.001; UK vs. C-China t(955)=-.908, p=.365; M-China vs. C-China t(201)=3.42, 
p<.001 (See Figure 5).  
The UK cohort had a median of 11 years in education which is equivalent to modern 
GCSE (secondary school). The Mandarin speaking China cohort (M-China) had a 
median of 12 years equivalent to A level education. The UK and M-China groups were 
not reliably different in their education levels t(282.06)=.207, p=.836 (See Figure 5)The 
Cantonese speaking China cohort (C-China) were significantly less educated from both 
former cohorts, with a median of 9 years C-China vs. UK: t(251.67)=8.40, p <.001, C-
China were less educated than M-China, t(341)=7.57, p<.001. 
Age did not correlate with education in the UK-Cohort (r=-.083, p =.411). In the M-
China cohort age positively correlated with education (r = .203, p =.006), showing older 
people were more educated. In the C-China the correlation was negative (r =-.281, p 
<.001) as younger people were more educated.   
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The UK and M-China cohorts had similar ratio of equal representation for both sexes, 
but C-China cohort was pre-dominantly females. There were sex differences in the level 
of education in the C-China cohort, male versus female t(78.33)=2.33, p=.022 equal 
variances not assumed. There were no sex differences in the level of education in the M-
China cohort, t(184)=-.587, p=.558, or in the UK cohort, t(98)=.076, p=.940. 
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Table 6. Demographic and clinical characteristics for Study 1 (Healthy Controls) 
 U.K Controls (n=100) Mandarin Controls (n=187) Cantonese Controls (n=156) 
 Mean (SD) Median Range Mean (SD) Median Range Mean (SD) Median Range 
Age (years) 70.65 (10.43) 69.5 52-97 65.71 (9.38) 65 50-92 65.74 (8.78) 64 50-86 
Gender (Male: Female) 54:46   97:92   41:115   
Years of Education 11.78 (2.46) 10.51 9-18 11.69 (4.16) 12 0-20 8.23 (4.26) 9 0-19 
Notes. SD: standard deviation. Barthel Index: higher score= more functional ability.  















Figure 5. Dark Blue= Cantonese cohort; Turquoise= Mandarin cohort; Yellow= UK 
cohort. (A) Control cohorts/ Years of Education. Years in education is presented in the 
x-axis, and numbers in each cohort is represented in the y-axis. (B) Control cohorts/ 




Table 7. Cognitive profile for participants in Study 1 (Healthy Controls) 
 UK Controls (n=100) Mandarin Controls (n=187) Cantonese Controls (n=156) 
 Mean (SD) Median Range  Mean (SD) Median Range  Mean (SD) Median Range  
Language -.005 (.59) .16 -2.77-.59 -.093 (1.09) .189 -12.03-.45 -.048 (.81) .19 -5.11-.49 
Attention and Executive Function .001 (.54) .13 -2.58-.77 -.099 (.813) .116 -4.19-.52 .013 (.54) .160 -2.50-.69 
Number -.014 (.72) .72 -3.02-.42 -.249 (1.37) .409 -5.96-.41 -.116 (.94) .914 -3.92-.61 
Praxis  -.005 (.56) .07 -2.13-.71 -.299 (1.31) .081 -6.63-.50 -.002 (.68) .200 -4.42-.65 
Memory -.004 (.64) .19 -2.77-.59 -.161 (.892) .137 -4.84-.57 .009 (.683) .141 -4.89-.73 
General Cognition -.006 (.39) .11 -1.14-.58 -.181 (.890) .094 -6.35-.45 -.025 (.91) .151 -3.00-.55 
MoCA    26.18 (2.98) 27 14-30 23.87 (3.51) 24 14-30 
Notes. SD: Standard Deviation. MoCA= Montreal Cognitive Assessment; Cognition is represented in z scores= standardised deviation from each control cohort. 
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There were differences in cognitive abilities between the three cohorts, despite the 
normalization (Table 7). However, these differences did not survive family-wise error 
correction. The large differences between the median, and average suggest that the 
distributions were positively skewed (e.g. the averages are often negative, while the 
medians are positive). 
Partial correlation analyses were computed across settings (UK and China). Education 
positively correlated across the domains (general cognition r=.268, p<.001) (Figure 6), 
and within each domain (language r=.187, p<.001; memory r=.203, p<.050; attention 
and executive function r=.248, p<.001; praxis r=.134, <.001 and number r=.282, 
p<.001). 
For each cohort (Table 8), we computed separate partial correlations of education after 
age had been removed with each cognitive measure. In the UK cohort, education 
positively correlated with language, praxis and general cognition with effect sizes of 
(Pearson r) from .233 to .350. Education positively correlated with all cognitive 
measures in the C-China cohort with effects (Pearson r) ranging from .229 to.531. The 
pattern was slightly different for the M-China cohorts, where the predictive value of 
education on cognition ranged from .210 to .258, and all cognitive domains had 
significant predictive value except language and praxis. General cognition was also 
assessed using the MoCA in the two China Cohorts, similar to the general cognition of 
the BCoS. Education correlated performance on the MoCA in both the control cohorts.
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Table 8. Correlation and regression models for Study 1 (Healthy Controls) 
 
Education 
Correlation Regression Model Predictors 
UK and China Controls 
   
Language .187**^ R2=.043, F(2,440)=9.89**^ +Education**-Age* 
Memory .203**^ R2=.170, F(4,438)=22.15**^ -Age**+Education**+Group* 
Attention and Executive Function .248***^ R2=.135, F(4,440)=17.07**^ -Age**+Education**+Group* 
Number .282**^ R2=.123, F(4,439)=15.31**^ +Education**-Age*+Group* 
Praxis .134*^ R2=.098, F(4,440)=11.78**^ -Age**+Education**+Group* 
General cognition .268**^ R2=.165, F(4,438)=21.40**^ +Education**-Age**+Group* 
UK Controls 
   
Language .255*^ R2=.179, F(2,99)=10.58**^ -Age** +Education* 
Memory .162 R2=.250, F(1,99)=10.25**^ -Age**  
Attention and Executive Function .141 R2=.081, F(1,99)=8.87**^ -Age**  
Number .222 R2=.096, F(2,99)=5.15**^  +Education* -Age* 
Praxis .233*^ R2=.138, F(2,99)=8.91**^ -Age** +Education** 
General cognition .350**^ R2=.364, F(2,99)=27.77**^  -Age** +Education** 
China Controls: Cantonese  
   
Language .293**^ R2=.109, F(1,155)=18.78**^  +Education** 
Memory .229*^ R2=.222, F(2,155)=21.79**^  +Education** -Age**  
Attention and Executive Function .489**^ R2=.314, F(2,155)=7.15**^ +Education** -Age* 
Number .531**^ R2=.320, F(1,155)=72.59**^  +Education** 





Correlation Regression Model Predictors 
China Controls: Cantonese     
General cognition .489**^ R2=.356, F(2,155)=42.29**^  +Education** -Age** 
MOCA .549**^ R2=.332, F(1,155)=55.11**^  +Education -Age* 
China Controls: Mandarin 
   
Language .116 N/A 
 
Memory .258**^ R2=.106 F(2,180)=10.65**^  +Education** +Age** 
Attention and Executive Function .216*^ R2=.080, F(2,184)=7.96**^ -Age** +Education* 
Number .210*^ R2=.038, F(1,183)=7.20**^  +Education** 
Praxis .109 N/A 
 
General cognition .217*^ R2=.063, F(2,182)=6.02*^  +Education** -Age* 
MOCA .252*^ R2=.063, F(1,147)=9.89*^  +Education** 
Notes. ** Significant at p<.001. * Significant at p<.050. +/- indicates a positive or negative direction.  ^ Survived correction for multiple comparison p= .005/6 or .005/7 
=.0083/.00071. 
In each regression model it contained a number of predictor variables. For the UK stroke cohort, beyond age it also included the HADs and Barthel Index.  
Only the predictor variables that survived the regression are reported as predictors. 
98 
 
      
 
Figure 6. Correlation of general cognition (y-axis) by years in education (x-axis). Three 
healthy ageing cohorts presented: Dark green circle- UK cohort, Red Star-Mandarin 
cohort, Blue circle- Cantonese cohort. General cognition is plotted after variability in 





3.4.2 Study 2: UK and China Stroke  
Table 9 reports the demographics of the three stroke cohorts. The UK stroke patients 
spent a median of 11 years in education, M-China 9 years and C-China 8 years ( 
Figure 7). The level of education in both the China Stroke patients was lower than the 
UK. UK vs. M-China were reliably different in their education levels t(80.77)=-3.35 , p 
<.001. The Cantonese speaking China cohort (C-China) were reliably less educated 
from both former cohorts, C-China vs. UK: t(154.01)=-11.19, p <.001; C-China vs. M-
China, t(203)=-4.66, p<.001.  
UK cohort median age was 72, M-China was 63 and C-China was 70; UK were older 
than. M-China t(100.85)=-4.77, p<.001; but not different to C-China t(955)=-.908, 
p=.365; M-China were younger than C-China t(201)=3.42, p<.001. Age correlated with 
education in the UK-Cohort (r= -.281, p <.001), and C-China (r= -.214, p =.014), but 
not in M-China (r= .030, p =.804). 
There was an equal representation of female to male stroke patients across all three 
cohorts. There was a small difference of education between the sexes in the UK cohort 
(r=.086, p=.013).  A minority of UK stroke patients had haemorrhagic stroke (114). 
Education level did not reliably differ between the stroke types.
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Table 9. Demographic and clinical characteristics for Study 2 (Stroke) 
 
U.K Stroke (n=826) Mandarin Stroke (n=73) Cantonese Stroke (n=132) 
 Mean (SD) Median Range Mean (SD) Median Range Mean (SD) Median Range 
Age (years) 69.92 (13.73) 72 18:95 64.26 (9.20) 63 41-88 69.03 (9.68) 70 50-94 
Years of Education 11.21 (2.69) 11 3-26 9.88 (3.29) 9 0-22 7.45 (3.70) 8 0-17 




Stroke to Assessment (days) 29   5   9   
Type of Stroke (Ischemic: Haemorrhagic) 712:114   73:0   132:0   
Neurological History (History: No History) 516:310    
     
Lesion Side (Left:Right:Bilateral) 251:289:286    
     
Baseline Barthel Index 13.17 (5.39) 13.25 0-20  
     
Baseline HADS anxiety 6.44 (4.35) 6.44 0-21  
     
Baseline HADS depression 6.03 (3.83) 6 0-21 
      
Notes. SD: standard deviation. Barthel Index: higher score= more functional ability.  

















Figure 7. Dark Blue= Cantonese cohort; Turquoise= Mandarin cohort; Yellow= UK 
cohort. (B) Stroke cohorts/ Years of Education. Years in education is presented in the x-
axis, and numbers in each cohort is represented in the y-axis. (C) Stroke cohorts/ Age. 
Age is presented in the x-axis, and numbers in cohort is represented in the y-axis. 
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Levels of cognition differed across the three stroke groups (Table 10). The UK stroke 
demonstrated more severe post-stroke cognitive abilities, compared to the Chinese 
stroke cohorts (e.g. for general cognition: UK vs. M-China t(427.55)=17.80, p<.001; 
UK vs. C-China t(736.99)=17.62, p<.001. The two Chinese cohorts demonstrated 
similar post-stroke cognition (e.g. for general cognition: C-China vs. M-China 
t(175.3)=-88, p=.339. 
    
Table 10. Cognitive profiles for participants in Study 2 (Stroke) 
 U.K Stroke (n=826) Mandarin Stroke (n=73) Cantonese Stroke (n=132) 
Language -5.73 (8.20) -2.28 -28.54-.46 -1.15 (2.22) -.376 -9.10-.45 -.99 (1.96) -.178 -8.31-.70 
Attention and Executive Function -.584 (6.49) -3.63 -31.11-.75 -.438 (1.24) -.117 -8.10-.42 -.647 (1.22) -.155 -5.21-.63 
Number -3.20 (4.05) -1.46 -11.30-14.81 -.765 (1.11) -.441 -398-.41 -.952 (1.61) -.312 -5.21-.61 
Praxis  -2.41 (3.21) -1.33 -12.28-15.45 -.438 (.94) -.201 -4.29-.55 -.773 (1.57) -.211 -7.21-.59 
Memory -4.76 (6.94) -1.97 -32.01-.62 -.508 (1.16) .136 -5.29-.57 -.810 (1.51) -.180 -7.19-.73 
General Cognition -4.93 (4.79) -2.65 -22.67-1.58 -.660 (1.08) -.355 -4.96-.47 -.811 (1.33) -.319 -6.05-.48 
MoCA    19.80 (6.47) 20 4-29 20.15 (5.86) 22 4-30 
Notes. SD: Standard Deviation. MoCA= Montreal Cognitive Assessment; Cognition is represented in z scores= standardised deviation from each of their own control cohort. 
104 
 
Partial correlation analyses were computed across settings (UK and China) to assess the 
impact of education on cognition in a stroke population, specifically in the short-term 
period following stroke. Education positively correlated across domains, general 
cognition r=.090, p<.050 (Figure 8), and within domains; language r=.103, p<.050 and 
number r=.101, p<.050. There were no significant correlations for memory, attention 
and executive function, and praxis.  
 
 
Figure 8. Correlation of general cognition (y-axis) by years in education (x-axis). Three 
stroke cohorts presented: Dark green circle- UK Stroke, Red Star-Mandarin Stroke, 





Table 11. Correlation and regression models for Study 2 (Stroke) 
 
 Education 
Correlation Regression Model Predictors 
UK and China Stroke    
Language .103*^ R2=.071, F(2,1027)=39.03**^  -Group**+Education* 
Memory .055 R2=.064, F(2,1027)=47.19**^  -Group**-Age** 
Attention and Executive Function .053 R2=.143, F(2,1027)=85.32**^  -Group**-Age** 
Number .101*^ R2=.093, F(3,1023)=35.05**^  -Group**-Age**+Education** 
Praxis .050 R2=.119, F(2,1027)=69.21**^  -Age**+Group** 
General cognition .090*^ R2=.102, F(3,1026)=51.99**^  +Group**-Age**+Education* 
UK Stroke 
   
Language .111**^ R2=.038, F(2,821)=16.11**^ +Baseline Barthel** +Education** 
Memory .056 R2=.051 F(3,821)=14.53**^  +Baseline Barthel**-Age**-Baseline Depression* 
Attention and Executive Function .054 R2=.088, F(3,821)=26.14**^ +Baseline Barthel**-Age**-Baseline Depression** 
Number .102*^ R2=.061 F(3,820)=17.84**^  +Baseline Barthel**-Age**+Education** 
Praxis .069*^ R2=.126, F(4,820)=29.35**^  -Age**+Baseline Barthel**-Baseline Depression* +Education* 
General cognition .096*^ R2=.087, F(4,820)=19.36**^  +Baseline Barthel**-Age**-Baseline Depression**+Education** 
China Stroke: Cantonese 
   
Language .167 R2=.040, F(1,130)=5.33*^ +Education* 
Memory .192*^ R2=.049, F(1,130)=6.66*^  +Education* 
Attention and Executive Function .131 NA 
 
Number .162 R2=.047, F(1,130)=6.30*^  -Age* 






Correlation Regression Model Predictors 
China Stroke: Cantonese    
General cognition .152 R2=.040, F(1,130)=5.39*^  -Age* 
MOCA .011 NA 
 
China Stroke: Mandarin 
   
Language .113 NA 
 
Memory -.074 NA 
 
Attention and Executive Function .101 NA 
 
Number .102 NA 
 
Praxis -.279*^ R2=.079, F(1,71)=5.96*^  -Education* 
General cognition .028 NA 
 
MOCA -.019 NA 
 
Notes. ** Significant at p<.001. * Significant at p<.050. +/- indicates a positive or negative direction.  ^ Survived correction for multiple comparison p= .005/6 or .005/7 
=.0083/.00071. For the UK stroke cohort, beyond age it also included the HADs and Barthel Index.  
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For each cohort (Table 11) we computed separate partial correlations of education with 
each cognitive measure. In the UK cohort education positively correlated with language, 
number, praxis, and general cognition with effect sizes of Pearson r from .069 to .111.  
For the C-China cohort the effect sizes (Pearson r) ranged from -.017 (praxis) to .192 
(memory), with only memory showing reliable relations. The pattern was slightly 
different for the M-China cohort, where the impact of education ranged from negative -
.279 (praxis) to positive .113 (language), with only praxis (-.279) showing reliable 
effects. The two China samples included the frequently used MoCA to assess general 
cognition following stroke. In neither of the cohort education MoCA scores (Table 11). 
Given the relatively small sample size in this cohort, inferences should be made with 
caution (see column 2 Table 11).  
The UK cohort included measures of functional abilities and mood. Step-wise 
regression included these variables and age. Education was a reliable predictor of 
general cognition, as well as praxis, number and language. Not surprisingly functional 
abilities (Barthel Index), depression levels (HADs), and age also contributed to 





3.4.3 Study 3: UK stroke recovery  
Baseline demographics of this cohort are reported in Table 8. Patients who were 
followed up presented a similar profile to the one in study 2 UK sample; this was true 
for age, gender, stroke type, and years of education (Table 12). Functional status, 
measured by the Barthel Index improved from baseline to follow up, as did mood 
measured by the HADs.  
Table 12. Demographic and clinical characteristics for Study 3 (Follow Up UK Stroke) 
 
U.K Stroke Follow Up (n=380) 
 Mean (SD) Median Range 
Age (years) 69.28 (12.87) 71 18-91 
Gender (Male: Female) 213:167   
Neurological History (History: No History) 127:253   
Type of Stroke (Ischemic: Haemorrhagic) 358:22:00   
Lesion Side (Left:Right:Bilateral) 110:151:46   
Stroke to Assessment (months) 0.55 0 0:14 
Baseline to Follow Up Assessment (months) 8.74 0 0:14 
Years of Education 11.62 (2.92) 11 3-24 
Baseline Barthel Index 12.63 (5.92) 13 0-20 
Baseline HADS anxiety 6.46 (4.48) 6 0-21 
Baseline HADS depression 6.23 (3.92) 6 0-20 
Follow up Barthel Index 17.02 (4.02) 19 0-20 
Follow up HADS anxiety 5.82 (4.33) 5.82 0-21 
Follow up HADS depression 5.87 (3.80) 5.87 0-20 
Notes. SD: standard deviation. Barthel Index: higher score= more functional ability. 
HADs= Hospital Depression and Anxiety scale: higher the score equals higher anxiety  





Table 13. Cognitive profiles for participants in Study 3 (Follow Up UK Stroke) 
 U.K Stroke Follow up (n=380) 
 Mean (SD) Median Range 
Language -2.47 (5.53) -.37 -25.05-.50 
Attention and Executive Function -2.41 (3.45) -.97 -20.80-.74 
Number -1.68 (3.14) -.125 -11.27-.44 
Praxis  -1.32 (2.62) -.548 -12.13-.71 
Memory -1.98 (3.95) -.31 -25.01-.61 
General Cognition -1.97 (.94) -1.36 -15.96-.54 
Notes. SD: Standard Deviation. MoCA= Montreal Cognitive Assessment. Cognition is represented 
in Z scores= standardised deviation from UK control cohort.   
Partial correlation analyses were computed to assess the impact of education on 
cognition at nine months following stroke (Table 14), controlling for age and baseline 
cognitive deficits. Education positively correlated across domains, general cognition 
r=.157, p<.001(Figure 9), and within domains; language r=.111, p<.005, number r=.173, 
p<.001. There were no significant correlations for memory, praxis and attention and 
executive function. Step wise regression included cognitive outcomes at baseline, age, 
functional abilities and mood measures at baseline, and follow up. Education was a 




Table 14. Correlation and regression models for Study 3 (Follow Up UK Stroke) 
 Notes. ** Significant at P<.001. * Significant at <.050. +/- indicates a positive or negative direction ^Survived correction for multiple comparison P = .005/6 =.0083. 
For the UK stroke cohort, beyond age it also included the HADs and Barthel Index. Note that in study 3, the baseline, and follow up measures of the HADs and 
Barthel Index and baseline cognition were included. 
 
Education 
Correlation Regression Model Predictors 
Baseline       
Language .204**^ R2=.0.76, F(2,379)=15.43**^ +Baseline Barthel**+Education** 
Memory .172*^ R2=.131, F(3,379)=25.81**^ +Baseline Barthel** +Education** -Baseline Depression* 
Attention and Executive Function .081 R2=.139, F(3,379)=20.17**^ +Baseline Barthel**-Age*-Baseline Depression* 
Number .166*^ R2=.0.80, F(2,379)=16.32**^  +Baseline Barthel** +Education** 
Praxis .115*^ R2=.140, F(4,379)=15.29**^ +Baseline Barthel** +Education*-Age*-Baseline Depression* 
General cognition .184**^ R2=.129, F(2,379)=27.97**^  +Baseline Barthel** +Education** 
Follow Up 
   
Language .111*^ 
R2=.414, 
F(2,379)=133.245**^ +Language Baseline**-Follow Up Depression* 
Memory .092*^ R2=.157, F(2,379)=35.00**^ +Memory Baseline**+Follow Up Barthel** 
Attention and Executive Function .173*^ R2=.411, F(4,379)=65.49**^ +Attention Baseline**+Follow Up Barthel **+Education**-Follow Up Depression** 
Number .173*^ R2=.412, F(3,379)=87.94**^ +Number Baseline**+Follow Up Barthel**+Education** 
Praxis .105*^ R2=.201, F(3,379)=31.52**^ +Praxis Baseline**+Follow Up Barthel**+Education* 




Figure 9. Correlation of UK stroke follow up general cognition (y-axis) by education 
years (x-axis). General cognition is plotted after variability in age, and baseline 
cognition were removed. 
Beyond education, not surprisingly, general cognition and abilities of memory, attention 
and executive function, number, and praxis were predicted by cognitive ability at 
baseline and functional ability (Barthel Index). Language ability at nine months 
following stroke were not affected by functional abilities. Higher levels of depression at 
follow up predicted language, attention and executive function and general cognition 




We next explored whether education predicted the rate of change from baseline to 
follow up. This was calculated by examining the percentage of change from baseline to 
follow up, relative to baseline. We computed Pearson correlations, and controlled for 
age, using Bonferroni correction (alpha = .05/12 comparisons, corrected alpha = .0042). 
Positive correlations indicated that more years in education related to larger recovery 
rates at nine months post-stroke.   
After controlling for age, education linearly predict the cognitive change rate, across 
domains (r = .234), and within the number (r = .236), language (r = .213) and attention 
and executive function (r = .188) domains, (all uncorrected p < .001). Recovery of 
praxis (r = .138, uncorrected p = .007), and memory (r = .144, uncorrected p = .005) 
only trended toward significance, after applying family wise error correction. 
In summary, after controlling for baseline ability, and age, years in education predicted 




The present chapter examined the impact of education on cognition in three 
neurological contexts. After age and cultural settings were controlled for, study 1 
showed that education interacted with (within and across) cognitive domains. Study 2 
demonstrated that education improved cognitive outcome following stroke. Study 3, 
showed that more years in education improved cognitive outcomes at nine months 
following stroke, and additionally accelerated the recovery rate.  
Study 1, replicated previous findings (Christensen et al., 2007; Farfel et al., 2013; 
Humphreys et al., 2016; Mirza et al., 2016; Pinter et al., 2015; Skoog et al., 2017) that 
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show that education positively impacted cognitive abilities in an ageing population. We 
found that beyond age, in the ageing population, education mediated cognition across 
general cognition, and across the key five cognitive domains (language, attention and 
executive function, praxis, memory and number). We show this across three cohorts 
who differ in ethnicity and language. Though, the relations were more reliable in the 
two China cohorts (see Table 8), potentially because these were larger cohorts, and they 
were more variable in their education levels. This effect was observed beyond age, 
though in most of the tests age was independently found to be a negative predictor; 
where cognitive ability was lower with increased age. Going beyond previous studies 
we showed that education affected cognition across different cultural settings, and found 
that it is primarily driven by the ability to retain language and number abilities.  
In study 1, all individuals were self-declared healthy, with no previously diagnosed 
neurological or cognitive impairment. However, within the C-China and especially the 
M-China cohort, some (18-30%) presented with lower than expected cognitive abilities 
for their age, showing less than 24 on the C-MoCA, exhibiting cognitive level akin to 
mild cognitive impairment and dementia (Tan et al., 2015). This was also evident in 
their C-BCoS scores, where they scored >4 std below their own group average on all 
domains. 
In study 2, education impacted cognitive outcomes within the first month post-stroke 
across different languages, and cultural settings. This observation replicates previous 
reports (Mirza et al., 2016; Sun et al., 2014; Withall et al., 2009). This was 
demonstrated with general cognition, and across all five cognitive domains, it was 
preserved beyond age and cultural settings. The effects overall were smaller than 
observed in study 1. The relations were more reliable in the UK than the China stroke 
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cohorts. This might have been because the UK stroke cohort was more than 7 folds 
larger, and the cognitive abilities of the stroke patients were more variable than either of 
the China cohorts.  
As the UK stroke sample included measures of functional independence and mood, we 
examined the contribution of education beyond these measures. The benefit of increased 
years in education, was observed after controlling for age, Barthel and HADs. In the C-
China, and M-China stroke cohort the effect of education on cognition varied between 
domains. Beyond age, education affected memory in the C-China, but only praxis in the 
M-China. Surprisingly, the impact of education on praxis in M-China was reversed, 
more education lead to poorer post-stroke praxis outcomes. This result is unclear and 
unexpected. It may reflect social-cultural differences that confound education. A part of 
the praxis assessment in the C-BCoS relies on gesture tasks. It has been suggested that 
gestures are used less frequently in China than the westernised culture (So, 2010), 
suggesting the gestures tasks may not be that reliable in the context of the China 
cohorts. Furthermore, gestures are more commonly used in one’s native language 
proficiency (Gregersen et al., 2009). Thus, it could be that for some M-China patients, 
especially those coming from rural regions, where mandarin was their non-native 
language, led them to be less experienced with mandarin gestures. Finally, in study 3 we 
demonstrated that beyond age and baseline cognition, education correlated with post-
stroke recovery at nine months of general cognition, language, praxis, and number 
domains. After controlling for depression and functional ability, education also 
predicted recovery of attention and executive function, but did not predict language 
recovery. When examining recovery rate, education accelerated recovery rate across 
domains (general cognition), and within domains. This finding challenges the argument 
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that education relates only to our cognitive ability and not necessarily the rate in which 
we decline (Berggren et al., 2018). In the present study we demonstrated that education 
related to both cognitive ability, and also to rate of decline/recovery. 
The mechanisms by which education protects cognition in different neurological 
contexts is assumed to be driven by an increase in cognitive reserve (Farfel et al., 2013; 
Stern, 2006; Stern, 2012). Cognitive reserve is a concept that is used to describe the 
resilience of humans’ function in light of adverse neurological events. It is assumed that 
education, together with other experiences across the life-span contribute to increased 
resilience. It is still unclear how brain reserve is manifested neurologically. One 
hypothesis suggests that education is associated with overall reduced grey matter 
atrophy, white-matter disease (Sun et al., 2014), and lesion load specifically in stroke 
patients (Umarova, 2017). Others have suggested cognitive reserve is made up of two 
mechanisms; neural reserve which refers to the brain networks that are less susceptible 
to neurological disruption, and neural compensation refers to the ability of the 
individual suffering from neurological disruption to use their brain structures to 
compensate for the damage (Stern, 2006) (See section – for a more detailed description 
on cognitive reserve).   
Alternatively, education may simply improve the ability of an individual to 
communicate with medical professionals, and understand their medical conditions 
(Willems et al., 2005) but see (DeVoe et al., 2009; Francis et al., 1969; Verlinde et al., 
2012). This in turn could lead to more effective responses to medical advice both in 
response to general health, and specifically following stroke.  
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We note here that cultural differences (UK vs. China), are evident in the present 
analysis, with differences between healthy controls, time of assessment (number of days 
since stroke), and severity of post-stroke cognition. To account for these potential 
cultural/sampling confounds, the cognition scores (Z) of each participant/patient were 
normalised in respect to their own cultural groups. This normalisation procedure 
enabled us to combined databases to achieve reasonable power to answer the research 
questions posed in this chapter. For completeness, I report analyses across cultural 
groups, as well as within each group separately. We acknowledge the potential affects 
that these difference may have had on the overall results, hence the separate statistical 
analyses across the groups are also provided. 
An important consideration is the sociodemographic status, general lifestyle and overall 
health of individuals which inherently relates to their education levels (Mirza et al., 
2016). 
CAMCOG is a large epidemiological longitudinal study examining the onset of 
dementia in an ageing cohort, and associated factors. They assessed cognition using the 
MMSE, and followed up participants in a varying time window (one year to 10 years 
after initial assessment) between 1990-1991 (Brayne et al., 2006). In a sub analyses of 
4,075 ageing individuals, it was reported that sex (women vs men), was directly 
associated with dementia onset, as was incidence of stroke, and education level trended, 
however social class did not contribute (Yip et al., 2006). A further study, examined 
education (and other socioeconomic indicators), and its relation to cognitive decline in 
15,594 women nurses, between 1995 and 2000. They found that less cognitive decline 
was evident in those with a bachelor or graduate degree, compared with those with a 
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nurse diploma. Their socioeconomic status measures were found to be less related to 
incidence of decline (Lee et al., 2003).  
As previously discussed, the present data is in line with evidence that supports the 
hypothesis of a positive relationship between education and cognition in both ageing 
and neurological insult. Previous studies show that these relations are evident even after 
socio-economic status (Yip et al., 2006), and occupation (Lee et al., 2003) are controlled 
for. However, as this information was not recorded in the current database, we cannot 
assess the impact of these factors on the current results. Due to the difficulties in 
partialing out education level, from socioeconomic status, and occupation these factors 
should not be excluded as a potential influencing variables, and should be taken into 
account where possible.  
The EClipSE collaboration, was a longitudinal epidemiological study, which collected 
data on cognition, dementia diagnoses, brain tissue, and other demographical details in 
90 individuals (Brayne et al., 2010). They found that education did not protect against 
accumulation of neurodegenerative, or vascular pathology in the brain, which was 
measured following death, but it did mitigate pathological burden, and cognitive 
decline. Those with higher education level, had reduced risk of dementia in older age. 
This finding supports Stern and the reserve hypotheses (Stern et al., 2018). They 
conclude that those with less education don’t necessarily have greater 
neurodegeneration than those with higher education, but those with higher education do 
have ‘heavier brains’ (higher brain volume), and maintain cognition in situations of 
pathological burden (Brayne et al., 2010). In the current chapter, we examined cognitive 
reserve in ageing, and also the reserve of individuals in relation to neurological insult 
(stroke). The results presented in Chapter three, also support the hypotheses that 
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cognitive reserve (education) may be the mechanism to which cognition is retained in 
the face of ageing and stroke. In the present chapter, we do not have further information 
on the profile of the individuals studied, for example to examine their brain volume, in 
order to fully comply with the cognitive/ brain reserve hypotheses. 
The present study used years of formal education as a marker of cognitive reserve and 
neurological reliance, which does not account for informal education, such as reading. 
We did not account for any of these factors. Therefore, we cannot rule out that the 
current results are potentially driven by any of these factors, rather than by formal 
education per se. However, the consistent correlations of education with both language 
and number domains, which are the most practiced domains during formal education, 




In these cohort analyses education was found to be a protective factor of cognitive 
ageing, it improved cognitive outcomes following stroke, and accelerated recovery rate 
in the first year following stroke. With concerns reported about an ever increasing 
ageing population (WHO, 2018), and the demands on the economy, increasing the 
education level of the population could provide a cost-effective way of increasing brain 












It is suggested that the hippocampus is a region in the brain vulnerable to diseases of old 
age and neurodegenerative damage. In Alzheimer’s research, it has been found that the 
hippocampus is a biomarker of cognitive decline. This suggests a relationship between 
pathology in the hippocampus and decline of cognition.  
4.1.2 Aims 
In the present chapter we examined post-stroke hippocampal pathology across three MR 
measures; 1H-MRS (magnetic resonance spectroscopy, metabolic), diffusion weighted 
imaging (mean diffusivity) and T1-weighted imaging (volumetric). Based on findings 
documented thus far for the onset of mild cognitive impairment, and progressive 
cognitive decline. We aimed to establish whether hippocampal pathology is also present 
in the stroke population across these three measures. Importantly, in none of the tested 
patients was the hippocampus directly affected by the ischemic event. To assess 
whether the association between hippocampus pathology and cognition was affected by 
stroke, we also recruited non-stroke aged matched control participants. If the incidence 
of stroke affected hippocampus pathology, we expected to find reliably stronger 
correlations between hippocampus and cognition in the stroke patients than in control 





A total of 42 stroke patients underwent detailed cognitive assessment using the BCoS. 
Post-stroke cognition was assessed within three months of stroke along five cognitive 
domains (language, memory, attention and executive function, number and praxis) and 
across domains (general cognition). Hippocampal pathology was examined using three 
magnetic resonance imaging methods; diffusion tensor imaging (mean diffusivity), T1-
weighted imaging (volumetric) and magnetic resonance spectroscopy (metabolite). In 
addition to these measures; mood (HADs), function (Barthel Index) and clinical 
demographics data was collected. An additional 17 healthy age-matched controls 
underwent the same protocol. To examine the relationship between hippocampal 
pathology, stroke incidence and post-stroke cognition, correlation analyses was 
computed. Moderation analysis was computed to establish whether stroke changes the 
relation between hippocampal pathology, on post-stroke cognition.  
4.1.4 Results 
Hippocampal pathology predicted language, number and general cognition at three 
months post-stroke across all three measures, even though it was not directly affected 
by the stroke. This was evident in grey matter volume, mean diffusivity, creatine, 
choline and N-acetylaspartate levels. Relationships between ischemic lesion volume, 
vascular health, small vessel disease, and regional atrophy (temporal lobe) with 
cognition were identified in the stroke group. Hippocampus pathology also predicted 
cognition in the healthy control cohort. No differences in the predictive value of 




This chapter finds that hippocampal pathology may be a biomarker for cognitive 
outcome in stroke, as it is in healthy ageing. Stroke did not moderate the relation 
between hippocampus pathology and cognition. Taken together the results suggest that 
hippocampus pathology is an independent risk factor of cognitive outcome in stroke.   
4.1.6 Introduction 
 
The hippocampus is a brain structure within the medial temporal lobe. The 
understanding of the hippocampus, and its impact on human cognition has developed 
over the years (Robinson et al., 2015). Initially based on the case of HM hippocampus 
was primarily thought to associate with memory (Scoville & Milner, 1957). More 
recently it has been suggested that the hippocampus contributes also to; inhibitory 
control of learned behaviour, spatial information processing, emotionality, memory and 
neuroendocrine control (Teyler & Discenna, 1984). The connectome network between 
the hippocampus, and other brain regions implicates its larger role across cognition 
(Shohamy & Turk-Browne, 2013). Ageing is associated with disturbances to the 
functions associated with the hippocampus. These can present themselves in 
deterioration of memory and lack of ability to learn new things (Samson & Barnes, 
2013). These disturbances of external functions are correlated with structural and 
cellular changes in the hippocampus (Bettio et al., 2017).  
Biological changes in the hippocampus have been linked to cognitive impairment. A 
longitudinal community non neurological cohort study observed decreased hippocampal 
volume over approximately five years, and this was linked to cognitive impairment in 
attention and executive function, but not memory (Evans et al., 2018).   
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Abnormal hippocampal pathology is associated with progressive deterioration of 
cognition, and the transition from mild cognitive impairment to Alzheimer’s disease 
(Mielke et al., 2012; van Uden et al., 2016).  It is suggested that ischemic stroke may 
also cause indirect structural, and cellular changes in the hippocampus, this is because 
the hippocampus is assumed to be vulnerable to diseases of later life such as ischemia 
(Wu et al., 2008).  
Research has found that reduced grey matter volume in the temporal lobe has been 
found in those with silent cerebral infarcts compared with control and this was 
associated with lower cognitive ability as measured by the MoCA (Yang et al., 2015). 
At six weeks post-stroke those with previous stroke incidence had lower hippocampal 
volume compared to first time ever stroke patients, and healthy controls (Werden et al., 
2017). Pathological changes have been observed in the acute stage following stroke. 
When examining cortical thickness within two hours of stroke onset, and at three 
months, Brodtmann and colleagues found a decrease in hippocampal and thalamic 
volume in stroke patients, compared with no changes observed in healthy controls 
across this time frame (Brodtmann et al., 2012). As mentioned above Tang and 
colleagues (2012) reported smaller hippocampal volume in chronic middle cerebral 
artery stroke patients in comparison to controls (Tang et al., 2012). 
Volumetric changes within this brain region and medial temporal lobe atrophy were 
associated with incidence of post-stroke dementia at three months post stroke 
(Pohjasvaara et al., 2000).  
Like hippocampal volume, mean diffusivity of the hippocampus is suggested to predict 
cognition (Carlesimo et al., 2010; den Heijer et al., 2012; Kliper et al., 2016). Increase 
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mean diffusivity in the hippocampus predicted progression of mild cognitive 
impairment to early Alzheimer’s disease (Mielke et al., 2012; van Uden et al., 2016). 
Compared to healthy controls, those with mild cognitive impairment had higher mean 
diffusivity in the hippocampus (Palesi et al., 2012), suggesting damage to 
microstructures within this brain structure. Furthermore, in 18 patients with mild 
cognitive impairment co-occurring increased left hippocampal mean diffusivity, and 
lower left hippocampal grey matter volumes were found to impact verbal memory 
abilities, but this was not found in the right hippocampus (Müller et al., 2005). 
This pattern of abnormal hippocampal pathology, and neurodegeneration is also seen in 
individuals following stroke. Higher mean diffusivity, and reduced volume in the 
hippocampus were identified as biomarkers for memory impairment in a stroke cohort 
with carotid artery disease (Hosseini et al., 2017). More recently this was observed 
longitudinally, over a period of one year (one month, three months and 12 months post-
stroke), hippocampal degeneration was measured using MRI in a cohort of nineteen 
stroke patients, ipsilesional volumes of the hippocampus decreased, and mean 
diffusivity increased (Haque et al., 2019). Both higher mean diffusivity, and lower grey 
matter volume in the hippocampus were found to be associated with impaired cognition 
at six and 12 months post-stroke (Kliper et al., 2016). Conversely, it has been reported 
in a cohort of stroke patients who were measured over a period of 10 years, that mean 
diffusivity did not affect memory when hippocampus volume was normal 
(Schaapsmeerders et al., 2015).  
Neuronal metabolites measured using 1H-MRS can also be used as hippocampus 
pathology biomarkers. In animals, metabolic reduction of N-acetylaspartate (NAA) in 
the hippocampus was associated with cognitive decline in memory, and learning 
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alongside decreased hippocampal volume (Liang et al., 2017). In humans, decreased 
NAA, and increased choline (Ch) in the hippocampus and other brain regions was 
observed in the progression of Alzheimer’s disease, compared to healthy controls 
(Kantarci, 2007; Targosz-Gajniak et al., 2013). This pattern of metabolic change in the 
hippocampus identifies those converting from mild cognitive impairment to dementia, 
at the early stages of decline (Seo et al., 2012; Tumati et al., 2013), with decreased 
NAA metabolic concentrations suggested to be a possible pre-clinical marker of 
Alzheimer’s disease (Kantarci et al., 2011; Waragai et al., 2017).  
In 21 Alzheimer’s patients, decreased NAA, and increased Creatine (Cr) in parietal and 
occipital regions was found, with NAA levels correlating with cognition (MMSE) 
(Huang et al., 2001). However, the direction of metabolite concentration is not always 
consistently reported across neurodegenerative diseases (Su et al., 2016), with Ch 
(Choline) measured in cerebrospinal fluid reported to be higher in those with vascular 
dementia and multiple infarct dementia, compared with Alzheimer’s type dementia, and 
healthy controls (Tohgi et al., 1996). Thus, metabolite concentrations may vary 
depending on the process of neurodegeneration occurring (Liu et al., 2013). Alzheimer’s 
disease patients were found to have a correlation between ratios of decreased 
NAA/myo-insitol in the mesial parieto-occipital lobes and lower scores on MMSE, with 
the same correlation not observed in vascular dementia patients. (Waldman & Rai, 
2003).  
Research looking at metabolite concentrations following ischemic injury, often focuses 
on measuring changes within the lesion. In animal models, metabolic concentrations 
have been examined following ischemic injury. Following acute middle cerebral artery 
stroke, concentrations of Ch in the ischemic tissue are reported to increase, and NAA to 
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decrease, compared to sham (Ruan et al., 2017). In humans, decreased Ch in the early 
post-stroke stage has been found in abnormal tissue, but recovered at three months, in 
contrast, reduced Cr in abnormal tissue is reported even at three months post-stroke 
(Muñoz Maniega et al., 2008). Similarly, NAA within the lesion site was found to be 
decreased in the acute stage post-stroke (Felber et al., 1992; Graham et al., 1993), and 
sub-acute phase (Wardlaw et al., 1998), with continued decreased NAA in relation to 
Ch at the chronic stage (Felber et al., 1992). Reductions in NAA concentrations at the 
acute phase, are associated with reduction in functional ability, measured by the Barthel 
Index (Federico et al., 1998). Thus, demonstrating the potential prognostic value of 
metabolite concentration in the post-stroke brain on outcomes.   
Additionally, cortical thickness and metabolic changes have been observed in the 
chronic stage following stroke, with lower tNAA in the ipsilesional motor cortex, and 
reduced precentral gyrus thickness (Jones et al., 2016). Furthermore correlations 
between peri-infract tNAA concentration level, and associated white matter atrophy in 
the infarcted hemisphere was identified in stroke patients between one and three months 
post-stroke (Yassi et al., 2016). As seen in mild cognitive impairment and Alzheimer’s 
disease, metabolic concentration levels are associated with impaired post-stroke 
cognition. As mentioned above, decreased ratio of NAA/Cr and increased ratio of ml/Cr 
are reported in the hippocampus of chronic stroke survivors relative to controls (Tang et 
al., 2012).  
In acute stroke patients with mild cognitive impairment, hippocampal NAA/Cr ratio 
was lower compared to those with no cognitive impairments, this was correlated with 
MoCA scores (Meng et al., 2016). Ross and colleagues suggest metabolite 
measurements of NAA may be more valid in identifying early cognitive impairment 
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following stroke than structural measurements, such as volume (Ross et al., 2006). They 
found that frontal region NAA/Cr concentration predicted cognitive decline over 12 
months, and up to three years post-stroke (Ross et al., 2006). Decreased NAA level in 
stroke patients with cognitive impairment was found, compared to stroke patients with 
no cognitive impairment, and healthy controls when matched on age, gender, education 
and time post stroke (Wang, 2017).  
To summarise the metabolite literature, NAA is a reliable biomarker for pathological 
brain tissue, shown in neurodegenerative research. Like all MRI measures, metabolites 
are also relative measures. Some authors use a ratio of metabolite to creatine (or 
choline) level to adjust the value. This assumes that creatine (or choline) is not affected 
by tissue pathology. Though, this assumption can be challenged by the above literature. 
For example, creatine is suggested to decrease flowing stroke; while choline is reported 
to decrease in early stages of stroke, but increase in Alzheimer disease. Therefore, in the 
current analysis the values of the metabolite will be scaled relative to lipid and overall 





Between July 2015 and January 2019, a total of 71 stroke patients were recruited to the 
Hippocampal pathology of post stroke cognitive impairment study (HiPPS-CI), from 
two West-Midlands hospitals (Queen Elizabeth Birmingham and Sandwell General 
Hospital) (See Appendix 4.2.1.1).    
The inclusion criteria for the study were (a) recent (less than three months) clinically 
diagnosed ischemic stroke, (b) age >18 to <90 years, (c) able and willing to provide 
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informed consent and (d) cognitive impairment (Montreal cognitive assessment MoCA 
<=26/30) (Nasreddine et al., 2005). Stroke patients were excluded from the study if they 
(a) had contraindication to have Magnetic resonance imaging (MRI) e.g. metal foreign 
body (pacemaker, aneurysm clip, possibility of metal fragments in the eye, etc), (b) 
unfit or unable to tolerate MRI e.g. unable to lie flat due to backache or severe kyphosis, 
shortness of breath, (c) Severe disabling stroke (m-Rankin Scale > 4) (Fish, 2011), (d) 
known pre-stroke dementia or cognitive impairment as confirmed by family members or 
medical documents. Stroke patients were recruited within their hospital admission. At 
this stage informed consent was taken, and clinical and demographic information 
recorded. They were invited to attend Birmingham University to take part in a cognitive 
assessment, and MRI within three months of stroke.  
A total of 20 control participants were recruited during the same period, they were 
recruited as relatives of stroke patients or from the local community. This was an 
opportunistic sample with the aim to match the stroke patients on age. The control 
participants were self-declared healthy. Inclusion criteria consisted of (a) no previous 
history of stroke, dementia or cognitive decline, (b) no contraindication to have MRI 
e.g. metal foreign body (pacemaker, aneurysm clip, possibility of metal fragments in the 
eye, etc). Exclusion criteria included (a) unfit or unable to tolerate MRI e.g. unable to 
lie flat due to backache or severe kyphosis, shortness of breath, and (b) less than 26 on 
the MoCA. (See Appendix 4.2.1.2) 
In the present analyses a total of 42 stroke patients and 17 controls were included. 
Reasons for participants not taking part in assessments following recruitment included 
a) withdrawal, b) unable to contact, c) death. Additionally, one participant was excluded 
as they had a stroke that directly affected bi-lateral hippocampi. Three controls were 
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excluded because of incidental findings (e.g. enlarged ventricles, silent stroke) or due to 
mild cognitive impairment as indicated by the MoCA score (<26). Of note, two of the 
controls that were excluded also reported some cognitive clinical symptoms when they 
were assessed. Across each MRI measure the number of individuals included varied. 
Reasons for the variation were due to; (a) not completing the scan, and (b) removal of 
data due to quality issues such as excessive movement, poor signal to noise. For each 
analyses the following number of participants were included; Grey matter hippocampal 
volume, 42 stroke patients and 17 controls; mean diffusivity, 35 stroke patients and 15 
controls, and for 1H-MRS, 31 stroke patients and 17 controls.  Due to the uneven 
numbers across the three MR measures, representative demographical and clinical 
information for both stroke patients and controls were taken from the grey matter 
volume cohort which was the largest (stroke n=42, control n=17) for descriptive 
statistics (Table 15). Stroke specific clinical information is reported in Table 16. We 
note a lower incidence of previous stroke in the sub-sample of mean diffusivity (20%) 
than in the grey matter volume cohort (16.6%), t(41)=2.91, p=.006. The 1H-MRS stroke 
sub-sample group were less educated than the grey matter volumetric cohort t(59)=2.02, 
p=.048. No other clinical-demographic variables varied between the sub-samples. 
Mean stroke severity as measured by the NIHSS was five, demonstrating a mild stroke 
severity cohort. Eight of the 42 stroke patients had been thrombolysed. The ischemic 
lesion characteristics of the cohort consisted of equal distribution of cortical vs 
subcortical; twice the number of left sided lesions compared with right lesions. There 
was little overlap between the lesions in the current cohort. Two patients had partial 




Ethical approval was given by the UK Health Research Authority and West Midlands 
Black Country Research Ethics Committee (15/WM/0209).  
4.2.2 Measures 
 
4.2.2.1 Demographic and clinical information 
 
For each stroke patient clinical and demographic data was collected. This included age, 
sex, and years of education, patient medical history (dementia, stroke, diabetes, 
hypercholesterolemia, atrial fibrillation, hypertension, ischemic heart disease, 
myocardial infarction, peripheral vascular disease), medication (anticoagulant, 
antiplatelet, hypertensive, statins, antidepressant), and cigarette smoking (per week) was 
collected. Stroke severity was recorded based on the national institute of health stroke 
scale (NIHSS), (Ortiz & L. Sacco, 2014)  assessed on admission to the emergency 
department. The scoring consists of a scale 0-42, with 42 documenting a severe stroke.  
For the control participants demographic data included: age, sex, years of education, 
medical history, medication, and cigarette smoking. Questionnaires were completed for 
both groups to assess activities of daily living (Barthel Index score) (Mahoney & 
Barthel, 1965), with a higher score demonstrating better functional ability. Mood was 
also assessed (Hospital anxiety and depression scale), with a higher score demonstrating 




Table 15. Demographic and clinical information including group differences (HiPPS-CI 
study) 
 Stroke (n=42)  Control (n=17)  
 Mean 
(Std) 
Median Range Mean 
(Std) 
Median Range P 
value 
Age (years) 63.48 
(12.66) 
63.50 34:85 62.18 
(10.10) 
63.00 39:76 .681 
Sex (male:female) 32:10   5:12   .000 a 
Education 11.90 
(2.58) 
11.00 9:19 14.94 
(3.19) 
16.00 10:20 .002 a 
HADs Anxiety 5.88 
(4.36) 
5.00 0:17 3.00 
(1.69) 
3.00 0:8 .001a 
HADs Depression 5.14 
(3.65) 
4.00 1:14 1.29 
(1.40) 
1.00 0:6 .000a 
Barthel Index 17.45 
(3.42) 
19.00 8:20 19.18 
(1.18) 
19.00 15:20 .006 
Vascular Risk 27.45 
(13.47) 
28.00 0:64 10.53 
(11.76) 
27.45 0:35 .000a 
MoCA 21.00 
(4.56) 
17.00 9:26 26.41 
(1.21) 





1462 1302:1720 1498 
(200) 





1.00 0:3 1.00 
(0.70) 





1.00 0:4 0.11 
(0.33) 





1.00 0:3 0.88 
(0.48) 
1.00 0:2 .017 
Notes. Std= Standard Deviation, HADs= Hospital Depression and Anxiety scale (higher scores indicate 
higher severity), Barthel Index (higher scores indicate more functional ability), Vascular risk score from 
FSRP (higher scores indicate higher vascular risk), MoCA= Montreal Cognitive Assessment (>26 




4.2.2.2 Vascular risk factors 
 
 A vascular risk score was calculated for both stroke patients and controls based on the 
Framingham stroke risk profile (FSRP). FSRP is an estimate of the individuals stroke 
risk in the next 10 years, and represents a level of vascular health (Wolf et al., 1991). 
FSRP includes the following risk factors: age, systolic blood pressure (taken at 
admission to hospital), antihypertensive medication, diabetes, cigarette smoking, history 
of cardiovascular disease, and atrial fibrillation. In this analysis, risk scores were 
calculated using different cut offs according to sex. We did not have information on left 
ventricular hypertrophy, which is traditionally used in this risk calculation. There was 
missing data for systolic blood pressure for all controls, a percentage vascular risk score 
was calculated on the available data for each individual. A higher vascular risk score 
indicated worse prognosis for further stroke incidence, and lower overall vascular 
health.  
4.2.2.3 Cognition measures 
 
Cognition was assessed using the Birmingham Cognitive Screen (Humphreys et al., 
2012). The data was pre-processed, and summarised as in previous chapters (2.3.3, 
3.3.2.1).  
4.2.2.4 MRI acquisition 
 
All images were acquired within three months of stroke on a 3T Philips Achieva 
Scanner using a 32channel head coil. The protocol consisted of the following 
sequences: Sagittal T1- weighted image (TR/TE= 8.4/3.8 ms, FOV=175, matrix= 
288x232, slice thickness 1mm, voxel dimensions 1x1x1). T1 was used for estimating 
the local volume of the hippocampus. DTI (TR/TE=7700/57 ms, FOV=86, 
matrix=224x224, b values= 1000 /mm2, voxel dimensions 2x2x2, and 32 gradient 
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directions) used for mean diffusivity analysis. 1H -MRS (TR/TE=2000/37 ms, 2048 
complex points, sampling frequency= 2000Hz, averages=12), both water suppressed 
and water reference data were collected. For the metabolite extraction two voxels of 
dimensions (20x15x30mm) placed on the left and right hippocampus were planned on 
T1-weighted anatomical images. The scanner was upgraded about half way through data 
collection (i.e. 14 of 42 stroke and 8 of 17 were collected before the scanner upgrade) in 
March 2017, this involved a workstation software upgrade on the Phillips Achieva MRI 
from release three to five. This upgrade primarily focused on changing of how dicom 
images were created, saved and stored. For example, image format was changed from 
Dicom, to the Dicom Enhanced format. Despite the scanner upgrade being a potential 
confound, we did not expect that this will impact the image quality and analyses. But as 
a precaution, we accounted for this potential confound in all statistical analyses anyway. 
The impact of the upgrade was assessed post-hoc, see analysis section below. 
4.2.2.5 Ischemic infarct identification, volume and brain health 
 
The presence of acute ischemic infarcts was identified from acute clinical imaging 
reports. Ischemic infarcts were defined as cortical (if they affected the cortex) or 
subcortical. Lesion side was defined as left, right or bilateral. Previous infarct (in the 
cases this was not their first stroke) identification was established via clinical reporting 
on the acute clinical imaging (see Table 16. Stroke clinical profile).  
Quantification of the ischemic lesions was performed manually by two rater’s using 
MRIcroGL. It was guided by clinical imaging reporting. The number of voxels of the 
lesion site ROI was multiplied by the voxels of the scan (lesion voxels x 0.56 x 0.56 x 
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1), the lesion was measured in mm^3. The lesion volume is presented as percentage of 
intracranial volume obtained from CAT12 (see 4.2.3.1).  
 
Table 16. Stroke clinical profile 
 Stroke (n=42) 
Mean (Std) Median Range 
    
NIHSS 5.02 (4.38) 0:20 5.00 0:20 
Thrombolysis (yes: no) 8:34   
Lesion Location (Cortical: Subcortical) 23:18   
Lesion Side (Left:Right:Bilateral) 21:13:8   
Lesion Volume mm^3 (%) 0.19 (0.46)  0.04 0:2.40 
Previous stroke (yes: no) 7:35   
Notes. Std= Standard Deviation, NIHSS= National Institute of Health Stroke Scale 












4.2.2.6 Parietal and Medial temporal lobe atrophy  
 
Parietal and temporal regions were graded for atrophy. This was computed for both 
stroke patients and control participants. Koedam score (parietal atrophy) (Koedam et al., 
2011), and MTA visual rating scale (temporal atrophy) (Scheltens et al., 1992) were 
used to rate the cortical atrophy using T1-Weighted images obtained at time of 
attendance to the imaging centre (<3 months post-stroke). The scale rated atrophy 
across a scale from 0-3, with 0 showing no cortical atrophy and 3 demonstrating end 
stage atrophy. Grading was completed by two rater’s, one a clinical radiologist. The 
ratings were calculated by the two rater’s with discussion and in references to guidance 
of the rating scales.  In five stroke patients and four controls, we were unable to 
complete the grading, and a mean of their respective groups was allocated. 
4.2.2.7 Small vessel disease  
 
In both stroke patients and control participants, level of small vessel disease was 
examined. The Fazekas Scale was used to rate the scale of small vessel disease using 
FLAIR images obtained at time of attendance to the imaging centre (<3 months post-
stroke). The scale rates the level of white matter changes from 0 no small vessel disease 
to chronic= 3 (Wardlaw et al., 2013). Grading was completed by two rater’s, one a 
clinical radiologist. The ratings were calculated by the two rater’s, with discussion and 
in references to guidance of the rating scales.  In five stroke patients and four controls, 
due to software upgrades, we were unable to complete the grading, and a mean of their 




4.2.3 Analyses of MR measures 
 
The effect of the scanner software upgrade was tested using two sample independent t-
tests, comparing the signal of all hippocampus measures before and after the upgrade 
for each measure, across the entire group and for stroke patients alone. No difference 
was found in the grey matter volume and mean diffusivity hippocampal measures (in 
the entire group and the stroke group alone, all Ps > .09). The right tNAA’s peak was 
higher after the upgrade compared to before, this was observed in the entire group (t(46) 
= 2.31, p =.026) and in the stroke group alone (t(29) = 2.1, p = .045). Note that this 
difference did not survive multiple comparison (Pcorr = .05/7 = .007). Nevertheless, we 
added scanner upgrade as a covariate in all the regression analyses, to ensure that the 
relations between hippocampal pathology and cognition was not driven by a difference 
due to scanner upgrade.  
4.2.3.1 Volumetric measurement of hippocampi 
 
The volumetric analysis was performed using the T1-weighted images in SPM12 
(www.fil.ion.ucl.ac.uk/spm/software/spm12) and CAT12 toolbox. Each patients’ T1-
weighted image was warped to the normalized MNI template using the unified 
segmentation algorithm. This resulted in a tissue probability map for the grey matter. 
Then each voxel intensity was modulated by the Jacobian deformation map. The 
modulated segmented images account for changes in local tissue volume, by weighting 
the value of each voxel by the deformation maps (if the hippocampus was stretched to 
fit the normalised template then the value of the grey matter voxels in this stretched area 
is reduced). Therefore, it is assumed that higher values in a voxel tissue probability map 
indicate larger grey matter volume. From this point forward, we will refer to the 
modified grey matter tissue probability measure, as grey matter volume. We tested for 
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each participant the quality of the normalization, and the segmentation by comparing it 
to SPM standard templates. 
The Automatic Anatomical Labelling (AAL) toolbox (Tzourio-Mazoyer et al., 2002) 
was used to define the left and right hippocampi. To obtain a summary statistic of the 
voxel’s volume within the hippocampus, the VOI toolbox (Eigen variate) of SPM12 
was used. This toolbox extracts the first eigen variate that best represents all voxels in 
the volume of interest (VOI). A higher value indicates more grey matter volume within 
the hippocampus structure. Intracranial volume was extracted from the CAT12 






Figure 11.  Coronal and sagittal slices of T1-Weighted image. 
Left Hippocampus shown in red, selected with AAL toolbox.  
4.2.3.2 Mean diffusivity of hippocampi  
 
Mean diffusivity was calculated using both FSL (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki, 
and SPM (www.fil.ion.ucl.ac.uk/spm/software/spm12). The data was corrected for eddy 
currents, and motion distortion using eddy correction (Andersson & Sotiropoulos, 
2016). Binary masks were created using FMRIB Brain Extraction Tool (BET) (Smith, 




used to register individual diffusion maps to T1-Weighed images. Mean diffusivity was 
extracted using masks from Automatic Anatomical Labelling (AAL) toolbox (Tzourio-
Mazoyer et al., 2002) for both the left and right hippocampi. The extracted mean 
diffusion values were measured as mm2, and scaled using 10^3 multiplication factor. In 
healthy brains mean diffusivity values are lower, with higher values demonstrating 
structurally disorganised, and disintegrated tissue due to water molecules having less 
restricted diffusion. Therefore, low mean diffusivity is associated with healthier grey 
matter tissue. Mean diffusivity is expected to negatively correlate with grey matter and 
with tNAA. When pre-processing the DTI data, we normalised the images prior to the 
MD extraction. In contrast to the pre-processing of the T1-weighted image, used for 
measuring the hippocampus volume, we did not modify the DTI signal by the Jacobian 
deformation map. For functional T2* signal (which is the same signal the DTI is based 
on), it is not recommended to adjust the signal intensity based on the normalization 
parameters. As we are focusing only on signal change and not volume, then normalising 
prior to extraction should not modulate, or cause any changes to the signal we extract. If 
we were extracting volume then it could cause an issue with values extracted from the 
images having been normalised (stretched and reduced), and may not represent true 












Figure 12. Mean diffusivity map of patient on coronal slice of a single patient. The red 
arrow points to the hippocampal region. This patient had reduced grey matter volume in 
their right hippocampus. 
4.2.3.3 Magnetic resonance spectroscopy of hippocampi  
 
1H-MRS data was processed using the LC Model analysis software. Absolute 
metabolite concentrations were calculated by normalising to the water reference 
acquisition and percentage white matter, grey matter and CSF voxel contributions 
calculated using SPM12 (www.fil.ion.ucl.ac.uk/spm/software/spm12). Voxel 
registration, and partial volume metabolite concentration corrections were applied using 
the ‘spant’ MRS analysis package for R https://cran.r-
project.org/web/packages/spant/index.html. This was processed for both left and right 
hippocampi. Quality of data was assessed by visually inspecting the spectrum, and 
examining the signal to noise ratio > 15 (Wilson, Andronesi, et al., 2019). We used a 
fairly liberal signal-to-noise ratio as the hippocampus is a challenging region to image, 




There were consistent issues with the right hippocampus, its spectrum (which was flat), 
and very low signal to noise ratio (SNR < 5) across most of the participants (>70%). 
Due to this, the right hippocampus was excluded from the analyses.  It is possible that 
the poor 1H-MRS signal from the right hippocampus was related to a failure in applying 
the correct shimming, due to a programming bug in the scanner software. In three stroke 
patients and three controls, SNR was lower than ten but higher than five in the left 
hippocampus, despite this, they were kept in the analysis as their spectrum showed the 
expected peaks.  
Magnetic resonance imaging (MRS) is a method of MRI that allows us to 
noninvasively measure alterations in metabolite levels. Deviation from ‘normal’ levels 
of metabolites within the brain, can indicate damage or disruption within the brain 
tissue. Three key metabolites that can reliably be captured by MRS include; N-Acetyl-
Aspartate (NAA), Creatine (Cr) and Choline (Cho) (Faghihi et al., 2017). MRS may 
allow the detection of changes in the brain of post-stroke patients, earlier than volume 
loss observations.  
N-Acetyl-Aspartate (NAA) is one of the most reliable neuronal health markers. Levels 
of NAA is decreased in situations of neuronal distress, and neuronal loss (Faghihi et 
al., 2017). Choline is a metabolism marker, and shows a decreased levels in 
demyelination, and is a marker of breakdown and synthesis of phospholipid membranes 
(Faghihi et al., 2017).  
Creatinine is an energy metabolism marker, rising levels have suggested to be early 
marker of cognitive decline (Faghihi et al., 2017). In Alzheimer’s disease, not 
surprisingly NAA shows a decreased profile, while ratio of NAA/Cr also show 
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reduction in temporal regions (Block et al., 2002; Faghihi et al., 2017). Demonstrating 
both neuronal distress, and decreased energy within the molecules in Alzheimer’s 
disease. Choline does not present with a consistent direction of change however (Faghihi et 
al., 2017). 
The metabolites that were examined included total Choline (tCh), total Creatinine (tCr) 
and total N-acetylaspartate (tNAA). Calculations for the metabolites consisted of the 
following; tCh = Glycerophosphocholine (GPC) + Phosphocholine (PCh), tCr = 
Creatine (Cr) + Phosphocreatine (PCr) and tNAA = N-Acetylaspartate (NAA) + 
(NAAG) NAA-Glutamic Acid. For tNAA higher values are expected in a healthy brain. 
It is expected that tNAA will positively correlate with grey matter volume and 
negatively with age. The expected impact of pathology on the concentration of tCr and 
tCh is unclear, as the previous reports provide inconsistent pattern. Suggesting changes 
in Creatine and Choline may differ depending on the disease type and/or progression 














Figure 13.  Magnetic resonance spectroscopy spectrum output  
(example from a stroke patient). Metabolites included in analyses are  
labelled NAA = N-Acetylaspartate; Cr= Creatine; Ch= Choline. 
 
4.2.3.4 Statistical analyses 
 
SPSS24 was used for all statistical analyses.  
Cognitive ability was computed as a deviation score from the controls 
(Z=(meanControl–Patient score)/stdevControl) (Sampanis, 2015). General cognitive 
ability was computed by averaging across the five domains. For a full description, see 






The differences between the stroke patients and control participants on all clinical, 
demographic and imaging measures were computed using t-tests, with equal variances 
not assumed (Chi-square for sex) (Table 15). 
To provide an internal validation for the data, the relations between the various 
measures were assessed. We first looked at the correlation between the demographic 
and clinical measures. We then correlated those with the hippocampal pathology 
measures (mean diffusivity, 1H-MRS, and grey matter volume), and then the cognitive 
domains. Correlations (Pearson r) were firstly computed across a combined group of 
stroke patients and control participants, and then separately for stroke patients. Due to 
the some of the variables being dichotomous, and some of the data not being normally 
distributed Spearman rank was also calculated. We note that the groups had unequal 
sizes. Hence the correlations in the combined sample were likely to be driven primarily 
by the largest group (the stroke patients). The control sample was relatively small, and 
hence was lacking the power to detect the relations between variables on their own 
(correlations for this group are reported in Appendices 4.6). 
The main question of this chapter was to assess whether hippocampus pathology 
predicts cognitive outcome following stroke, and whether this pattern is different for 
stroke patients and control participants. We analysed each hippocampal pathology 
measure independently to the varying number of participants in each measure. 
Correlation was used to assess the relations of each hippocampus pathology measure, 
and cognitive domain, this was done for the entire group and each group separately.  
To formally test whether the relations between hippocampus pathology, and cognition is 
affected by stroke incidence we used moderation analyses. This was done by computing 
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an interaction variable for each of the MRI hippocampal measures and stroke condition. 
To compute the impact of stroke, we conducted a regression analysis across two models 
using the combined group of stroke patients and controls. Both models included age, 
scanner upgrade, and the specific hippocampal measurement as potential predictors of 
cognition, and differed in the inclusion of the moderated hippocampal variable in the 
combined group. Beyond the contribution of each variable, these analyses formally 
assessed whether the two models reliably differed. In other words, did the inclusion of 
the moderation variable improve the ability to predict the cognition, suggesting that the 
relations between hippocampal pathology, and cognition were altered following the 
stroke. As the main interest of this thesis was to examine cognitive outcomes following 
stroke, we also report a separate regression for the stroke group, to test whether 
cognition was predicted by the hippocampal pathology after controlling for age and 
scanner upgrade.  
As the correlation analyses (see below) suggested that multiple clinical-demographic 
variables correlate with cognition, we further assessed whether the relation between 
cognition and hippocampus pathology in the stroke group is preserved even after 
controlling in the model for stroke history, lesion volume, stroke severity (NIHSS), 
vascular risk, and education level. Age was not included in this model, as vascular risk 
uses age as one of its parameters.  
The analysis was run separately for each MR hippocampal measure (i.e. 7 measures). 
This was due to the high level of correlation between predictors, specifically in small 
sample size this can lead to spurious findings.  
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It is important to note that multiple analyses have been conducted on the same set of 
data, leading to multiple comparisons. As the aim was to explore the data in this new 
area of research (i.e. not much is yet know about spectroscopy and stroke), a large 
proportion of the analyses was to establish the internal validity of the measures. We 
have taken, where possible a hypothesis driven approach, with knowledge gained from 
other disease areas such as Alzheimer’s disease. We took caution with interpreting 
statistical results that were weak, due to the issues surrounding interpretation of multiple 
comparisons. In each analysis information is provided of whether significance remained 





4.3.1 Demographic and clinical profile 
 
4.3.1.1 Comparison between the controls and the stroke patients 
 
Table 15 presents clinical and demographic data for both stroke patients and control 
participants. Due to the recruitment criteria, age did not differ between the two groups. 
Not surprisingly the stroke group were significantly less functionally independent. The 
rate of vascular risk for stroke was double in the stroke patients, compared with control 
participants. The stroke patients and controls differed in their representation of sex, with 
stroke patients predominantly male, and the control group predominantly female. The 
stroke and control groups were reliably different in their education levels, with the 
stroke patients having significantly less education years. Mood measured using the 
HADs, demonstrated significantly higher levels of both anxiety and depression in the 
stroke patients. The stroke patients scored five points lower than the control group on 
the MoCA, an effect that is partly driven by the recruitment procedure. Intracranial 
volume was measured across the two groups; there were no significant differences in 
volume. The rate of cortical temporal atrophy differed across stroke patients and 
controls, with stroke patients demonstrating a higher rate of atrophy. In the parietal lobe 
the stroke patients didn’t show increased rate of atrophy, as compared to controls. When 
examining small vessel disease, we found that stroke patients had a significantly higher 
rate compared to controls.  
4.3.1.2 Associations between the demographic and clinical measures 
 
The relations between the demographic and clinical measures are reported in table 
(Table 17 and Table 18).  
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Table 17. Demographic and clinical variable correlations for stroke and controls 
combined 
 1 2 3 4 5 6 7 
1 Age -       
2 Sex .06 -      
3 Education -.33*+a -.23 -     
4 HADs A -.01 -.02 -.15 -    
5 HADs D .05 .08 -.20+a .67**++a -   
6 Barthel Index .09 .08 .05 -.40**+a -.43**+a -  
7 Vascular Risk .68**++a .15 -.49**++a .17 .27*++a -.13 - 
Notes. All N=59, Stroke N=42, Control N=17. Numbers on the X –axis represent the  
same variables as the Y-axis. 
HADs= Hospital Anxiety and Depression scale, A= Anxiety, D=Depression. 
Vascular Risk= Framingham stroke risk score  
- Indicates a negative correlation. Parametric correlation = ** p<.001 * p<.050,  
Non-parametric correlation= ++ p<.001, +p<.050.  aBonferonni FME 0.5/7=0.07 
 
Not surprisingly vascular risk (calculated from medical history) was associated with 
severity of small vessel disease (estimated from MR scans) in the entire sample, and the 
sub-sample of stroke. This is evidence of validation of these two clinical measures. 
For both groups combined, age positively correlated with vascular risk score, atrophy 
rate (temporal and parietal), and small vessel disease; this also held in the correlation 
within the stroke group only. The correlation of age, and vascular risk should be 
interpreted with cation as age was included as a parameter in the vascular risk 
calculation. Taken together, as expected age had an adverse effect on overall brain 
health. 
Education level negatively correlated with age, suggesting the older participants were 
less educated than their younger counterparts, both when considering the entire sample 
and the subsample of stroke only. Education negatively correlated with vascular risk, 
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temporal lobe atrophy and small vessel disease across the entire group. When 
considering the stroke group on their own education negatively correlated with vascular 
risk, small vessel disease and positively with intracranial volume. Taking together 
education was an overall protective factor of measures of brain health, though this was 
potentially confounded by the age differences observed in education level. 
As expected sex affected intracranial volume, with males showing large volumes than 
females, this was true for the entire sample as well as for the sub-sample of stroke 
patients only. In the entire sample temporal lobe atrophy was different across sex, with 
higher atrophy rate for male than females. In the stroke group, females showed more 
severe small vessel disease than males. Education and age were not different between 
the two sexes in the entire sample and also in the sub-sample of stroke.  
Most of the stroke patients and control participants in this sample showed normal level 
of anxiety and depression; with only a few classing as severe. Only two stroke patients 
presented with severe anxiety level, six stroke patients with moderate anxiety level, and 
five with a moderate depression level. As expected, the level of anxiety correlated with 
the level of depression, for the combined analysis (r = .67), and specifically for stroke 
patients (r = .61); the effects were reliable when using Pearson and Spearman tests. 
Depression positively correlated with increased vascular risk only in the entire group (r 
= .27), as well as with education (r = -.20), the latter effect was only reliable in the non-
parametric tests. Sex, age, and degree of brain health were not related to level of anxiety 
or depression.  
4.3.1.3 Association of demographic-clinical profiles and stroke specific measures 
 
Age, sex, and anxiety and depression level did not associate with any of the stroke 
measures (Table 18). Stroke severity (NIHSS) at admission, and history of previous 
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stroke also did not relate to any of the clinical and demographic measures. Patients with 
cortical lesions had larger lesion volumes. It worth noting that the correlation with the 
right parietal atrophy in general, was only reliable when using Pearson test, suggesting 
this was primarily driven by small number of people. Furthermore, as clinical marking 
of atrophy is based on the sulci structure it is not directly affected by the presence of a 
lesion. Lesion side (left, right, bilateral) did not affect any of the clinical-demographic 
variables (uncorrected p>.093). Functional independence was higher in the less anxious 
(r = -.32) and depressed (r = -.34) stroke patients. Education was associated with 
thrombolysis, where those who had thrombolysis had higher education levels, these 
patients also had less severe small vessel disease, and not surprisingly also had larger 
intracranial volume. Lesion location and lesion volume did not differ between those 
who were thrombolysed and those who were not, and there was no difference in stroke 
severity at admission in this sample.  
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Table 18. Demographic and clinical variable correlations for stroke group 
 1 2 3 4 5 6 7 8 9 10 11 12 
1 Age -            
2 Sex -.03 -           
3 Education -.41**++ a .17 -          
4 HADs A -.03 -.27 -.03 -         
5 HADs D -.01 -.23 .00 .61**++ a -        
6 Barthel Index .12 .25 -.06 -.32* a -.34*+ a -       
7 Vascular Risk .73**++ a -.20 -.37*++ a -.00 -.00 .03 -      
8 NIHSS -.02 .07 .18 -.04 .06 -.05 .02 -     
9 Thrombolysis -.27 .26 .35* a -.08 -.10 -.15 .-.20 .13 -    
10 Lesion Location .01 -.13 .02 .09 .01 .04 .12 .20 -.06 -   
11 Lesion Volume -.08 -.11 .04 .12 .06 .02 -.21 -.09 -.06 .30+ -  
12 Previous stroke .02 -06 .01 -.03 -.10 .24 .02 .14 .10 .01 -.07 - 
Notes. Stroke N=42. Numbers on the X –axis represent the same variables as the Y-axis. HADs= Hospital Anxiety and Depression scale, A= Anxiety, D=Depression. 
Vascular Risk= Framingham stroke risk score. NIHSS= National Institute of Health Stroke Scale. - Indicates a negative correlation. Parametric correlation = ** p<.001 
* p<.050, Non-parametric correlation= ++ p<.001, +p<.050, 
aBonferonni FME 0.5/12=0.04. 
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There were no significant relations between lesion side (left, right, bilateral) and any of 
the clinical, demographic, cognitive or hippocampal measures, although tNAA trended 
toward being reliable, F(2,29)=2.59. p=.093.  
4.3.1.4 Summary clinical-demographic profile 
 
The analyses above showed the expected relations between the clinical and 
demographic measures, providing an internal validity for these measures. In the current 
sample stroke patients were poorer on all clinical and demographic variables, but age 
did not differ. The differences observed between groups is important, as it is important 
to understand when establishing inferences regarding stroke specific effects on 
cognition and hippocampus pathology. 
4.3.2 Cognitive profile 
 
4.3.2.1 Comparison between controls and stroke patients  
 
Cognition was measured using the BCoS across five cognitive domains; language, 
memory, attention and executive function, number and praxis. A composite cognitive 
measurement of the five domains was also calculated (general cognition) (Table 19). 
The cognitive data were not equally distributed, in both stroke patients and control 
participants. In some cognitive domains this was due to outliers. Overall as expected the 
stroke group, had significantly lower cognitive ability compared with the controls 
across the five cognitive domains and general cognition, unequal variances assumed 




Table 19. Cognitive profile of stroke and control participants including group 
differences 
Cognitive Domains Stroke (n=42) Control (n=17) 
Mean 
(Std) 
Median Range Mean 
(Std) 




















































Notes. Std= Standard Deviation, Cognitive domains from the Birmingham Cognitive Screen, including  
composite domain (general), Cognitive Domain values are normalized Z scores.  
aBonferonni FME 0.5/6=0.08. Stroke N=42. 
Table 20. Cognitive Domain correlations for stroke and controls combined and stroke 
 1 2 3 4 5 6 
1 Language - .75**++ .53**++ .60**++ .59**++ .86**++ 
2 Memory .77**++ a - .50**++ .36**++ .37**++ .75**++ 
3 Attention and Executive Function .52**++ .43**++ - .36**++ .47**++ .75**++ 
4 Number .58**++ .31*++ .30++ - .44** 78**++ 
5 Praxis .54**+ .31* .39* .36* - .69**++ 
6 General .87**++ .74**++ .72**++ .75**++ .62**+ - 
Notes. All N=59, Stroke N=42, Control N=17.Stroke data presented in the lower half of the matrix,  
and control and stroke combined data presented in the upper half. - Indicates a negative correlation. 
Numbers on the X –axis represent the same variables as the Y-axis.Parametric correlation = ** p<.001, 
*p<.050, Non-parametric correlation= ++ p<.001, +p<.050.  




4.3.2.2 Association between cognitive measures and clinical demographic 
measures 
In the combined sample (stroke and controls) the five cognitive domains correlated with 
each other. Similar effects were seen in correlations across all cognitive domains only in 
the stroke group (Table 20). The relationship between cognition and 
demographic/clinical variables were examined across the two groups combined (Table 
21) and for stroke specific (Table 22).  
Across the entire sample, general cognitive ability reduced linearly with age, 
participants who were less educated, had higher vascular risk, more severe small vessel 
disease, larger degree of atrophy in the temporal, and parietal lobes and higher 
intracranial volume. In the stroke sample only, age showed a similar effect size on 
cognition but was not reliable, potentially due to the small sample size. Education, 
vascular risk, and small vessel disease did not affect general cognition, but level of 
parietal and temporal atrophy, and overall intracranial volume affected general 
cognition. This potentially reflects the dominant impact of the lesion on general 
cognition, see below. It also suggests that the correlation of cognition, with vascular 
risk, and education in the entire sample was confounded by the difference in this 
variable, between the stroke patients and control participants.  
Not surprisingly participants with higher levels of atrophy in temporal, and parietal 
regions performed poorly on all cognitive domains. Education, intracranial volume, and 
vascular risk only affected praxis and number related abilities. Age positively correlated 
with number abilities.   
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Specifically, in the stroke patients, like in the entire sample, parietal atrophy impaired 
performance on all cognitive domains; while temporal lobe atrophy affected 
performances on memory and number. Reduced intracranial volume was associated 
with poor abilities in language, numbers and praxis. Education, vascular risk, lesion side 
and small vessel disease did not relate to abilities on any of the cognitive domains.  
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Table 21. Demographic, clinical and imaging variables correlations for stroke and controls combined 
 1 2 3 4 5 6 7 
1 Age -       
2 Sex .06 -      
3 Education -.33*+ -.23 -     
4 HADs A -.01 -.02 -.15 -    
5 HADs D .05 .08 -.20+ .67**++a -   
6 Barthel Index .09 .08 .05 -.40**+a -.43**+a -  
7 Vascular Risk .68**++a .15 -.49**++a .17 .27*++ -.13 - 
 8 Parietal Lobe Atrophy .36**++a .15 -.13 -.18 -.11 .08 .12 
 9 Temporal Lobe Atrophy .48**++a .27*+ -.40**++a .05 .05 -.02 .42**a 
10 Small Vessel Disease .51**++a -.091 -.46*++ .11 .11 -.09 .56**++a 
11 Left GM Volume -.52**++a .20 .45**a -.17 -.15 .09 -.47**++a 
12 Right GM Volume -.51**++a .16 .47**a -.18 -.26*+ .15+ -.45**++a 
13 Left MD .26 -.15 -.05 -.16 .03 -.03 .14 
14 Right MD .25 -.19 -.04 -.20 .10 -.09 .13 
15 tNAA -.24 -.10 .01 .02 -.11 .15 -.23 
16 tCh -.14 -.14 -.05 .07 -.04 .12 -.11 
17 tCr -.03 -.15 .06 .05 -.17 .21 -.15 
Notes. HADs= Hospital Anxiety and Depression scale, A= Anxiety, D=Depression. Vascular Risk= Framingham stroke risk score.  
GM= Grey matter.MD= Mean diffusivity. - Indicates a negative correlation. Parametric correlation = ** p<.001, *p<.050,  
Non-parametric correlation= ++ p<.001, +p<.050. aBonferonni FME 0.5/17=0.02. GM; Stroke N=42, Control=17, MD; Stroke=36, Control=15. t=Total,  
tNAA= Total N-Acetylaspartate, tCho= Total Choline, Cr=Total Creatine; Stroke N=31, Control=17. Note that with a binary categorical variable,  
Pearson correlation is mathematically equivalent to independent two sample t-test (e.g. sex).  
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Table 22. Demographic, clinical and imaging variables correlations for stroke group 
 1 2 3 4 5 6 7 8 9 10 11 
1 Age -           
2 Sex -.03 -          
3 Education -.41**a .17 -         
4 HADs A -.03 -.27 -.03 -        
5 HADs D .01 -.23 .00 .61**a -       
6 Barthel Index .12 .25 -.06 -.32* -.34*+ -      
7 Vascular Risk .73**++a -.20 -.37*++ -.00 -.00 .03 -     
8 NIHSS .02 -.07 .18 -.04 .06 -.05 .02 -    
9 Thrombolysis -.27 .26 .35* -.08 -.10 -.15 -.20 .13 -   
10 Lesion Volume -.08 -.11 .04 .12 .06 -.02 -.21 -.09 -.06 -  
11 Previous stroke .02 -06 .01 -.03 -.10 .24 .02 .14 .10 -.07 - 
12 Parietal Lobe Atrophy .41**++a .25 -.27 -.20 -.14 .08 .18 .10 -.04 .32* -.04 
13 Temporal Lobe 
Atrophy 
.54**++a .06 -.34 -.08 -.17 .08 .29+ -.01 -.24 .19 .06 
14 Small Vessel Disease .51**++a -.39**+a -.51**+a .03 -.01 -.04 .59**++a -.13 -.36* -.14 -.16 
15 Left GM Volume -
.64**++a 
.37*++ .43**+a -.16 -.12 .07 -.57**++a .04 .37* .03 .09 
16 Right GM Volume -
.63**++a 
.35*++ .43**+a -.12 -.18 .09 -.49**++a .07 .39* -.13 .11 
17 Left MD .34*+ -.16 -.02 -.20 .10 -.08 .27 .08 -.11 -.08 .09 
18 Right MD .32 -.22 -.02 -.23 .19 -.14 .24 .16 -.17 -.12 .16 
19 tNAA -.32 .00 -.05 .09 -.05 .16 -.26 .22 .20 -.36* -.09 
20 tCh -.34 -.28 -.08 .10 -.08 .21 -.33 .11 -.05 -.31 -.02 
21 tCr -.16 -.21 -.05 .11 -.14 .19 -.18 .07 -.00 -.30 -.11 
Notes. GM; Stroke N=42. MD; Stroke=36. t=Total, tNAA= Total N-Acetylaspartate, tCho= Total Choline, tCr=Total Creatine; Stroke N=31. HADs= Hospital Anxiety 
and Depression scale, A= Anxiety, D=Depression. Vascular Risk= Framingham stroke risk score. NIHSS= National Institute Stroke Scale. GM= Grey matter. MD= 
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Mean diffusivity. - Indicates a negative correlation. Parametric correlation = ** p<.001, *p<.050, Non-parametric correlation= ++ p<.001, +p<.050. aBonferonni FME 
0.5/21=0.02. Note that with a binary categorical variable, Pearson correlation is mathematically equivalent to independent two sample t-test (e.g. sex, previous stroke).  
Numbers on the X –axis represent the same variables as the Y-axis.
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4.3.2.3 Summary of cognitive profiles  
 
The analyses above showed that while the stroke patients were more impaired 
cognitively, the relations between brain health (cortical atrophy) and cognition were 
preserved.  The variability of general cognitive ability (averaged abilities across all five 
domains) was most robustly associated with the clinical demographic variables, in the 
current sample. 
4.3.3 Hippocampal pathology profile 
 
4.3.3.1 Comparison between control and patients 
 
Table 23. Hippocampal brain measures of stroke and control participants including 
group differences 
 Stroke Control 
Mean 
(Std) 
Median Range Mean 
(std) 






0.61 0.44:0.86 0.65 
(0.50) 





0.63 0.59:0.81 0.67 
(0.05) 
0.67 0.59:0.81 .059 
Left Hippocampal 
Mean diffusivity mm3 
1.00 
(0.32) 
1.00 0.40:1.01 1.04 
(0.35) 
1.10 0.20:1.80 .684 
Right Hippocampal 
Mean diffusivity mm3 
0.98 
(0.38) 
1.00 0.20:1.80 1.02 
(0.30) 
1.00 0.30:1.60 .740 
Total NAA 10.52 
(3.29) 
10.89 0:15.46 11.56 
(1.29) 
11.56 8.90:13.80 .219 
Total Choline 3.41 
(1.21) 
3.51 .03:6.26 3.58 
(0.98) 
3.73 0.49:5.52 .607 
Total Creatine 10.70 
(3.98) 
10.57 0:21.19 11.89 
(2.15) 
11.05 9.01:16.56 .189 




Group differences across the hippocampal pathology measures were examined. There 
were no significant differences between stroke patients and control participants for 
intracranial volume (Table 15), or any of the other brain imaging measures (Table 23). 
Reduced grey matter volume of the right hippocampus in patients compare to controls 
trended toward significance, but this was not corrected for the multiple comparisons.   
4.3.3.2 Validation of Hippocampal measures 
 
As a validation of the brain measures, we examined the interrelation between them. 
Across stroke patients and control participants combined, left and right hippocampal 
grey matter volume, as well as left and right hippocampus mean diffusivity were highly 
correlated with each other (Table 24). The metabolites were positively correlated with 
each other. The same pattern was observed for the stroke only group. 
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Table 24. Imaging measures correlations for stroke and controls combined and stroke only group 
 1 2 3 4 5 6 7 8 9 10 11 
1 Intracranial volume - .02 .16 -.14 .47**++ a .47*a -.07 -.07 .04 .00 .06 
2 Parietal lobe atrophy .09 - .38**a .09 -.30* -.30* .08 .11 -.30* -.33* -.24 
3 Temporal lobe atrophy .15 .48**+a - .40** -.39**+a -.45++** .06 .09 -.18 .00 .07 




.20 .13 -.07 .10 .26 




- .90**++ a -.26 -.22 .42** a .28 .23 




.92**++ a - -.28 -.26 .46**a .28* .25 
7 Left MD .02 .12 .22+ .27 -.19 -.31 - .85**++ a -.37* -.17 -.18 
8 Right MD .02 .14 .21 .16 -.16 -.27 .83**++ a - -.43**a -.26 -.18 
9 tNAA .05 -.33 -.15 -.00 .45* .49** a -.45* -.47* - .70**++ a .69**++ a 
10 tCh -.10 -.48**a .01 .10 .31 .35 -.22 -.30 .79**++ a - .71**++ a 
11 tCr -.07 -.37* .14 .25 .21 .26 -.21 -.23 .79**++ a .88**++ - 
Notes. Top half of matrix is stroke and controls combined, below half of matrix is stroke group only. GM; Stroke N=42, Control=17, MD; Stroke=36, Control=15. 
t=Total, tNAA= Total N-Acetylaspartate, tCho= Total Choline, tCr=Total Creatine; Stroke N=31, Control=17. GM= Grey matter. MD= Mean diffusivity. - Indicates a 
negative correlation. Parametric correlation = ** p<.001, *p<.050, Non-parametric correlation= ++ p<.001,  
+p<.050. aBonferonni FME 0.5/11=0.04. 
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As expected tNAA positively correlated with left and right hippocampal grey matter 
volume, and negatively correlated with left and right mean diffusivity.  
In the entire sample, and the stroke specific sample, intracranial volume positively 
correlated with left and right grey matter volume, suggesting that the correction of grey 
matter signal intensity, by CAT12 was done based on local structures size as intended 
(Ashburner & Friston, 2005), (www.fil.ion.ucl.ac.uk/spm/software/spm12). Intracranial 
volume did not correlate with mean diffusivity, or any of the metabolites. 
Not surprisingly, in the entire sample as well as in the stroke specific, the rating of 
atrophy severity in the temporal (and parietal) lobes negatively correlated with grey 
matter volume in the left and right hippocampus, but not with mean diffusivity. 
Demonstrating an increase in severity of atrophy, was associated with lower grey matter 
volume in the hippocampus. The parietal lobe atrophy, but not the temporal negatively 
correlated with tNAA and tCh in the combined group, and in the stroke group parietal 
lobe atrophy correlated negatively with tCh and tCr (Table 24). The correlation of 
parietal atrophy, and tNAA was not reliable in the stroke only group, but the effect size 
was similar to the ones observed in the combined group analysis. Higher rates of small 
vessel disease correlated with lower left and right hippocampal grey matter volume, but 
not with mean diffusivity or any of the metabolites.  
4.3.3.3 Hippocampal measures and clinical-demographic data 
 
Bivariate correlations were computed to examine interactions between hippocampal 
measures, and demographic variables (Table 21, Table 22). In the combined sample 
(stroke and control participants), left and right hippocampal grey matter volume 
negatively interacted with age, and vascular risk, atrophy and small vessel disease, and 
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positively correlated with education. Hippocampal mean diffusivity, and metabolites did 
not correlate with any of the clinical or demographic variables.  
In the stroke group alone, age negatively correlated with left and right hippocampal grey 
matter volume, and positively with left hippocampal mean diffusivity. Education 
positively correlated with left and right hippocampal grey matter volume, but not with 
mean diffusivity or any of the metabolites. Sex impacted left and right hippocampal 
grey matter volume, males had larger volume than female.  
4.3.3.4 Association of hippocampus pathology profiles and stroke specific 
measures  
Stroke severity at admission, lesion side, and history of previous stroke did not affect 
any of the measures of hippocampus pathology. Patients who were thrombolysed had 
larger left, and right hippocampal grey matter volume, than those who were not. Lesion 
volume negatively correlated with tNAA.  
4.3.3.5 Summary of hippocampus pathology profile 
 
The analysis above showed the expected correlation between the various hippocampal 
measures. In the context of the metabolites, variability in the tNAA was mostly related 
to the other MRI measures. Grey matter volume was more related to the clinical and 
demographic variables, than mean diffusivity and metabolites. This provides an internal 
validity of these measures, specifically for the grey matter volume, and tNAA.  
Stroke patients and control participants did not reliably differ on any of the hippocampal 
pathology measures. The relations between hippocampal measures, and the clinical 
demographic variables appeared to be unaffected by stroke.  
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Next, the relation of each MRI measure and cognition will be examined separately in 
more detail, as this is the main focus on the current chapter.  
4.3.3.6 Hippocampal grey matter volume and cognition 
 
Hippocampal grey matter was examined looking at voxel density within both the left 
and right hippocampi. We were able to obtain hippocampal volume values in 42 stroke 
patients and 17 controls. To understand the relationship between hippocampal volume 
and cognition, we firstly computed correlations across these two cohorts combined 
(Table 25). Across the combined sample, this revealed strong associations between level 
of left and right hippocampal volume general cognition and all cognitive domains (apart 
from an unreliable correlation between the left hippocampus volume and attention & 
executive function). Similar pattern was observed in the analysis that included the 
stroke patients only (Table 26). Left and right hippocampus volume positively 
correlated with general cognition, and number abilities, and right hippocampal grey 










Figure 14. Coronal slices of T1-Weighted images showing Hippocampi. A) Control 
participant, B) Stroke patient with no impairment in general cognition, C) Stroke patient 
with impairment in general cognition. 
To formally test whether the observed relation between the left and right hippocampal 
grey matter measures and cognition were different in stroke and control, we used 
moderation analysis, separately for each side and each cognitive domain. This was 
followed by the analysis of only the control groups.
L R L R L R 
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Table 25. Cognition, clinical, demographic and imaging variables correlations for stroke and controls combined 
Notes. GM; Stroke N=42, Control=17, MD; Stroke=36, Control=15. t=Total, tNAA= Total N-Acetylaspartate, tCho= Total Choline, tCr=Total Creatine; Stroke N=31, 
Control=17.Vascular Risk= Framingham stroke risk score. GM= Grey matter. MD= Mean diffusivity. - Indicates a negative correlation. Parametric correlation = ** 
p<.001, *p<.050, Non-parametric correlation= ++ p<.001, +p<.050. aBonferonni FME 0.5/14=0.03.  
  
 Language Memory Attention and 
Executive Function 
Number Praxis General 
Age -.15 -.03 -.08 .34**a -.15 -.21++ 
Education -.19 .20 .24 .21++ .24++ .29* 
Vascular Risk -.63 .03 -.06 -.35**a -.31**++a -.23++ 
Intracranial volume .18 .03 .04 .19++ .35+ .14++ 
Parietal lobe atrophy -.40**a -.42**a -.36**a -.26* -.25* -.43*++ 
Temporal lobe atrophy -.34**+a -.38**++a -.25++ -.41**a -.25* -.48**++ 
Small Vessel Disease -.12+ -.03 -.18 -.22 -.14 -.19+ 
Left GM Volume .29*++ .14++ .12 .45**++a .25*++ .35*++ 
Right GM Volume .40**++a .29*++ .25*+ .56**++a .29*++ .49**++a 
Left MD -.26 -.15 -.21 -.35* -.25 -.34* 
Right MD -.25 -.03 -.20 -.33* -.23 -.30* 
tNAA .34* .09 .45**a .52** .31* .46**a 
tCh .23 .08 .34* .32* .20 .30 
tCr .37**a .12 .39**a .34* .36*+ .38**a 
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Table 26. Cognition, clinical, demographic and imaging variables correlations for stroke 
 Language Memory Attention and 
Executive Function 
Number Praxis General 
Age -.12 -.01 -.07 -.33* -.18 -.22 
Education .03 .12 .12 .11 .07 .14 
Vascular Risk .04 .23 .15 -.25 -.12 -.00 
NIHSS -.07 -.02 .06 .22 -.01 .09 
Thrombolysis .22 .02 .17 .20+ .03 .18 
Lesion Volume -.39**a -.58**a -.31* .02 -.08 -.33* 
Previous stroke .10 .15 -.07 -.03 -.10 .00 
Intracranial volume .13+ .02 .07 .27++ .06++ .17++ 
Parietal lobe atrophy -.49**+a -.48**a -.45**++a -.30* -.34* -.54**+a 
Temporal lobe 
atrophy 
-.29 -.33* -.15 -.35* -.12 -.35*+ 
Small Vessel Disease -.04 .01 -.12 -.16 -.05 -.12 
Left GM Volume .25 .12++ .10+ .47**++a .21 .34*++ 
Right GM Volume .36* .28++ .22+ .58**++a .21 .48**++a 
Left MD -.31 -.24 -.28 -.46** -.33* -.47** a 
Right MD -.27 -.06 -.25 -.40* -.27 -.38* 
tNAA .41* .02 .45**a .53**a .29 .47**a 
tCh .39* .08 .41* .39* .24 .39* 
tCr .41* .09 .37* .34* .32 .38* 
Notes. GM; Stroke N=42. MD; Stroke=36. t=Total, tNAA= Total N-Acetylaspartate, tCho= Total Choline, tCr=Total Creatine; Stroke N=31. HADs= Hospital Anxiety 
and Depression scale, A= Anxiety, D=Depression. Vascular Risk= Framingham stroke risk score. NIHSS= National Institute stroke scale. GM= Grey matter. MD= 
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Mean diffusivity. - Indicates a negative correlation. Parametric correlation = ** p<.001, *p<.050, Non-parametric correlation= ++ p<.001,  
+p<.050. aBonferonni FME 0.5/14=0.03. 
 
   
4.3.3.6.1 General Cognition 
 
General cognition was reliably (F(4,54)=5.97, p =.001, R2=.30) predicted by stroke 
(standardised β (sβ) = -.39, p = .001), left hippocampal volume (sβ =.28, p = .037), and 
scanner upgrade trended (sβ =.21, p = .078),  age was included in the model but was not 
a reliable predictor. The relations between left hippocampal volume and general 
cognition, were not affected by stroke condition (i.e. there was no difference between 
the basic model - without the moderation and the model that included the moderation 
variable).  
When considering the stroke group alone, general cognition was (F(3,38)=2.87, p =.049, 
R2=.19) predicted by left hippocampal volume (sβ =.40, p = .048), and it trended with 
scanner upgrade (sβ = -.26, p = .086), but not with age. After controlling for clinical and 
demographic variables (e.g. education, vascular risk, NIHSS, lesion volume and 
previous stroke), left hippocampal volume was still a reliable predictor (sβ =.53, p = 
.008), as was lesion volume (sβ = -29, p = .050). 
Similarly, to the left hippocampus, general cognition was reliably (F(4,54)=8.79, p 
<.001, R2=.39) predicted by the right hippocampal volume (sβ =.47, p = .001), stroke 
condition (sβ = -.33, p = .004), and scanner upgrade (sβ =.24, p = .034) age was also 
included in the model but was not a reliable predictor. The relations between right 
hippocampus volume and general cognition were not affected by the stroke. See Figure 
15.  
When considering the stroke group alone, general cognition was predicted (F(3,38) 
=7.00, p = .001, R2=.36) by right hippocampal volume (sβ =.68, p <.001), and scanner 
upgrade (sβ =.33, p=.019),  age was included in the model but was not reliable. After 
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controlling for the effects of demographic and stroke specific variables the right 
hippocampus volume remained a reliable predictor of general cognition (sβ =.70, p < 
.001), as did scanner upgrade (sβ =.32, p =.024).  
 
Figure 15. Right hippocampal grey matter volume/ General cognition (after controlling 
for age). Control participants, N= 17 (black triangle), Stroke patients, N=42 (Red 
circles). 
Taken together, the results suggest that beyond the stroke and age, general cognition 
was predicted by left and right hippocampal volume. However, stroke did not affect the 
relations between hippocampal pathology and general cognition, in this case. In the 
stroke group, beyond clinical and demographic variables, left and right hippocampal 
volume predicted post-stroke general cognition. 
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4.3.3.6.2  Language 
 
Language was reliably (F(4,54)=2.89, p =.031, R2=.11) predicted by stroke (sβ = -.28, p 
= .033), the left hippocampal volume trended (sβ =.27, p = .075), age and scanner 
upgrade were also included in the model but was not a reliable predictor.  The relations 
between left hippocampus volume and language were not affected by the stroke.  
When considering the stroke group alone, language was not predicted by left 
hippocampus volume, age or scanner upgrade. When controlling for clinical-
demographic variables the model trended (F(7,34)=2.08, p =.072, R2=.30), with left 
hippocampal volume (sβ =.42, p = .035), and lesion volume (sβ =-.38, p = .016), 
reliably predicting post-stroke language abilities.  
Language was reliably (F(4,54)=4.30, p =.004, R2=.24) predicted by right hippocampal 
volume (sβ =.41, p = .006), and stroke condition trended (sβ =-.22, p = .074), but age 
and scanner upgrade were not a reliable predictors. The relations between right 
hippocampus volume and language were not affected by stroke.  
When considering the stroke group alone, language was predicted (F(3,38) =3.20, p = 
.034, R2=.20) by right hippocampal volume (sβ =.54, p = .008), age and scanner 
upgrade were included in the model but were not reliable. After controlling for clinical 
and demographic variables the right hippocampus volume remained a reliable predictor 
of post-stroke language ability (sβ = .50, p = .009), and lesion volume trended (sβ = -
.28, p = .063).  
The results suggest that, beyond the stroke and age, language was predicted by the right 
hippocampal volume and to lesser degree by the left hippocampus. In the stroke group, 
lesion volume also contributed to post-stroke language abilities. Furthermore, stroke 
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condition did not affect the relations between hippocampal pathology and language 
ability.   
4.3.3.6.3 Memory 
 
Memory was not reliably predicted by left hippocampal volume, furthermore the 
relations between left hippocampus volume, and memory were not affected by the 
stroke condition.  
When considering the stroke group alone, memory ability was not predicted by left 
hippocampal volume. In the model with clinical and demographic predictors 
(F(7,34)=4.46, p =.001, R2=.48), memory was predicted by lesion volume (sβ =-.53, p 
<.001), and vascular risk trended (sβ =.31, p = .057). 
Memory trended toward being reliably predicted (F(4,54)=2.45, p =.057, R2=.15), by 
right hippocampal volume (sβ =.35, p = .023), stroke condition, scanner upgrade and 
age were included in the model but were not reliable predictors. The relations between 
right hippocampus volume and memory were not affected by stroke.  
When considering the stroke group alone, memory trended towards bring predicted by 
right hippocampal volume (F(3,38)=2.67, p =.061, R2=.17), (sβ =.52, p = .011). When 
clinical and demographic variables were controlled for, right hippocampal volume still 
predicted memory (sβ =.37, p = .025), as did lesion volume (sβ =-.47, p = .001), and 
vascular risk (sβ =.34, p = .031). 
Taken together, the results suggest that beyond the stroke and age, memory was 
predicted by the right hippocampal volume and but not the left hippocampus. In the 
stroke group, lesion volume, and vascular risk status also contributed to post-stroke 
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memory ability. Stroke incidence did not affect the relations between hippocampus 
volume and memory abilities.   
4.3.3.6.4 Attention and executive function 
 
Attention and executive function was predicted (F(4,54)=3.10, p =.022, R2=.19), by 
stroke (sβ =-35, p = .007), and scanner upgrade (sβ =.29, p = .034), but not left 
hippocampal volume or age. Furthermore, the relations between left hippocampal 
volume, and attention and executive function were not affected by the stroke condition.  
When considering the stroke group alone, attention and executive function was not 
predicted by left hippocampus volume, age or any of the other clinical-demographic 
factors.  
The right hippocampus volume (F(3,54)=3.89, p =.008, R2=.16), did not reliably predict 
attention and executive function although it trended (sβ =.25, p = .093), however stroke 
reliably predicted attention and executive function (sβ =-.31, p = .015), as did scanner 
upgrade (sβ =.29, p = .023). The relations between right hippocampus volume and 
attention and executive function were not affected by stroke via moderated variable.  
When considering the stroke group alone, attention and executive function was 
predicted (F(3,38)=3.14, p =.036, R2=.19), by right hippocampal volume (sβ =.41, p = 
.039), and scanner upgrade (sβ =.38, p = .015), but not age. When controlling for 
clinical-demographic variables right hippocampal volume still predicted attention and 
executive function (sβ =.43, p = .028), as did scanner upgrade (sβ =.34, p = .031).  
Taken together, the results suggest that attention and executive function was not reliably 
predicted by left or right hippocampal volume. However, stroke did predict attention in 





Number was reliably (F(4,54)=5.20, p <.001, R2=.28) predicted by stroke (sβ = -.24 p = 
.045) and left hippocampal volume (sβ =.36, p = .010), age and scanner upgrade were 
also included in the model but were not reliable predictors. The relations between left 
hippocampus volume and number were not affected by the stroke.  
When considering the stroke group alone, number was predicted (F(3,38) = 3.79, p = 
.018, R2=.23) by the left hippocampal volume (sβ = .43, p = .026), age and scanner 
upgrade were included in the model but were not reliable. After controlling for clinical 
and demographic variables, left hippocampal volume remained a reliable predictor of 
number (sβ = .55, p = .006).  
Similarly, to the left hippocampus, number was reliably (F(4,54)=7.32, p <.001, R2=.35) 
predicted by right hippocampal volume (sβ =.49, p <.001). Stroke, age, and scanner 
upgrade were included in the model but were not reliable predictors. The relations 
between right hippocampus volume, and language were marginally affected by stroke. 
The stroke by right hippocampal volume moderator variable trended towards 
significance (sβ =-.23, p =.056). This demonstrates that the relation between number 
ability, and right hippocampus volumes were stronger in the stroke than the control 
group.  
When considering the stroke group alone, number was predicted (F(3,38) =6.58, p 
=.001, R2=.29) by the right hippocampal volume (sβ = .62, p =.001) age and scanner 
upgrade were included in the model but were not reliable. After controlling for clinical 
and demographic variables, the right hippocampal volume remained a reliable predictor 
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of number abilities (sβ = .75, p <.001). And stroke severity (NIHSS) trended (sβ =.25, p 
=.070), as did education (sβ =-.26, p =.099). 
Taken together, the results suggest that beyond the stroke and age, number was 
predicted by the left and right hippocampal volume. In the stroke group, lesion volume 
and stroke severity also contributed to post-stroke number abilities. Interestingly stroke 
moderated relations between the right hippocampus and number abilities, suggesting 
that following stroke those with larger volume in the hippocampus performed better on 
the number tasks. 
4.3.3.6.6 Praxis 
 
Praxis was reliably (F(4,54)=3.10, p =.022, R2=.19) predicted by stroke (sβ = -.35, p = 
.007), and scanner upgrade (sβ =.27, p = .034), but not the left hippocampal volume, or 
age was also included in the model but was not a reliable predictor. The relations 
between left hippocampus volume and number were not affected by the stroke.  
When considering the stroke group alone, praxis was not predicted by the left 
hippocampal volume, but only scanner upgrade (F(3,38)=6.97, p =.001, R2=.36), (sβ = 
.56, p<.001). When controlling for clinical-demographic variables, left hippocampal 
volume was a predictor of praxis (F(7,34)=3.05, p =.013, R2=.39), (sβ =.36, p=.047), as 
was scanner upgrade (sβ =.58, p<.001). 
Similarly, to the left hippocampus, number was reliably (F(4,54)=3.89, p =.008, R2=.24) 
predicted by stroke (sβ = -.31, p =.015), and scanner upgrade (sβ =.29, p =.023), but not 
right hippocampal volume although it trended (sβ =.25, p =.093), age was also included 
in the model but was not a reliable predictor. The relations between right hippocampus 
volume and praxis were not affected by the stroke.  
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When considering the stroke group alone, praxis was not predicted by right 
hippocampal volume or age, but only scanner upgrade (F(3,38)=7.52, p <.001, R2=.37), 
(sβ =.58, p<.001), with right hippocampal volume trending (sβ =.32, p=.066). When 
controlling for clinical-demographic variables, right hippocampal volume was a 
predictor of praxis (F(7,34)=3.35, p =.008, R2=.41), (sβ =.42, p=.023), as was scanner 
upgrade (sβ =.62, p<.001). 
Taken together, the results suggest that beyond the stroke and age, praxis was not 
predicted by the right or left hippocampal volume. However, in the stroke group, when 
controlling for clinical and demographic variables, left and right hippocampal volume 
was a predictor of post-stroke praxis ability.  
4.3.3.6.7 Summary of hippocampal volume and cognition 
 
On the whole cognition was predicted by the grey matter volume of the left and right 
hippocampi. This was observed beyond the stroke condition and age. The relations were 
more robust with the right than the left hippocampus; and were mostly pronounced 
when considering general cognition, the language, number and memory domains.  
With respect to the main research question, stroke only moderated the relations between 
hippocampus volume and number ability, this association was stronger in the stroke 
than the control group. 
4.3.3.7 Hippocampal mean diffusivity and cognition 
 
In addition to hippocampal grey matter, mean diffusivity of both the left and right 
hippocampus was examined in relation to cognition. We obtained hippocampal mean 
diffusivity data in 35 stroke patients and 15 controls. We firstly computed correlations 
across these two cohorts combined (Table 25). Surprisingly, left and right mean 
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diffusivity predicted only the ability on the number and general cognition. Similar and 
stronger correlations were observed for the stroke patients group only (Table 26), with 
number praxis and general cognition domains. 
4.3.3.7.1 General Cognition 
 
General cognition was reliably (F(4,45)=6.45, p <.001, R2=.37) predicted by stroke (sβ 
= -.44, p = .001), and the left hippocampus mean diffusivity (sβ =-.32, p = .013), age 
was also included in the model but was not a reliable predictor, although it trended (sβ 
=-.22, p = .077), scanner upgrade was not a reliable predictor. The relations between left 
hippocampus mean diffusivity and general cognition, were not moderated by the stroke 
condition.  
When considering the stroke group alone, general cognition was predicted by 
(F(3,31)=3.75, p <.021, R2=.27) left hippocampus mean diffusivity (sβ = -.41, p = .019), 
but not age and scanner upgrade. When controlling for clinical-demographic variables 
this relation did not survive.  
Similarly, to the left hippocampus, general cognition was reliably (F(4,45)=5.74, p 
<.001, R2=.34) predicted by stroke (sβ = -.44, p = .001), and the right hippocampus 
mean diffusivity (sβ =-.27, p = .038), age was also included in the model but was not a 
reliable predictor, although it trended (sβ =-.24, p = .066). Scanner upgrade was not a 
reliable predictor. The relation between right hippocampus mean diffusivity and general 
cognition were not affected by the stroke. See Figure 16.  
When considering the stroke group alone, general cognition was not predicted by any of 
the predictors. Although it trended (F(3,31) = 2.70, p = .063, R2=.20) with right mean 
diffusivity (sβ = -.31, p = .075). After controlling for clinical and demographic 
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variables, right hippocampal mean diffusivity predicted general cognition (sβ = -.40, p = 
.040), although the full model was not significant (F(7,27) = 1.07, p = .448, R2=.20).  
Taken together, the results suggest that beyond the stroke and age, general cognition 
was predicted by the left and right hippocampal mean diffusivity. However, stroke did 
not affect the relations between left and right hippocampus and general cognition.  
 
Figure 16. Right hippocampal mean diffusivity/ General cognition (after controlling for 
age). Control participants, N= 15 (black triangle), Stroke patients, N=36 (Red circles). 
 
4.3.3.7.2  Language 
 
Language was reliably (F(4,45)=2.66, p = .045, R2=.19) predicted by stroke (sβ = -.30, p 
= .033), and the left hippocampus mean diffusivity trended towards reliability (sβ =-.23, 
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p = .096), age and scanner upgrade were also included in the model but were not 
reliable predictors. The relations between left hippocampus volume and language were 
not affected by the stroke.  
When considering the stroke group alone, language was not predicted by left 
hippocampus mean diffusivity, age or scanner upgrade. Furthermore, clinical and 
demographic variables did not mediate this relationship.  
Language trended towards being reliably (F(4,45)=2.53, p =.053, R2=.18) predicted by 
stroke (sβ =-.289, p = .035), but not right hippocampal mean diffusivity, age or scanner 
upgrade. The relations between right hippocampus volume, and language were not 
moderated by stroke condition.  
When considering the stroke group alone, language was not predicted by right 
hippocampus mean diffusivity, age, or scanner upgrade. Furthermore, clinical and 
demographic variables did not mediate this relationship.  
Taken together, the results suggest that beyond age, language was predicted by stroke 
condition alone. Although stroke predicted language, it did not moderate the relations 
between hippocampal mean diffusivity and language ability. Furthermore, in the stroke 
group language ability was not predicted by hippocampal mean diffusivity.   
4.3.3.7.3 Memory 
 




When considering the stroke group alone, memory was not predicted by left 
hippocampus mean diffusivity or age or scanner upgrade. Furthermore, clinical and 
demographic variables did not mediate this relationship.  
Memory was not predicted by right hippocampal mean diffusivity, or by age or scanner 
upgrade.  
Similarly, to left hippocampus mean diffusivity, in the stroke group alone, memory was 
not predicted by right hippocampus mean diffusivity, age or scanner upgrade. 
Furthermore, clinical and demographic variables did not mediate this relationship.  
Memory domain ability was not predicted by mean diffusivity in the left or right 
hippocampus, and this was the case for stroke and control groups combined and for 
stroke specifically. Due to the known association of memory and mean diffusivity in the 
hippocampus (Hosseini et al., 2017), these findings were surprising. We specifically the 
immediate recall recognition task from the memory domain, as task which tests verbal 
memory abilities. However, we also found no predictive value of left or right mean 
diffusivity on this memory task.  
4.3.3.7.4 Attention and executive function 
 
Attention and executive function (F(4,45)=3.16, p =.022, R2=.22) was not reliably 
predicted by left hippocampal mean diffusivity, although it trended (sβ =-.25, p = .081), 
but was by stroke condition (sβ =-.38, p = .007), with scanner upgrade also trending (sβ 
=.25, p = .073). Furthermore, the relations between left hippocampus mean diffusivity, 
and attention and executive function were not moderated by the stroke.  
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When considering the stroke group alone, attention and executive function was not 
predicted by left hippocampus mean diffusivity, age or any of the other clinical and 
demographic variables.  
Similarly, the right hippocampus mean diffusivity, did not reliably predict attention and 
executive function, however stroke reliably predicted (F(3,36)=2.80, p =.050, R2=.16), 
(sβ =-.33, p = .019). The relations between right hippocampus volume, and attention 
and executive function were not affected by stroke via the moderated variable.  
When considering the stroke group alone, attention and executive function was not 
predicted by right hippocampal mean diffusivity, age, or any of the other clinical or 
demographic variables.  
Taken together, the results suggest that attention and executive function was not reliably 
predicted by left or right hippocampal volume. However, stroke did predict attention 
and executive function in the left and right hippocampal mean diffusivity models. 
However, attention and executive function was not moderated by stroke. Furthermore, 




Number was reliably (F(4,45)=4.36, p =.005, R2=.28)  predicted by left hippocampal 
mean diffusivity (sβ =-.29, p = .030, and stroke (sβ = -.29, p = .032), age trended 
towards predicting number ability (sβ = -.24 p = .087). The relations between left 
hippocampus mean diffusivity and number trended towards being moderated by stroke 
(sβ = .79, p = .064).   
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When considering the stroke group alone, number ability was predicted (F(3,31) = 3.98, 
p = .016, R2=.28) by left hippocampus mean diffusivity (sβ =-.39, p = .023), age and 
scanner upgrade were included in the model but were not reliable. After controlling for 
the clinical and demographic variables the left hippocampus mean diffusivity remained 
a reliable predictor of number (sβ = -.44, p = .013), but the full model was not 
significant (F(7,27) = 2.00, p = .091, R2=.34) .  
Similarly, to the left hippocampus, number was reliably (F(4,45)=4.11, p =.006, 
R2=.268) predicted by right hippocampal mean diffusivity (sβ =-.27, p =.045), stroke 
condition also predicted number ability (sβ =-.28, p =.037),  and age trended towards 
being reliable (sβ =-.24, p =.080). However, the relations between right hippocampal 
mean diffusivity and number were not affected by the stroke.  
When considering the stroke group alone, number was predicted (F(2,34) = 3.16, p 
=.038, R2=.23) by the right hippocampus mean diffusivity (sβ =-.32, p =.066) which 
trended towards significance, age and scanner upgrade were included in the model but 
were not reliable. After controlling for the clinical and demographic variables, the right 
hippocampus mean diffusivity remained a reliable predictor of post-stroke number 
abilities (sβ =-.40, p =028). Although stroke severity (NIHSS) trended towards 
significance (sβ = .32, p =.068), but the full model was not significant (F(7,27) =1.71, p 
=.149, R2=.31). 
Taken together, the results suggest, number abilities were predicted by the left and right 
hippocampal mean diffusivity. Interestingly stroke increased the relations between the 
mean diffusivity in the left hippocampus and number abilities. In the stroke group, 
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beyond clinical and demographic variables, mean diffusivity predicted post-stroke 
number abilities.  
4.3.3.7.6 Praxis 
 
Praxis was reliably (F(3,45)=10.26, p <.001, R2=.47) predicted by stroke (sβ = -.51 p < 
.001), and left hippocampus mean diffusivity (sβ = -.26, p = .027), age (sβ = -.26, p = 
.025), and scanner upgrade (sβ = .44, p <.001). The relations between left hippocampus 
volume and praxis were not affected by the stroke.  
In the stroke group alone, number was reliably (F(3,31)=6.13, p =.002, R2=.37) 
predicted by scanner upgrade only (sβ = .46, p =.003), and age trended (sβ = -.26, p = 
.097), but left hippocampus mean diffusivity was not reliable. When clinical and 
demographic variables were controlled for, left mean diffusivity was still not a reliable 
predictor.  
Similarly, to the left hippocampus, number was reliably (F(4,45)=9.65, p <.001, R2=.47) 
predicted by stroke (sβ = -.50, p < .001), right hippocampus mean diffusivity (sβ = -.22, 
p =.058), age (sβ = -.28, p = .022), and scanner upgrade (sβ =.44, p<.001). The relations 
between right hippocampus volume and praxis were not affected by the stroke.  
In the stroke group alone, number was reliably (F(3,31)=5.72, p =.003, R2=.36) 
predicted by scanner upgrade only (sβ = .46, p =.003), and age trended (sβ = -.28, p = 
.076). When clinical and demographic variables were controlled for, right mean 
diffusivity was still not a reliable predictor, though scanner upgrade was (sβ = .46, p = 
.007), and vascular risk trended (sβ = -.31, p = .081), despite the full model only 
trending (F(7,27)=2.52, p =.061, R2=.37)  .  
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Taken together, the results suggest that beyond the stroke and age, praxis was predicted 
by the left or right hippocampal mean diffusivity, although this was not moderated by 
stroke. In the stroke group specifically though this did not translate, mean diffusivity did 
not predict post-stroke praxis abilities.  
4.3.3.7.7 Summary of hippocampal mean diffusivity and cognition 
 
On the whole cognition was not reliably predicted by the mean diffusivity of the left and 
right hippocampi. Although for number, praxis and general cognition domains mean 
diffusivity did predict abilities. With respect to the main research question, stroke did 




4.3.3.8 Hippocampal magnetic resonance spectroscopy and cognition 
 
Finally, we examined metabolic regulation in the left hippocampus using 1H-MRS, 
across three metabolites tNAA, tCh and tCr. To understand their relationship with 
cognition, we first computed correlations across the two cohorts combined (Table 25, 
Table 26). We had data for 31 stroke patients and 17 controls. For tNAA, it correlated 
with language, number, praxis and general cognition abilities. In the stroke only tNAA 
correlated with language, attention and executive function, number, and general 
cognitive abilities. tCh correlated with number, and attention and executive function 
abilities. In the stroke group it correlated with abilities in language attention and 
executive function, number and general cognition.  
tCr positively correlated with language, attention and executive function, number, 
praxis, and general cognition abilities. In the stroke group tCr, also correlated with 
cognitive abilities in language, attention and executive function, number, and general 
cognition abilities. 
We next explored using regression, the predictive value of these metabolites of 
cognition at three months post-stroke while considering the moderator effect of stroke 
and controlling for other relevant confounds. 
4.3.3.8.1 General cognition 
 
General cognition was reliably (F(4,43)= 12.38, p <.001, R2=.54) predicted by stroke 
(sβ = -.49, p <.001), tNAA (sβ = .38, p =.001), age (sβ = -.45,  p <.001), and scanner 
upgrade (sβ = .38,  p =.004). The relations between tNAA and general cognition were 
not affected by the condition of stroke.  
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When considering the stroke group alone (F(3,27)=8.26, p<.001, R2=.48) , general 
cognition was predicted by age (sβ = -.46, p = .005), tNAA (sβ = .48, p = .004), and 
scanner upgrade (sβ = .42, p = .011). When controlling for other clinical-demographic 
variables tNAA was still a reliable predictor of general cognition (sβ = .68, p = .002). 
See Figure 17.  
General cognition was reliably (F(4,43)=8.95, p <.001, R2=.40) predicted by stroke (sβ 
= -.48, p < .001), age (sβ = -.47, p =.001), tCh (sβ = -.23, p =.052), and scanner upgrade 
(sβ = .29, p =.032). The relations between tCh and general cognition were not affected 
by the stroke.  
When considering the stroke group alone (F(3,27)=5.03, p =.007, R2=.36) , general 
cognition was predicted by age (sβ = -.48, p = .010), but not tCh. When controlling for 
other clinical demographic variables tCh was a reliable predictor of general cognition 
(sβ =.41, p = .053), 
General cognition was reliably (F(4,43)=9.65, p <.001, R2=.42) predicted by stroke (sβ 
= -.47, p <.001), age (sβ = -.48, p <.001), and tCr,(sβ = .27, p = .022). The relations 
between tCr and general cognition were not affected by the stroke.  
When considering the stroke group alone (F(3,27)=5.58, p =.004, R2=.38) , general 
cognition was predicted by age (sβ = -.51, p = .004), and tCr trended towards 
significance (sβ = .30, p = .057), but scanner upgrade was not reliable. When controlling 
for clinical demographic variables, tCr reliably predicted post-stroke general cognition 
(sβ = .40, p = .045), 
Taken together, the results suggest that beyond the stroke and age, general cognition 
was predicted by tNAA, tCr, and tCh, although the relationship between general 
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cognition and hippocampal tNAA, tCh, and tCr was not moderated by stroke. 
Specifically, in the stroke group, tNAA was a reliable predictor of post-stroke general 
cognition, for tCh and tCr this was true after controlling for clinical-demographic 
predictors. Scanner upgrade also contributed to predicting post-stroke general cognition, 
which suggests bias of cognitive severity before and after scanner upgrade. 
 
 
Figure 17. Right hippocampal tNAA/ General cognition (after controlling for age). 






Language was reliably (F(4,43)=4.90, p =.002, R2=.31) predicted by stroke (sβ = -.36, p 
= .011), age (sβ = -.38,  p = .010), tNAA (sβ = .28,  p = .045), and scanner upgrade (sβ 
= .30,  p = .052). Though the relations between tNAA, and language were not 
moderated by stroke condition. 
When considering the stroke group alone (F(3,27)=3.81, p =.021, R2=.30) language was 
predicted by tNAA (sβ = .42, p = .027), but not age, or scanner upgrade. When 
controlling for clinical demographic variables, tNAA was still a reliable predictor of 
post-stroke language abilities (sβ = .65, p = .004).   
Language was reliably (F(4,43)= 4.04, p =.007, R2=.27) predicted by stroke (sβ = -.38, p 
= .010), age (sβ = -.40,  p = .009), but not tCh, or scanner upgrade. The relations 
between tCh, and language were not moderated by stroke condition. 
When considering the stroke group alone language was not predicted by age or tCh.  
Language was reliably (F(4,43)=5.17, p =.003, R2=.32) predicted by stroke (sβ = -.32, p 
= .024), age (sβ = -.39,  p = .008), and tCr (sβ = .29,  p = .029). The relations between 
tCr and language were not moderated by stroke condition. 
When considering the stroke group alone (F(3,27)=3.61, p =.026, R2=.29) language was 
predicted by age (sβ = -.36,  p = .052), and tCr (sβ =.36,  p = .035). When clinical-
demographic variables were controlled for tCr was predictive of post-stroke language 
(sβ = .49, p = .014). 
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The results suggest that tNAA, and tCr were reliable predictors of language ability, 
beyond age and stroke. When clinical demographic variables were controlled for, tNAA 






Memory was reliably (F(4,43)= 3.16, p =.023, R2=28) predicted by stroke (sβ = -.41, p 
= .006), and age (sβ = -.36,  p = .021), but not tNAA or scanner upgrade. The relations 
between tNAA and memory were not moderated by stroke condition.   
When considering the stroke group alone tNAA did not predict post-stroke memory 
abilities. 
Memory was reliably (F(4,43)= 3.16, p =.023, R2=.23) predicted by stroke (sβ = -.41, p 
= .006), and age (sβ = -.36,  p = .022), but not tCh, or scanner upgrade. The relations 
between tCh and memory were not moderated by stroke condition. 
When considering the stroke group alone memory ability was not predicted by age, tCh 
or scanner upgrade.  
Memory was reliably (F(4,43)=3.17, p =.023, R2=.23) predicted by stroke (sβ = -.41, p 
= .008), age (sβ = -.39,  p = .022), but not tCr, or scanner upgrade. The relations 
between tCr and memory were not moderated by stroke condition. 
When considering the stroke group alone memory was not predicted by age or tCr.  
No metabolites predicted memory ability, at the combined group level, or in the stroke 
specific group.  
4.3.3.8.4 Attention and executive function 
 
Attention and executive function was reliably (F(4,43)=9.45, p =.000, R2=47) predicted 
by stroke (sβ = -.45, p < .001), age (sβ = -.40,  p = .002),  tNAA (sβ =.38,  p = .003), 
and scanner upgrade (sβ =.34,  p = .015). The relations between tNAA and attention and 
executive function were not moderated by stroke condition.   
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When considering the stroke group alone (F(3,27)=6.21, p =.002, R2=.41), attention and 
executive function was reliably predicted by tNAA (sβ =.45,  p = .011), age (sβ =-.43,  p 
= .014), and scanner upgrade (sβ =.35,  p = .042). When controlling for clinical 
demographic variables, tNAA still reliably predicted post-stroke attention and executive 
function (sβ =.58, p = .009).  
Similarly to tNAA, attention and executive function was reliably (F(4,43)=7.57, p 
=.000, R2=.41) predicted by stroke (sβ = -.47, p < .001), age (sβ = -.42, p = .002), and 
tCh (sβ = .27, p = .028), but not scanner upgrade. The relations between tCh and 
attention and executive function were not moderated by stroke condition. 
When considering the stroke group alone (F(3,27)=4.31, p =.013, R2=.32), attention and 
executive function was not predicted by tCh or scanner upgrade, but only by age (sβ = -
.42, p = .024). 
Attention and executive function was reliably (F(4,43)=7.96, p <.001, R2=.42) predicted 
by stroke (sβ = -.42, p = .002), age (sβ = -.42,  p = .002), and tCr (sβ =.29,  p = .017), 
but not scanner upgrade. The relations between tCr and attention and executive function 
were not moderated by stroke condition. 
When considering the stroke group alone (F(3,27)=4.53, p =.011, R2=.34) attention and 
executive function was predicted by age (sβ =-.48,  p = .009), but not tCr, although it 
trended (sβ =.39,  p = .066).  
Taken together, the results suggest that beyond the stroke and age, attention and 
executive function was predicted by tNAA, tCr and tCh, although this relationship was 
not moderated by stroke. Specifically, in the stroke group, tNAA was a reliable 
191 
 




Number was reliably (F(4,43)= 10.51, p <.001, R2=45) predicted by stroke (sβ = -.38, p 
= .004), age (sβ = -.42,  p = .001), tNAA (sβ =.45,  p < .001), and scanner upgrade (sβ 
=.29,  p=.034). The relations between tNAA and number were not moderated by stroke 
condition.   
When considering the stroke group alone (F(3,27)=7.73, p =.001, R2=.46), number was 
reliably predicted by tNAA (sβ =.51,  p = .003), and age (sβ =-.42,  p = .012). When 
controlling for clinical demographic variables, tNAA still reliably predicted post-stroke 
number ability, tNAA (sβ =.65, p = .002).  
Similarly to tNAA, number was reliably (F(4,43)=6.49, p =.000, R2=.38) predicted by 
stroke (sβ = -.39, p = .005), age (sβ = -.46, p = .005), and tCh (sβ = .25, p = .049). The 
relations between tCh and number were not moderated by stroke condition. 
When considering the stroke group alone (F(3,27)=4.14, p =.015, R2=.32), number was 
not predicted by tCh, but only by age (sβ = -.44, p = .020). 
Number was reliably (F(4,43)=6.65, p <.001, R2=.38) predicted by stroke (sβ = -.34, p = 
.013), age (sβ = -.46,  p = .001), and tCr (sβ =.26,  p = .039). The relations between tCr 
and number function were not moderated by stroke condition. 
When considering the stroke group alone (F(3,27)=4.29, p =.013, R2=.32) number was 
predicted by age (sβ =-.48,  p = .008), but not tCr,  
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Taken together, the results suggest that beyond the stroke and age, number ability was 
predicted by tNAA and tCr. Although this relationship was not moderated by stroke. 
Specifically, in the stroke group, tNAA was a reliable predictor of post-stroke number 
ability even after controlling for clinical-demographic predictors.  
4.3.3.8.6 Praxis 
 
Praxis was reliably (F(4,43)=10.09, p <.001, R2=48) predicted by stroke (sβ = -.59, p 
<.001), tNAA (sβ =.32,  p = .009), age (sβ =-.25,  p = .046), and scanner upgrade (sβ 
=.54, p <.001). The relations between tNAA and praxis were not moderated by stroke 
condition.   
When considering the stroke group alone praxis was predicted by (F(3,27)=7.71, p 
<.001, R2=.46), tNAA (sβ =.45, p =.007), and scanner upgrade (sβ = 67, p =.00). When 
controlling for clinical and demographic variables tNAA still predicted post-stroke 
praxis, as did lesion volume (sβ =.32, p =.045). 
Praxis was reliably (F(4,43)=7.71, p <.001, R2=.42) predicted by stroke (sβ = -.62, p < 
.001), age (sβ = -.28, p =.037), but not tCh. The relations between tCh and number were 
not moderated by stroke condition. 
When considering the stroke group alone praxis was not predicted by age or tCh, but 
was by scanner upgrade.  
Number was reliably (F(4,43)=8.53, p <.001, R2=.44) predicted by stroke (sβ = -.58, p 
<.001), and age (sβ = -.28, p =.037), with tCr trending (sβ =.23, p = .060). The relations 
between tCr and praxis were not moderated by stroke condition. 
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When considering the stroke group alone praxis was not predicted by age or tCr, but 
was by scanner upgrade.   
Taken together, the results suggest that beyond the stroke and age, tNAA was the only 
predictor of praxis abilities. Although this relationship was not moderated by stroke. 
Specifically, in the stroke group, tNAA predicting post-stroke praxis abilities.  
4.3.3.8.7 Summary of hippocampal metabolites and cognition 
 
On the whole cognition was reliably predicted by hippocampal metabolites. 
Specifically, tNAA was a predictor of cognition across both groups, in general 
cognition, language, attention and executive function and number. In the stroke group 
the same pattern was observed, with the addition of tNAA predicting praxis. tCh did 
predict abilities in general cognition, number and attention and executive function, 
similarly tCr predicted abilities in general cognition, number, attention and executive 
function, language and praxis. With respect to the main research question, stroke did not 






In the current chapter we investigated the relation of hippocampal pathology with 
cognition at three months post-stroke, and in age matched controls. We examined 
hippocampal pathology in three ways; volumetric measurement looking at grey matter 
integrity, mean diffusivity, and metabolic measurement of tNAA, tCr and tCh. We also 
collected detailed clinical and demographic information, including both neurovascular 
and overall brain health.  
We demonstrated high internal validity for all the hippocampal pathology measures by 
replicating expected relations between them. These relations were observed in the entire 
sample (both groups combined), and in the stroke group alone.  
In relation to the research question, there were no significant differences between the 
stroke patients, and control participants across any of the hippocampal pathology 
measures. There were however significant differences between the two groups in 
cognitive ability, across the five cognitive domains and within general cognition.  
Hippocampal pathology determined by three MRI measurements, predicted cognition in 
the combined sample (stroke and control participants), as well as independently in the 
stroke group. The moderation analyses showed that across all MRI measures the 
relation between hippocampus pathology, and cognition was not affected by stroke 
(Table 27). This suggests that at three months post stroke, hippocampus pathology 
contributes to cognition beyond, and independent to the incidence of stroke. The 
relations were most pronounced when considering the general cognition measures; but 
were most robust in the number domain.  
195 
 
There was no difference in hippocampal volume between the stroke patients and control 
group. Hippocampal volume reduced with age, and increased with education. As 
expected we found hippocampal grey matter volume predicted cognition. Hippocampus 
volume predicted language, memory, and number abilities, as well as the composite 
general cognition domain. This in agreement with previous literature, showing the 
importance of hippocampus to cognition (Mielke et al., 2012; van Uden et al., 2016). 
The strong relation between hippocampal volume, and number domain was not 
expected.    
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Table 27. Hippocampal imaging measures summary table 
Hippocampal 
measure 
Effect  General 
Cognition 









ÖÖ XÖ$ XX XX ÖÖ XX 
 Moderation  X X X X X X 





ÖÖ ÖÖ Ö$X Ö$X ÖÖ Ö$X 
 Moderation  X X X X Ö$ X 
 Strokeb ÖÖÖ ÖÖÖ ÖÖÖ ÖÖÖ ÖÖÖ Ö$XÖ 
Left MD Stroke + 
Controla 
ÖÖ XÖ$ XX Ö$X ÖÖ ÖÖ 
 Moderation  X X X X X X 
 Strokeb ÖÖX XXX XXX XXX ÖÖ$ XXX 
Right MD Stroke + 
Controla 
ÖÖ XX XX XX ÖÖ XÖ$ 
 Moderation  X X X X X X 
 Strokeb Ö$ XX XXX XXX XXX Ö$Ö$Ö$ XXX 
tNAA Stroke + 
Controla 
ÖÖ ÖÖ XX ÖÖ ÖÖ XÖ$ 
 Moderation  X X X X X X 
 Strokeb ÖÖÖ ÖÖÖ XXX ÖÖÖ ÖÖÖ ÖÖÖ 
tCh Stroke + 
Controla 
ÖÖ XX XX ÖÖ ÖÖ ÖX 
 Moderation  X X X X X X 
 Strokeb XXÖ$ XX XXX XXX XXX XXX 
tCr Stroke + 
Controla 
ÖÖ ÖÖ XX ÖÖ ÖÖ ÖÖ$ 
 Moderation  X X X X X X 
 Strokeb XÖ$Ö ÖÖÖ XXX ÖÖ$ XXX XXX 
Notes. Stroke + Controla . The significance reported in combined analysis of the stroke and control groups 
(i) the reliability of correlation between the hippocampus pathology measure and the cognitive domain 
(first mark),  and (ii) whether the relations remain reliable after controlling for age, stroke condition, and 
scanner upgrade (second mark). Moderation effect reports whether the addition of the stroke-by-
hippocampus moderation predictor improved the model. Strokeb. The significance reported in the stroke 
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only tests, (i) the correlation cognition and hippocampus measure (first mark), (ii) the significance of the 
relations after controlling for age and scanner upgrade (middle mark), (ii) the significance after 
controlling for clinical-demographic variables. Ö, p < .05; Ö$, p < .1; X p > .1 n.s. MD= mean diffusivity. 
GM=Grey matter. 
 
We did not find significant differences between stroke patients, and controls in 
hippocampal volume as reported in the literature (Brodtmann et al., 2012; Tang et al., 
2012). However others have also struggled to find these differences three to six months 
after the ischemic event (Sachdev et al., 2007). It could be possible that it is too early in 
the post-stroke trajectory to observe hippocampal changes, with some reporting changes 
at 12 months, and three years’ post-stroke (Ross et al., 2006). The data did not suggest 
that stroke ignited hippocampal volume loss within three months of stroke.  
Hippocampus volume predicted cognition in the combined, and the stroke group alone. 
Stroke condition did not moderate the relations between hippocampus volume and 
cognition. It could be that sub-clinical hippocampus pathology, and cognitive deficiency 
were present in some stroke patients before the ischemic event (Yang et al., 2015). This 
supports the idea that pre-stroke brain health (including hippocampal pathology), 
specifically vascular pathology contributes to cognitive ability, and preservation of 
cognition following stroke (Debette et al., 2011).  
Significant correlations between vascular risk, and grey matter volume of left and right 
hippocampi were found in the stroke patients. Hippocampus volume also correlated 
with other measures of brain health, such as level of atrophy, and small vessel disease. 
Similar to previous studies, overall brain health caused by vascular disease impacted 
cognition in this stroke cohort, furthermore the current cohort had significantly overall 
lower brain health (small vessel disease and regional atrophy) than the healthy controls 
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(Hennerici, 2009; Lawrence et al., 2013; Leys et al., 2005). This suggests that in some 
stroke individuals the hippocampus is vulnerable, due to low vascular and general brain 
health pre-dating the stroke. Though in the current study hippocampus pathology 
predicted cognition, beyond other measures of brain health and clinical and 
demographics.  
Stroke incidences may accelerate the damage, and in turn affect cognition (Werden et 
al., 2017), though we did not find evidence for an acceleration hippocampus pathology 
following stroke within three months. The relation between hippocampus volume, and 
cognition were similar for the control and the stroke group.   
A similar but less reliable relation was found between hippocampal mean diffusivity 
and cognition, in comparison to the predictive hippocampal grey matter volume. This is 
contrary to previous literature that reported mean diffusivity to be more predictive of 
cognitive ability than hippocampal grey matter volume (Carlesimo et al., 2010; den 
Heijer et al., 2012; Kliper et al., 2016). Although there have been studies that show no 
difference in cognition, in those with high mean diffusivity compared to low 
(Schaapsmeerders et al., 2015). The internal validity analysis showed an expected 
pattern, with left and right hippocampal mean diffusivity correlating with each other, 
and mean diffusivity was negatively associated within tNAA. This suggests that lack of 
reliable effects is unlikely to be driven by poor data quality. 
There was no significant difference in mean diffusivity between stroke patients and 
control participants. Left and right hippocampal mean diffusivity predicted only number 
abilities and general cognition. These relations were not moderated by stroke. We did 
not observe effects of mean diffusivity on memory as reported before (Hosseini et al., 
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2017). It is difficult to account for this discrepancy. It is possible that the current study 
lacked the power to detect the findings of previous studies.  
Finally, all three metabolites (tNAA, tCr and tCh) predicted cognition with the most 
reliable effects observed for tNAA. Like the other hippocampal pathology measures, 
stroke did not reliably affect hippocampus pathology; neither did it affect the relations 
between hippocampus pathology and cognition. There is relatively limited literature in 
the area of stroke and spectroscopy, although decreased NAA in the hippocampus has 
been found in those with cognitive impairment following stroke (Wang, 2017), and a 
decrease in hippocampal NAA/Cr ratio was reported for chronic stroke relative to 
controls (Tang et al., 2012).  
Despite the lack of significant difference between stroke and control participants, the 
pattern of metabolite rate in tNAA for both cohorts, fits with previous literature 
examining cognitive impairment and dementia; with lower tNAA in people with poorer 
brain health, and lower cognition. The literature is less consistent with respect to Cr and 
Ch as biomarkers for pathology. The positive correlation of tCr and tCh, with tNAA, 
and the positive correlation of tCh with grey matter volume in the right hippocampus 
give some validation in the measures of these two metabolites. Like the tNAA, tCh and 
tCr showed positive relation with cognition, primarily when considering the two groups 
combined. The current data suggests that a decrease in Cr and Ch concentration in the 
hippocampus may mark malfunctioning of the hippocampus in the stroke and ageing 
population. 
As previously mentioned, in the current chapter, the relation between hippocampus 
pathology, and cognition was not reliably different between the stroke and the control 
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group. Weak trends for moderation effects were observed for number abilities, when 
considering right hippocampal volume, and left hippocampal mean diffusivity. These 
trends can also be seen in the plots of general cognition and the hippocampal pathology 
measures (Figure 15, Figure 16, Figure 17). We see that hippocampal pathology appears 
to be a better prediction of cognition in stroke, than controls. Hence it is possible that 
following stroke, hippocampus health can serve as a protective factor against cognitive 
impairment caused by stroke. In the current cohort, education correlated with grey 
matter volume of the hippocampus. It could be possible, mechanism that protects 
against the impact of stroke on cognition, as described in chapter three, through its 
association with hippocampal pathology.    
4.4.1.1 Findings outside the main research question 
 
Beyond the original research question, we encountered some interesting findings worth 
noting. Although, we should mention that findings outside the main research question 
should be interpreted with caution due to the relatively small sample size and 
heterogeneous sample of stroke patients.  
We observed a correlation between thrombolysis and level of education. The eight 
patients who were thrombolysed, had a higher education level than those that were not 
Although our sample is small, and only 20% of the patients had thrombolysis, our 
findings concur with previous literature that report this relationship (Stecksén et al., 
2014). This finding demonstrates the importance of education. As it is likely that 
educated individuals are more aware of the clinical symptoms of stroke, and the 
potential time constrains associated with various treatments, leading them to seek 
medical advice earlier. This suggests that education may provide two routes of 
improving outcomes and recovery; 1) through direct impact at neuronal level, or 2) 
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simply at a level comprehension of information. In both cases level of education can 
have a positive impact on stroke treatment, and stroke outcomes.  
When examining the stroke group, we find more temporal lobe atrophy compared to the 
control participants. The association of temporal lobe atrophy following stroke and 
neurodegeneration onset is well documented. This is an interesting finding, and fits with 
previous literature. We also find more severe small vessel disease, and lower vascular 
health in this stroke cohort. Again, it is well documented within the stroke population 
that small vessel disease is a prominent feature. The brain health of individuals who had 
stroke was overall lower than those who did not. This again raises the question of 
whether the stroke incident, and its impact on cognition should be viewed in isolation of 
other measures of brain health. While stroke has an abrupt effect on the brain, it may be 
one spike on lifelong trajectory of poor brain health. 
Interestingly, in the stroke group small vessel disease was highly linked to grey matter 
volume in the hippocampus, with higher levels of small vessel disease leading to lower 
grey matter volume in this brain region. This supports a potential common physiological 
cause for both grey matter loss disease (like Alzheimer’s disease), and vascular based 
diseases (small vessel disease).  
Spectroscopy is well documented in terms of measuring abnormal tissue within the 
brain, and it has also been used to examine neurodegeneration. Little research has used 
spectroscopy to measure neurodegeneration in the stroke population. In this chapter we 
find that it may be a reliable measure of post-stroke cognition. It would be interesting to 
examine its predictive value in post-stroke cognitive trajectory, when measuring more 
than one time-point. We observed strong positive correlations between all three 
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metabolites in the stroke cohort, suggesting that in fact they all decrease along with each 
other. As mentioned in (1.5.4.3), tNAA level decreases in neurodegeneration, but the 
reports of tCh and tCr are not as consistent. However, it is suggested that tCh and tCr 
are decreased within brain tissue following an ischemic event, although this relates to 
tissue affected by the ischemia and not a neurodegenerative process.  
As mentioned in the introduction, the hippocampus is mainly associated with memory 
function and learning, although some suggest a wider role of the hippocampus within 
different cognitive functions. In the current analyses, we observe very weak associations 
with memory ability and hippocampal measures, but strong associations with number 
ability. We can only hypothesise why this may have occurred, as number has not been 
documented in the literature as being associated with the hippocampus. The tasks that 
make up the number domain, include writing prices which involve symbols; this could 
be a potential link to the hippocampus. It seems that there is a link between number 
ability and hippocampal pathology, across both control participants and stroke, and 
needs further investigation.  
4.4.1.2 Methodological consideration and limitations 
 
The MRI data presented in the current study was internally valid, which suggests 
evidence of good quality of data. Internal validity was examined by examining the level 
to which the hippocampal pathology measures correlated. We found that that measures 
of homologues regions highly correlate. Furthermore, as expected grey matter volume 
positively correlated with tNAA.  
As discussed in the methods, there are some limitations with the measure of 
spectroscopy in the hippocampus. Low signal to noise ratio meant that we had to 
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exclude the right hippocampus from this measure. Even though the method of 
spectroscopy is continuing to develop, there are known limitations with its reliability 
(Wilson, Andronesi, et al., 2019).  
We accounted for the potential impact of the scanner upgrade in all statistical analyses. 
The upgrade had a weak correlation to one of the MRS measurements, however this did 
not survive Bonferroni corrections. The scanner upgrade interacted with some of the 
cognitive measurements in the regression models, however it is important to note that 
we observe a recruitment bias from before and after the scanner upgrade, with patients 
having more severe cognitive deficits before scanner upgrade. It is also important to 
note that across the hippocampal measurements, they represent slightly different patient 
and control cohorts, due to the difference in numbers in each group (See Page 127). We 
conclude that this is interacting with the scanner upgrade, and it is not due to any 
technical differences with the MRI acquisition. 
The distribution of the data was not normal for almost all measures used, evident by the 
differences observed between the mean and the median. This was true for both the 
stroke patients and the control participants. Abnormal distribution is a violation of the 
assumptions of parametric statistics, leading to potential spurious statistical tests. To 
partly account for this, we computed non-parametric correlations to verify that our 
results are not driven by outliers. Though it is typically considered that for sample size 
above 40 this is of minimal concern (Ghasemi & Zahediasl, 2012). The multiple 
analyses across the same dataset presented in the current chapter is at risk of type 1 
error. We took caution with interpreting statistical results that were weak, due to the 
issues surrounding interpretation of multiple comparisons. In each analysis information 
is provided of whether significance remained after using Bonferroni-Holmes 
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corrections. In the majority of the analyses presented in this chapter, significance 
remained after correcting for multiple comparisons.  
There were lots of clinical and demographic differences observed between the stroke 
patients, and the control participants which were not directly related to the stroke 
incidence. The control participants overall were more educated, with overall good 
health status (lower vascular risk), better brain health (less small vessel disease and 
atrophy), and were pre-dominantly female. Thus, it is difficult to attribute any effects of 
stroke incidence on cognition to the stroke alone. It is therefore interesting that despite 
this recruitment bias (cognitive severity and software upgrade), the relations between 
hippocampal pathology, and cognition were not affected by the stroke condition. 
A subject that is debated when researching cognition is the use of healthy controls. In 
our sample we attempted to recruit controls that were age matched, and considered 
appropriate in terms of health, and lack of cognitive impairment and/or decline. We 
must consider however that within an ageing cohort, there will in turn be ageing 
consequences in health and cognition. Although we excluded cases where this was too 
severe to be considered healthy, we observe that our control group present with similar 
atrophy in the parietal region as the stroke patients.  
The current sample was very heterogeneous (e.g. there was little overlap of lesions, and 
high variability of cognition ability). This was an advantage, as most of the analyses 
relied on variability between individuals (i.e. correlation and regression), but the 
downside of this, was that the data had a large proportion of unexplained variability 
which reduced the overall power of the analysis. The sample size was also fairly small, 
especially in the control group, which again hindered the study power. The lack of 
reliable differences between the groups may have been potentially masked by the high 
205 
 
variability, and the small sample size. Hence, interpretation of null results should be 
made with caution, and they require further investigation.  
4.4.1.3 Conclusion 
 
Hippocampus pathology predicted cognitive outcome, though the relation between 
hippocampus pathology, and cognition were not affected by stroke.   
The data suggests that some stroke patients may be on a linear trajectory of cognitive 
decline. And in these cases, the ischemic incident is one time-point on their trajectory, 
with vascular health, prior cognitive level (education), and brain pathology 
(hippocampal) all contributing to this trajectory. Though importantly, this was not true 
for all patients. Thus, hippocampus pathology may serve as a marker of decline 








This thesis aimed to establish neurocognitive predictors of post-stroke cognitive 
outcome and trajectories, using neuropsychological, demographical, and brain imaging 
data (DTI, 1H-MRS, grey matter volume). Through this investigation, we found that, (a) 
there are three distinct cognitive recovery trajectories that occur following stroke. Most 
stroke patients recovered around 50% of their cognitive deficits at nine months, while a 
small proportion of stroke patients showed a declined or accelerated recovery, (b) 
trajectory of cognitive recovery following stroke can be predicted by modifiable factors 
such as education. Education improved cognition in ageing, and beyond age it improved 
post-stroke cognitive outcomes, and accelerated recovery, and finally (c) beyond stroke 
and age, hippocampal pathology, and overall brain health impacted cognitive ability 
following stroke. Furthermore, hippocampal pathology represented by grey matter 
volume interacted with education and age. This suggests that hippocampus pathology 
may be one contributing factor to cognitive recovery following stroke. We conclude that 
pre-stroke factors modulate cognitive outcomes, and especially the potential for 
recovery post-stroke.
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5.2  Going beyond existing literature 
 
Chapter two examined whether the proportional recovery rule applies for cognition in a 
heterogeneous sample of 380 stroke patients. 
Replication: In line with previous reports of motor recovery (Krakauer, 2006; 
Krakauer, 2015), aphasia (language) (Lazar et al., 2010), neglect (spatial attention) 
(Marchi et al., 2017), and across cognitive domains (Ramsey et al., 2017) we found that 
cognitive recovery after stroke is proportional to the initial deficit.  
We also identify ‘non-fitter’s’ as reported in the motor-recovery literature (Buch et al., 
2016; Shyam et al., 2007), who do not recover as expected, showing a decelerated 
recovery. In the motor recovery literature, the non-fitters, were those who were initially 
severely impaired. In contrast, in this thesis cognition decelerated recovery was 
independent of initial severity, and was observed in patients who initially were mildly 
impaired, as well as in those who were severely impaired.   
Going beyond: We used analysis methods that were not susceptible to mathematical 
coupling, and spurious results (Hope, 2018). We showed that when considering 
performance along a continuum rather than using cut-offs, the proportion of recovery is 
larger (40% vs. 50%). Improvement in cognitive abilities (i.e. a positive recovery 
trajectory) were observed from one month till at least nine months post stroke (previous 
research examined recovery along shorter time scales from three to 90 days (Krakauer 
& Marshall, 2015; Lazar et al., 2010; Ward, 2017). Comparing across domains, 
recovery of language abilities was most variable; with the largest recovery seen for the 
memory and praxis domains. We identified two groups of non-fitters, patients who 
showed accelerated, and decelerated recovery relative to what is expected. This variable 
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pattern in recovery is consistent with subjective self-reports of recovery trajectories 
(Hawkins et al., 2017).  
Future research should aim to replicate the observation of the two non-fitter groups, 
and focus on identifying factors that can predict individual trajectories. Understanding 
the mechanisms that boost, or hinder recovery can potentially lead to improved care 
pathways, and rehabilitation procedures following stroke.  
To understand further why stroke patients, recover at different rates, chapter three 
examined the role of prior cognitive ability, in the form of education level using two 
databases (UK and China)  
Replication: In line with previous literature we showed that beyond age, education 
level predicted general cognitive ability. This is consistent with many previous reports 
(Pinter et al., 2015). We also showed that education improves general cognitive 
outcomes following stroke, as suggested by previous meta-analyses (e.g. (Chaudhari et 
al., 2014; Chen et al., 2016; Elkins et al., 2006; Leys et al., 2005; Parisi et al., 2012; 
Pendlebury, 2009)).  
Going beyond: We showed a similar pattern of results across three versions of the same 
cognitive screen (English-BCoS, mandarin-BCoS, and Cantonese-BCoS). We showed 
that the effect of education on general cognition is most driven by the language and 
numerical domains, stressing a potential direct role of formal education in post-stroke 
recovery. The data suggested that the impact of education on cognition drops (effect 
size, r < .1) at early stages following stroke (around one month), but returns to effect 
sizes seen in ageing (r ~.15-.2) at nine months post stroke. Finally, we showed that 
education accelerated recovery rate following stroke. 
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Future research should aim to examine the neurocognitive mechanisms that mediate 
the impact of education on cognition. This should include measures regarding life-style 
and socio-economic status which are associated with education. 
Finally, we investigated the impact of brain health on post-stroke cognition. We 
specifically focused on the hippocampus, as it is a key brain region involved in 
cognitive decline and ageing (i.e. Alzheimer). We used DTI to establish mean 
diffusivity, T1-weighted imaging to obtain grey matter volume, and 1H-MRS to 
measure metabolites (tNAA, tCh and tCr) in the hippocampus, within three months of 
ischemic stroke (Table 27).  
Replication: In contrast to previous literature (Brodtmann et al., 2012; Haque et al., 
2019; Ross et al., 2006; Tang et al., 2012; Wang, 2017; Yang et al., 2015) we did not 
find differences in hippocampal pathology between stroke patients, and control 
participants (lack of difference was reported before: (Sachdev et al., 2007).  
In line with some previous literature we did find that hippocampus pathology predicted 
general cognition. Replicating effects observed in grey matter volume in aging (Mielke 
et al., 2012; van Uden et al., 2016) and specifically in stroke (Kliper et al., 2016; 
Pohjasvaara et al., 2000; Yang et al., 2015). Similarly mean diffusivity in the 
hippocampus was associated with poorer cognition as reported in ageing studies 
(Carlesimo et al., 2010; den Heijer et al., 2012; Kliper et al., 2016), and specifically in 
stroke (Kliper et al., 2016). The current study replicated the positive association 
between NAA concentrations in the hippocampus and cognition, observed in ageing 
research (e.g. (Kantarci, 2007; Targosz-Gajniak et al., 2013). 
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In contrast to previous literature (e.g. (Hosseini et al., 2017), we did not find robust 
relations between hippocampus pathology and the memory domain. Only the right 
hippocampus volume reliably related to memory abilities in the combined group. 
Going Beyond previous studies, we used advanced neuroimaging methods to 
characterise hippocampus pathology, and added valuable data to sparse literature on 
hippocampus pathology, and cognition following stroke. We used a combination of MR 
measures (local grey matter volume, mean diffusivity, metabolites) to assess 
hippocampus pathology, and provided converging evidence across these various 
methods. We showed that at three months post-stroke, the stroke event did not affect the 
relationship between hippocampus pathology and cognition. This suggests that 
hippocampus pathology should be viewed as an independent contributor to post-stroke 
cognition.  
The data demonstrated that hippocampus pathology, specifically grey matter volume 
correlated with education. The association between general cognition, and hippocampus 
pathology was primarily driven by the number, and then the language domain. These 
observations suggest that hippocampal health may be one mechanism by which 
education reduces cognitive impairment following stroke. 
Future research should aim to replicate the current study with larger sample size. It 
should additionally focus on examining the potential of pre-stroke markers of brain 




5.3  Post-stroke cognitive trajectory  
 
The current thesis suggests that cognitive trajectory is affected by three factors: the 
severity of your cognitive impairment following stroke, your pre-stroke demographic 
status (age and education), and your hippocampal pathology (brain health).   
In the introduction we discuss research that focuses on post-stroke cognitive 
trajectories, and factors that have been found to impact these trajectories. An important 
review by Mijajlović and colleagues suggest that not all patients follow the same 
recovery trajectory (Mijajlović et al., 2017), see Figure 1. In this thesis, we provide 
empirical data that supports the existence of different recovery trajectories. Going 
beyond this, we specifically show three potential cognitive trajectories; improved 
abilities in proportional to initial deficits as expected, accelerated recovery trajectory 
and declined trajectory (see Figure 18). Additionally Mijajlović and colleagues suggest 
that individuals have different cognitive states, and abilities prior to stroke (Mijajlović 
et al., 2017). Data provided in chapter three and four, supports this statement, showing 
that eductaion and age are associated with cognition in ageing, and also in stroke 
(potentially reflecting pre-stroke cognitive ability). Going beyond the proposed model 
(Figure 1), we showed that cognitive outcomes at one to three months post stroke 
depend on patients pre-stroke demographic (age and education), and brain health 
(hippocampus pathology, small vessel disease, cortical atrophy, vascular risk factors) 
which are indepepndet contributors to the stroke event itself (stroke severity, lesion 
volume). This demonstrates that not all stroke patients begin with the same cognitive 
impairment severity. While initial severity dictates a proportional recovery trajectory for 
majority of patients (80%), chapter two showed that independent of initial severity 10% 
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of pateints fail to recover as expected, and even decline, while some patients who 
initially showed severe cognitive imparments had an accelerated recovery. 
The time scale proposed in the Mijajlović model (Mijajlović et al., 2017), is not fully 
supported by the current data. Specifically, Mijajlović and colleages suggest that 
cognition deficits stabalise, and reach their peak recovery potential at six months. In 
contrast the data in chapter two suggests that all three cognitive trajectories are dynamic 
at least up to nine months post-stroke, and the majority (more than 90% of patients) 
showed improved cognition at nine months compared with baseline ablities. Due to the 
fact that we only measured two time points, we do not know exactly when/whether 
these recovery trajectories will have become stable, but we do know that they were 
present at nine months post-stroke (see Figure 18), and were independent of the baseline 






Figure 18. Proposed cognitive trajectories following stroke.  
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5.4  Post-stroke cognitive trajectory and neurocognitive predictors 
 
How does pre-stroke cognition contribute to post-stroke outcome and recovery? A 
review on stroke and traumatic brain injury suggest that one possibility is through 
cognitive reserve, which is assumed to be boosted by education level (Nunnari et al., 
2014). Cognitive reserve may protect individual’s cognitive impairment following 
stroke. In previous research into vascular cognitive impairment, those with severe MRI 
changes were able to utilise their cognitive reserve (level of education) to protect 
themselves from neuronal damage (Zieren et al., 2013). As documented above, we 
found the protective factor of education on both post stroke cognition, and recovery 
trajectories.  
As with our findings in chapter two, with initial severity not always predicting cognitive 
trajectory, in chapter four, stroke severity measured by the NIHSS did not play an 
important role in predicting cognitive outcomes, previously it has been reported as 
being a significant predictor of outcomes (Chaudhari et al., 2014; Leys et al., 2005). 
Other factors did play a role in predicting cognitive outcomes, such as lesion volume. 
This may relate to the model of cognitive reserve proposed by (Stern, 2012), the larger 
the lesion the more it impacts both brain structure and in turn brain networks (Alstott et 
al., 2009), without the cognitive reserve to bolster the disruption, the impact on 
cognitive outcomes are worse. Additionally, in the measurement of metabolites, age did 
play a role in predicting cognitive outcomes at three months post-stroke alongside 
tNAA and tCr, which was previously documented (Wang, 2017).  
In chapter two, we identify different recovery rates for number and language domains, 
which is also evident in chapter three, where level of education was a strong predictor of 
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language and number cognitive outcomes and ability at nine months post-stroke. In 
chapter four, we see a strong relationship between hippocampal pathology and post-
stroke number abilities. This common theme across all three chapters, demonstrates the 
impact of these predictors on post-stroke cognition, and the potential interaction 
between education and hippocampal pathology.  
As mentioned above, we identified hippocampal pathology as a predictor of post-stroke 
cognition, and this was found beyond the impact of age (Stebbins et al., 2008). We 
further found that small vessel disease, and generalised atrophy in temporal region had 
an impact on post-stroke cognition, demonstrating that overall brain health is an 
important predictor of post-stroke cognition as previously reported (Ebrahim et al., 
1985; Gorelick et al., 2011; Hennerici, 2009; Lawrence et al., 2013; Leys et al., 2005; 
Mijajlović et al., 2017; Mok et al., 2016; Sun et al., 2014; Wolfe et al., 2011).  
Research focusing on post-stroke cognition, and recovery often look to the lesion 
location as a predictor of outcome and trajectory (Chechlacz et al., 2012; Hope et al., 
2013). In the current study, we did not look at lesion location, only lesion side of which 
we found zero predictive value. Looking at the lesion location only restricts us to a 
‘topological’ perspective, when a ‘hodological’ perspective is proposed to be of more 
use, allowing us to examine networks across wide ranging cortical regions, compared to 
cortical areas in isolation (Bartolomeo, 2011; Catani, 2007). This allows us to consider 
the whole brain and unaffected areas as predictors, as we did with the hippocampus. 
With this approach, we were able to establish the predictive value of hippocampal 




5.5   Strengths and limitations 
The strengths of the research presented in this thesis, is that it uses a detailed cognitive 
assessment tool which is validated specifically for stroke. Many research studies 
examining cognitive recovery following stroke use short, and limited cognitive 
assessment tools, not designed specifically for stroke (Lees et al., 2014). We used a 
comprehensive cognitive assessment tool (Humphreys et al., 2012), that provides a 
complete cognitive profile of stroke patients across five key cognitive domains. 
Although due to the depth of the assessment, it can be too cognitively taxing for some, 
and recruitment can be limited to those who are able to complete it (concentration > 35 
minutes). Additionally, there are further potential limitations when collecting large 
cognitive databases, specifically with the consistency of administration of cognitive 
assessments. Despite these databases being administered by healthcare professionals 
who had been centrally trained on the BCoS, there is room for measurement biases in 
the data coming from both administration and scoring of assessments. 
Despite the benefits of detailing cognition across multiple domains, we found that our 
composite domain (general cognition), which is calculated using the scores across all 
five cognitive domains, to be more reliably associated with hippocampal pathology, 
than the five cognitive domains individually. This may suggest that the same approach 
neuropsychological tests take by calculating an overall cognition score, may enable 
stronger associations with brain measures, by accounting for all areas of cognition, 
rather than focusing on specific cognitive abilities. Due to the fact we were not 





This thesis benefited from the large amount of data collected in the BUCS study 
(Bickerton et al., 2015; Humphreys et al., 2012). Not only did this provide large sample 
size to work with (chapter two and three), but it was also was an example of efficient 
use of resources. Although due to the nature of working with pre-existing databases, we 
were limited to asking questions of the available data. We were lacking important 
clinical information about the stroke cohorts presented in chapter two and three. 
Specifically, we did not know about prior cognitive impairment. We report the 
incidence of previous stroke, but we do not know levels of cognitive impairment prior 
to data collected for these studies. In chapter four, stroke patients were recruited with 
known previous stroke, but no previous cognitive impairment or clinically diagnosed 
dementia. However in all three chapters, we do not know exactly their individual 
cognitive trajectories, and any underlying cognitive impairment that we were not made 
aware of (Elliott et al., 2019; Mijajlović et al., 2017).  
As the literature suggests, there are many factors that contribute to cognitive 
trajectories. In chapter two we lack potentially important information that would be 
useful to factor into calculating recovery trajectories. We collected some information 
such as; previous stroke, and some basic information about lesion location, however this 
is relatively limited in terms of individual stroke profiles. It would have been useful to 
know more information such as lesion size, and previous cognitive impairment as a 
result of pervious stroke, or by other pathology. For the categorisation of  previous 
neurological history, which included previous stroke, dementia etc, we relied upon self-
reported information, which is limits our data to information that the patient is aware of. 
Using this self-report approach, we are potentially unaware of  early stages of 
neurodegeneration, which we cannot account for in this dataset. 
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Across all three chapters we did not have information on rehabilitation (formal or 
informal), which is likely to contribute to individual cognitive recovery trajectories 
(Cumming et al., 2012). In chapter two, this limits the degree to which we can conclude 
about proportional recovery in cognition, as we are unable to partial out the effects of 
rehabilitation on the recovery, especially as the two time point measurements were 
taken in the key period where rehabilitation was likely to occur. 
In chapter three we were fortunate to work with a large cross-cultural database; however 
this suffers from similar issues as documented with chapter two in terms of 
interpretation of cognitive assessments, and scoring by healthcare professionals. The 
china database was collected by personnel that were of similar healthcare background to 
the UK, and were trained by the same team as the UK. However, we cannot exclude 
potential differences between healthcare professionals, and  also differences between 
cultures in interpretation of scoring, and execution of assessment. Furthermore, as 
discussed in chapter three, we found that there were significant differences in the 
cognitive abilities within the UK stroke cohort, demonstrating more variable and overall 
more severe cognitive deficits than the two China cohorts. In relation to this, 
conclusions cross -culturally should be taken with caution. Although despite these 
differences, even when we examined the role of education on cognitive outcomes 
following stroke separately across the groups, we see the consistent positive effect of 
education on cognitive outcomes. 
We document that defining controls for neuropsychological, and clinical research is 
difficult, especially when using age matched controls. Inherently ageing processes will 
affect control cohorts, which is evident within this thesis, in chapter three and four. In 
chapter three specifically, we observe the effects of ageing on controls. In this chapter 
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both of the China cohorts demonstrated lower than expected cognition, with up to 30% 
presenting with less than 24 on the C-MoCA, which could be diagnoses as cognitive 
impairment. Furthermore, they scored > 4 std below their own group(s) on the C-BCoS. 
This may be due to the fact some controls would have been from rural communities, 
and less familiar, and practiced at cognitive style testing (in comparison to the UK 
cohort). It could be debated that these participants are not appropriate controls, however 
to exclude them would also lead to excluding a true representation of control 
participants for the Chinese stroke patients. In chapter four, we also observed the reality 
of recruiting, and assessing control participants from the community. We excluded two 
controls due to incidental findings on their imaging (enlarged ventricles, and silent 
stroke), and one demonstrated a lower than expected MoCA score indicating mild 
cognitive impairment. Although we excluded these individuals based on findings, we 
cannot exclude the possibility that other control participants in chapter four may have 
confounding profiles, which was not detected through the assessments we conducted. 
We did observe that the control cohort in chapter four demonstrated similar levels of 
parietal atrophy as the stroke patients. However, as previously stated, we believe that it 
is important to include true control recruits from the community, and exclude only those 
that clearly cannot be included for analyses. 
In chapter two and three, the data represents recruitment with little restrictions on 
inclusivity, which allowed us work with data which represents the heterogeneous nature 
of stroke data, and work with large databases. Furthermore, it gave us the opportunity 
for generalisability to the stroke population. Despite the heterogeneous nature of the 
data, and size of dataset there were biased distribution which led to ceiling/ floor effects 
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in the measurements (for example in chapter two when investigation proportional 
recovery) (Hope et al., 2018).   
The biased distributions in the dataset which caused ceiling/ floor effects may have 
inflated the conclusions of proportional recovery, that were made within this chapter. 
This should be taken into consideration when making conclusions about proportional 
recovery in cognition. 
The exploratory nature of chapter four allowed us to utilise three different MRI 
modalities, in an investigation into post-stroke pathology of the hippocampus. However 
we did encounter issues with some of the MR measurements.’ In chapter four, when 
examining hippocampal pathology we only had one time-point measurement which 
meant we could not specifically comment on cognitive recovery trajectory, but 
cognitive outcomes only (Hurford et al., 2013). Furthermore, we were unable to find 
hippocampal changes relating to stroke incidence, or hippocampal pathology relating to 
cognitive impairment only in the stroke cohort (Sachdev et al., 2007). It is possible that 
our measurement of the hippocampus was to early post-stroke (three months) to detect 
pathological changes, and a later measurement would reveal detectable changes.  
Finally, in chapter four low signal to noise ratio led to exclusion of the right 
hippocampus in the measurement of metabolites. There are known limitations with its 
reliability (Wilson, Andronesi, et al., 2019), with susceptibility to hardware and 
software issues. Furthermore we were unable to replicate previous findings of higher 
hippocampal mean diffusivity in the stroke cohort (Kliper et al., 2016). The 
measurement of a small brain structure such as the hippocampus, near to the ventricles 
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poses issues with specificity of voxel placement and identification, causing noise in the 
data. 
In chapter four the sample size of both the control participants, and stroke patients were 
average for an MRI study in stroke, however due to the nature of the chapter, being in 
the main exploratory, we did enter into the issue of type 1 error due to multiple 
comparisons. We calculated Bonferroni correction for all statistics, which in the 
majority of cases allowed us to conclude that the findings were significant even after 
controlling for multiple comparisons. 
As documented in chapter four, we underwent a scanner upgrade during the data 
acquisition, even though there were some marginal impact on some of the MR measures 
(not surviving multiple comparisons). We concluded that actually, we experienced less 
impact on our analyses from the scanner upgrade itself, and specifically a recruitment 
bias of severity of stroke patients recruited pre and post scanner upgrade.  
Finally, although no stroke patients lesions to the hippocampai, (one patient was 
excluded due to this), we are aware that lesions in the surrounding area in some patients 
may have impacted the MR measurements of observed pathology (e.g hippocampal 
volume). It may be useful in future to have more stringent criteria for recruitment in 
terms of lesion location, to avoid any potential confounds of lesions near to the area of 
measurement (in this case the hippocampus). 
5.6  Future directions 
 
We observed the impact of hippocampal pathology on post-stroke cognition, however 
we were unable to replicate previous findings that found hippocampal pathology to be 
different in stroke patients compared with healthy controls, even in the early stages 
225 
 
post-stroke (three months) (Brodtmann et al., 2012). The hippocampus should be further 
investigated and its predictive value of post-stroke cognitive recovery, we suggest that 
two or more time points should be acquired to sufficiently measure post-stroke 
hippocampal pathological changes, and its impact on post-stroke cognitive recovery.  
Studies examining post-stroke cognitive recovery should look to use a wider range of 
MR measures, such as 1H-MRS. In this thesis, we demonstrate its predictive value in 
post-stroke cognition. It may provide insight into pathological changes at an earlier 
stage than grey matter volume, and able to detect those that are cognitively declining 
following stroke.  
We discovered the strength of education level on cognitive recovery following stroke. 
This provides a window of opportunity for a cost-effective way to impact a modifiable 
risk factor of cognitive decline following stroke, by increasing cognitive reserve 
allowing networks and structure to be more robust when neurological disruption 
(stroke) occurs.  
Now we have a greater understanding of cognitive trajectories following stroke, and the 
factors that may predict recovery, those in high stroke risk groups should be under a 
higher level of monitoring. Examining their modifiable and non-modifiable risk factors, 
their cognition, and brains (health, networks, structure). Not only will this facilitate a 
finer grained understanding of their cognitive trajectories, prior to stroke, but in the 
event of a stroke, this information would be vital to predicting their recovery, and the 
best approach to assist in achieving the best outcomes for them as individuals. The 
monitoring of individuals after stroke is also important. As we showed not all of 
individuals that declined initially had severe stroke symptoms (cognitive deficits). As a 
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result, it may be important to monitor post-stroke individuals, not focused solely on 
their stroke deficits (which may be mild) but to also examine their cognitive and health 
history, which combined could lead them down a cognitive decline trajectory. This 
thesis also demonstrates that those with seemingly ‘good’ health, should also be 
championing for their own monitoring. In chapter four alone, we observed pathological 
findings without cognitive symptoms in healthy controls. Which leads us to suggest that 
future research in stroke, should aim where possible to obtain a control sample that is 
matched on health profile and age, in order to mediate any potential confounding 
variables in the control sample. In clinical trials this is often common practice, but not 
as stringent in observational studies. 
5.6   Conclusions 
The data presented in the current thesis suggested find that not one rule fits all regarding 
post-stroke cognitive recovery trajectories. While the majority recover proportionally to 
their initial deficits, there is a minority who present an accelerated, or declined recovery 
trajectory. Pre-stroke socio-clinical-demographic (age, education, vascular risk), and 
brain health factors (hippocampus health, small vessel disease and cortical atrophy), 
potentially affect pre-stroke cognition, modulating post-stroke cognitive outcomes, and 
recovery rate, beyond the stroke itself. These findings support the hypothesis that brain 
(cognitive) reserve can be utilised to protect the adverse effect of neurological insult 
(stroke). The data suggests that the hippocampus may play an important role in post-
stroke recovery, through its association with education and age. The multiple factors 
demonstrated as contributing to post-stroke cognitive outcomes, suggest that there is not 
one defining factor that determines an individual’s post-stroke cognitive trajectory, but 
a combination. Thus, the heterogeneous nature of stroke, and its varying cognitive 
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outcomes, are due to the different profile each individual present with prior to the 
stroke, and immediately following it. The thesis raises the additional intriguing 
possibility that the stroke can be viewed as a spike (that can often be predicted), along 
an individual cognitive trajectory which is determined by pre-stroke socio-clinical-
demographic factors. In this case post-stroke cognitive trajectory (as measured by 
change rate) would follow the direction of the initial trajectory a person was on. This 
thesis demonstrated the utility of re-analysing large existing databases of observational 
studies, combined with collection of new data in answering questions regarding post-
stroke cognitive outcomes. A question that has been the top priority for research for 
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4.2.1.1 HiPPS-CI Patient Consent form 
PATIENT CONSENT FORM (V4.1, 7th October 2017) 
 
Title of Study: The role of hippocampal pathology in post-stroke cognitive 
impairment  
 
REC ref: 15/WM/0209   
Name of Researchers: Dr A. Hosseini, Prof D. Auer, Dr S. Ispoglou, Dr 
Rotshtein, Dr T. Hayton, Dr V. Sawlani,,Miss R. Laverick, Dr Don Sims, Dr 
Kurdow Nader.    
 
Name of Participant: 
 
Project Identifier – ID    Initials/DOB   
  
 
1. I confirm that I have read and understand the information sheet (Version 
4, 23rd February 2017) for the above study and have had the opportunity 
to ask questions.  
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, and without my medical 
care or legal rights being affected. I understand that should I withdraw 
then the information collected so far cannot be erased and that this 
information may still be used in the project analysis. 
 
3. I understand that relevant sections of my medical notes and data collected 
in the study may be looked at by authorised individuals from the research 
group, regulatory authorities or from the NHS Trust where it is relevant to 
my taking part in this study. I give permission for these individuals to have 
access to these records and to collect, store, analyse and publish 
information obtained from my participation in this study. I understand that 
my personal details will be kept confidential. 
 
4. I agree to take part in the above study. 
 













4.2.1.2 HiPPS-CI Control Consent form 
HEALTHY VOLUNTEER CONSENT FORM 2 (V4, 23rd February 2017) 
 
Title of Study: The role of hippocampal pathology in post-stroke cognitive 
impairment  
 
REC ref: 15/WM/0209   
 
Name of Researchers: Dr A. Hosseini, Prof D. Auer, Dr S. Ispoglou, Dr Rotshtein, Dr 
T. Hayton, Dr V. Sawlani, Miss. R Laverick, Dr Don Sims    
   
 
Name of Participant: 
 
Project Identifier – ID    Initials/DOB   
  
 
1. I confirm that I have read and understand the information sheet  (Version 
6, 23rd February 2017) and MRI general information sheet (Version 2.2, 
November 2011) for the above study and have had the opportunity to ask 
questions. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, and without my medical 
care or legal rights being affected. I understand that should I withdraw 
then the information collected so far cannot be erased and that this 
information may still be used in the project analysis. 
 
3. I understand that I will have memory tests using pen and paper as part of 
this study. I give permission for these individuals to collect, store, analyse 
and publish information obtained from my participation in this study. I 
understand that my personal details will be kept confidential. 
 
 
4. I give permission to retain my anonymised scans for use in future    
research by joining the volunteer panel of the School of Psychology 
(University of Birmingham). 
  





5. I agree to take part in the above study. 
 
 









4.6.1 Demographic and clinical variable correlations for controls 
 1 2 3 4 5 6 7 
1 Age -       
2 Sex .27 -      
3 Education -.19 -.40 -     
4 HADs A .01 .07 .17 -    
5 HADs D .19 .05 .07 .70**a -   
6 Barthel Index .85 .23 -.17 -.77**a -.86**+a -  
7 Vascular Risk .86**++a ,12 -.27 .09 .35 -.26 - 
Notes. N=17. HADs= Hospital Anxiety and Depression scale, A= Anxiety, D=Depression.  
Vascular Risk= Framingham stroke risk score. GM= Grey matter. MD= Mean diffusivity. 
 - Indicates a negative correlation. Parametric correlation = ** p<.001, *p<.050,  
Non-parametric correlation= ++ p<.001, +p<.050. aBonferonni FME 0.5/7=0.07
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4.6.2 Demographic and clinical variable correlations for controls 
 1 2 3 4 5 6 7 
1 Age -       
2 Sex .27 -      
3 Education -.19 -.40 -     
4 HADs A .01 .07 .17 -    
5 HADs D .19 .05 .07 .70**a -   
6 Barthel Index -.05 .23 -.17 -.77**a -.86**+a -  
7 Vascular Risk .86**++a .12 -.27 .09 .35 -.26 - 
 8 Parietal Lobe Atrophy .15 .00 .13 -.05 .06 .07 .08 
 9 Temporal Lobe Atrophy .29 .56*+ -.17 -.11 .05 .10 .31 
10 Small Vessel Disease .59*+ .43 -.12 .07 .05 .14 .23 
11 Left GM Volume .07 .07 .57*+ .02 .04 -.05 .05 
12 Right GM Volume .01 .18 .46 -.13 -.20 .19 -.01 
13 Left MD .07 -.09 -.20 .01 -.15 .15 .04 
14Right MD .02 -.14 -.16 -.00 -.26 .22 -.05 
15 tNAA .19 -.18 .49 .20 .41 -.55* .34 
16 tCh .48*+ -.21 -.08 .17 .45 -.49* .53*++ 
17 tCr .52*++ -.29 .17 .22 .24 .04+ .32 
Notes. GM, N=17, MD, N=15. t=Total, tNAA= Total N-Acetylaspartate, tCho= Total Choline, tCr=Total Creatine, N=17.  
Vascular Risk= Framingham stroke risk score. GM= Grey matter. MD= Mean diffusivity. - Indicates a negative correlation.  
Parametric correlation = ** p<.001, *p<.050, Non-parametric correlation= ++ p<.001, +p<.050. aBonferonni FME 0.5/17=0.02.  
    
4.6.3 Demographic and clinical variable correlations for controls 
 1 2 3 4 5 6 7 8 9 10 11 
1 Intracranial volume -           
2 Parietal lobe atrophy -.15 -          
3 Temporal lobe atrophy .52*+ .00 -         
4 Small Vessel Disease .31 .36 .09 -        
5 Left GM Volume .60*++ -.33 .43 -.21 -       
6 Right GM Volume .67**++a -.27 .40 -.32 .80**++a -      
7 Left MD -.20 -.02 -.74**+a .07 -.55*+ -.28 -     
8 Right MD -.29 .00 -.69**+a .10 -.53*+ -.30 .94**++a -    
9 tNAA .01 -.45 .44 -.26 .10 .08 -.25 -.38 -   
10 tCho .15 .01 .18 .21 .12 .02 -.10 -.17 .35 -  
11 tCr .38 .14 .24 .66** .25 .02 -.12 -.02 -.22 .01 - 
Notes. GM, N=17, MD, N=15. t=Total, tNAA= Total N-Acetylaspartate, tCho= Total Choline, tCr=Total Creatine, N=17.  
GM= Grey matter. MD= Mean diffusivity. - Indicates a negative correlation. Parametric correlation = ** p<.001, *p<.050, Non-parametric correlation= ++ p<.001, 





4.6.4 Demographic and clinical variable correlations for controls 
 1 2 3 4 5 6 
1 Language -      
2 Memory .06 -     
3 Attention and Executive 
Function 
-.03 -.09 -    
4 Number .53* .52* .05 -   
5 Praxis .61**+a .24 .19 .13 -  
6 General .79**++a .47 .34 .73**+a .70**++a - 
Notes. N=17. - Indicates a negative correlation. Parametric correlation = ** p<.001, *p<.050,  












4.6.5 Demographic and clinical variable correlations for controls 
 Language Memory Attention and 
Executive Function 
Number Praxis General 
Age -.29 -.19 -.09 .61**a .20 -.34 
Education .22 .29 .23 .07 .39 .37 
Vascular Risk -.34 -.37 -.07 -.72**a .01 -.49 
Intracranial volume .42 .13 -.17 .04 .77**++a .39 
Parietal lobe atrophy -.03 -.22 .48*+ -.23 .11 .03 
Temporal lobe atrophy .21 -.49*+ .10 -.17 .25 .04 
Small Vessel Disease -.17 -.01 .26 -.18 .24 .01 
Left GM Volume .41+ .11 -.07 .11 .60*+ .39 
Right GM Volume .43+ .13 -.16 .18 .53*+ .37 
Left MD -.22 .20 -.24 -.02 -.38 -.24 
Right MD -.26 .13 -.17 .06 -.50+ -.26 
tNAA -.51* .08 -.14 -.36 -.17 -.42 
tCho -.40 -.14 -.02 -.51* -.13 -.42 
tCr -.08 -.17 .32 -.25 .39 .04 
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Notes. GM, N=17, MD, N=15. t=Total, tNAA= Total N-Acetylaspartate, tCho= Total Choline, tCr=Total Creatine, N=17.  
GM= Grey matter. MD= Mean diffusivity. - Indicates a negative correlation. Parametric correlation = ** p<.001, *p<.050, Non-parametric correlation= ++ p<.001, 
+p<.050. aBonferonni FME 0.5/14=0.03.  
